Sentence,class,file
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1534ance for health care is single insurer.,Non-OADS,/arxiv_data1/oa_pdf/c8/e3/ymj-55-1533.PMC4205692.pdf
Cost-Effectiveness of DESs vs. BMSs in Korea Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1535reduced to 1%.,Non-OADS,/arxiv_data1/oa_pdf/c8/e3/ymj-55-1533.PMC4205692.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1536with DESs than with BMSs in the low-risk CAD and MI  populations.,Non-OADS,/arxiv_data1/oa_pdf/c8/e3/ymj-55-1533.PMC4205692.pdf
Cost-Effectiveness of DESs vs. BMSs in Korea Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1537after four years of follow-up.,Non-OADS,/arxiv_data1/oa_pdf/c8/e3/ymj-55-1533.PMC4205692.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1538thrombosis, in-stent restenosis, target lesion revascularization  and MACE.",Non-OADS,/arxiv_data1/oa_pdf/c8/e3/ymj-55-1533.PMC4205692.pdf
Cost-Effectiveness of DESs vs. BMSs in Korea Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1539The ICER for CAD patients was 387682 KRW associated  with a 1% avoided death rate after six months of follow-up.,Non-OADS,/arxiv_data1/oa_pdf/c8/e3/ymj-55-1533.PMC4205692.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1540of drug-eluting stents.,Non-OADS,/arxiv_data1/oa_pdf/c8/e3/ymj-55-1533.PMC4205692.pdf
Cost-Effectiveness of DESs vs. BMSs in Korea Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1541tients undergoing percutaneous coronary revascularization: results  from the TAXUS-IV Trial.,Non-OADS,/arxiv_data1/oa_pdf/c8/e3/ymj-55-1533.PMC4205692.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1542Comparison of the Efficacy and Safety of Sodium Phosphate  Tablets and Polyethylene Glycol Solution for Bowel Cleansing   in Healthy Korean Adults  Seung-Hwa Lee,1 Duck-Joo Lee,1 Kwang-Min Kim,1 Sang-Wook Seo,1  Joon-Koo Kang,2 Eun-Hye Lee,3 and Dong-Ryul Lee4 1Health Promotion Center, Ajou University School of Medicine, Suwon; 2Department of Gastroenterology, Ajou University School of Medicine, Suwon; 3Department of Anesthesiology, Seoul National University College of Medicine, Seoul; 4Health Promotion Center, Wonkwang University College of Medicine, Gunpo, Korea.",Non-OADS,/arxiv_data1/oa_pdf/a7/e4/ymj-55-1542.PMC4205693.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  Bowel cleansing is generally regarded as time-consuming and unpleas - ant among patients.",Non-OADS,/arxiv_data1/oa_pdf/a7/e4/ymj-55-1542.PMC4205693.pdf
"Key Words:    Sodium phosphate tablet, polyethylene glycol, bowel preparation,  safety, efficacy INTRODUCTION Colonoscopy is accepted as an effective and powerful method for the diagnosis of Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.6.1542 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(6):1542-1555, 2014",Non-OADS,/arxiv_data1/oa_pdf/a7/e4/ymj-55-1542.PMC4205693.pdf
"Efficacy and Safety of Sodium Phosphate Tablets Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1543aforementioned agents.16-19 However, to date, most of these  studies have focused on the bowel cleansing efficacy and  patient compliance; only a few studies have compared the  safety (including laboratory data) of the two regimens, es - pecially tablet-type formulation NaP .",Non-OADS,/arxiv_data1/oa_pdf/a7/e4/ymj-55-1542.PMC4205693.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1544lets taken in the same way on the next morning, 3‒5 hours  prior to colonoscopy).",Non-OADS,/arxiv_data1/oa_pdf/a7/e4/ymj-55-1542.PMC4205693.pdf
"Efficacy and Safety of Sodium Phosphate Tablets Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1545polypectomy according to their size and shape, and then the  specimens were sent for pathological analysis.",Non-OADS,/arxiv_data1/oa_pdf/a7/e4/ymj-55-1542.PMC4205693.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1546deviation, whereas categorical variables were presented as  numbers and percentages.",OADS,/arxiv_data1/oa_pdf/a7/e4/ymj-55-1542.PMC4205693.pdf
"Efficacy and Safety of Sodium Phosphate Tablets Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1547the procedural parameters, such as CIR, CIT, TIIR, TIIT,  WT, TPT, PDR, and ADR, between the two groups.",Non-OADS,/arxiv_data1/oa_pdf/a7/e4/ymj-55-1542.PMC4205693.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 15480.001) (Fig.,Non-OADS,/arxiv_data1/oa_pdf/a7/e4/ymj-55-1542.PMC4205693.pdf
"Efficacy and Safety of Sodium Phosphate Tablets Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1549abdominal pain, and bloating/distension in both groups.",Non-OADS,/arxiv_data1/oa_pdf/a7/e4/ymj-55-1542.PMC4205693.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1550Table 4.,Non-OADS,/arxiv_data1/oa_pdf/a7/e4/ymj-55-1542.PMC4205693.pdf
Efficacy and Safety of Sodium Phosphate Tablets Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1551Table 5.,Non-OADS,/arxiv_data1/oa_pdf/a7/e4/ymj-55-1542.PMC4205693.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1552ration in the NaP group, compared with the PEG group,  there were no serious complications recorded, and these  values returned to their normal levels during follow-up lab - oratory tests at 1 week after the colonoscopy.",Non-OADS,/arxiv_data1/oa_pdf/a7/e4/ymj-55-1542.PMC4205693.pdf
"Efficacy and Safety of Sodium Phosphate Tablets Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1553for the differences in patient-related outcomes, such as tol - erability and preference, between the groups.",Non-OADS,/arxiv_data1/oa_pdf/a7/e4/ymj-55-1542.PMC4205693.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1554tial risks in such patients and situations.,Non-OADS,/arxiv_data1/oa_pdf/a7/e4/ymj-55-1542.PMC4205693.pdf
Efficacy and Safety of Sodium Phosphate Tablets Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1555solution in the preparation of patients for colonoscopy.,Non-OADS,/arxiv_data1/oa_pdf/a7/e4/ymj-55-1542.PMC4205693.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1556Psychological Problems and Clinical Outcomes of Children   with Psychogenic Non-Epileptic Seizures Yoon Young Yi,1 Heung Dong Kim,2 Joon Soo Lee,2 Keun-Ah Cheon,3 and Hoon-Chul Kang2 1Department of Pediatrics, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul; 2Division of Pediatric Neurology, Department of Pediatrics, Pediatric Epilepsy Clinic, Severance Children ’s Hospital,  Epilepsy Research Institute, Yonsei University College of Medicine, Seoul; 3Division of Child and Adolescent Psychiatry, Department of Psychiatry, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/fb/75/ymj-55-1556.PMC4205694.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  Our purpose was to investigate psychological problems and clinical out - comes in children with psychogenic non-epileptic seizures (PNES).",Non-OADS,/arxiv_data1/oa_pdf/fb/75/ymj-55-1556.PMC4205694.pdf
"In many previous studies, clinical outcomes in adults Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.6.1556 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(6):1556-1561, 2014",Non-OADS,/arxiv_data1/oa_pdf/fb/75/ymj-55-1556.PMC4205694.pdf
"Children with Psychogenic Non-Epileptic Seizures Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1557pression, posttraumatic stress disorder, conversion disorder,  anxiety, somatization disorder, or psychosis.",Non-OADS,/arxiv_data1/oa_pdf/fb/75/ymj-55-1556.PMC4205694.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1558stopped having seizures after starting video EEG monitoring  for 6 months until last follow-up.,Non-OADS,/arxiv_data1/oa_pdf/fb/75/ymj-55-1556.PMC4205694.pdf
Children with Psychogenic Non-Epileptic Seizures Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1559and increased the detection rate of PNES.,Non-OADS,/arxiv_data1/oa_pdf/fb/75/ymj-55-1556.PMC4205694.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1560randomized control trial in adults reported that treating co - morbid depression using sertraline achieved a 45% reduc - tion in PNES rate, compared to an 8% increase in the place - bo group.14 The effect of psychopharmacological therapy in  children might not be the same as in adults; some studies  have reported on the usage of psychopharmacological drugs  in children.13,15,16 The patients described in the present study  were treated with psychotherapy or combined psychothera - py and psychopharmacological therapy at the discretion of  the psychiatrists.",Non-OADS,/arxiv_data1/oa_pdf/fb/75/ymj-55-1556.PMC4205694.pdf
Children with Psychogenic Non-Epileptic Seizures Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 15617.,Non-OADS,/arxiv_data1/oa_pdf/fb/75/ymj-55-1556.PMC4205694.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1562Coxsackievirus B Infection Is Highly Related with Missed  Abortion in Korea  Jung Hye Hwang,1 Jeong Wook Kim,1 Ji Young Hwang,2 Kyung Min Lee,2 Hye Min Shim,2  Young Kyung Bae,3 Seung Sam Paik,4 and Hosun Park2 Departments of 1Obstetrics and Gynecology and 4Pathology, College of Medicine, Hanyang University, Seoul; Departments of 2Microbiology and 3Pathology, College of Medicine, Yeungnam University, Daegu, Korea.",Non-OADS,/arxiv_data1/oa_pdf/44/a7/ymj-55-1562.PMC4205695.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  This study investigated the possible relationship between viral infection  and first trimester pregnancy loss.",Non-OADS,/arxiv_data1/oa_pdf/44/a7/ymj-55-1562.PMC4205695.pdf
"1-7 However, clinical outcomes following CVB infection during early gesta - tion are unclear.8,9  The etiology of miscarriage is diverse, but may include maternal age, chromosomal Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.6.1562 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(6):1562-1567, 2014",Non-OADS,/arxiv_data1/oa_pdf/44/a7/ymj-55-1562.PMC4205695.pdf
Coxsackievirus B Infection in Missed Abortion Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1563detection of enteroviruses.,Non-OADS,/arxiv_data1/oa_pdf/44/a7/ymj-55-1562.PMC4205695.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1564ysis.,Non-OADS,/arxiv_data1/oa_pdf/44/a7/ymj-55-1562.PMC4205695.pdf
Coxsackievirus B Infection in Missed Abortion Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1565muscle (Fig.,Non-OADS,/arxiv_data1/oa_pdf/44/a7/ymj-55-1562.PMC4205695.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1566tions, leading to miscarriage.",Non-OADS,/arxiv_data1/oa_pdf/44/a7/ymj-55-1562.PMC4205695.pdf
Coxsackievirus B Infection in Missed Abortion Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 15679.,Non-OADS,/arxiv_data1/oa_pdf/44/a7/ymj-55-1562.PMC4205695.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1568The Modified Glasgow Prognostic Scores as a Predictor in  Diffuse Large B Cell Lymphoma Treated with R-CHOP Regimen Yundeok Kim, Soo Jeong Kim, Dohyu Hwang, Jieun Jang, Shin-Young Hyun, Yu Ri Kim,   Jin Seok Kim, Yoo Hong Min, and June-Won Cheong Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/25/64/ymj-55-1568.PMC4205696.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  The modified Glasgow Prognostic Score (mGPS) consisting of serum  C-reactive protein and albumin levels, shows significant prognostic value in sever - al types of tumors.",Non-OADS,/arxiv_data1/oa_pdf/25/64/ymj-55-1568.PMC4205696.pdf
"3,4 Because the R-CHOP regimen has become the current  standard treatment for patients with DLBCL, the question of whether, and to what  extent, prognostic factors change with novel treatment strategies has been debated.5Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.6.1568 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(6):1568-1575, 2014",Non-OADS,/arxiv_data1/oa_pdf/25/64/ymj-55-1568.PMC4205696.pdf
"Modified Glasgow Prognostic Scores as a Predictor Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1569CRP , albumin levels and IPI group (scored from 0 to 5 by  age >60, stage ≥3, ECOG PS ≥2, LDH higher than upper  limit of normal range and number of extranodal involve - ment ≥2) were collected and incorporated as potential prog - nostic factors in various analyses.",Non-OADS,/arxiv_data1/oa_pdf/25/64/ymj-55-1568.PMC4205696.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1570cant differences.,Non-OADS,/arxiv_data1/oa_pdf/25/64/ymj-55-1568.PMC4205696.pdf
"Modified Glasgow Prognostic Scores as a Predictor Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1571(p<0.001), advanced stage ( p<0.001), elevated LDH ( p=  0.001), baseline ALC <1.0×109/L (p=0.039), and mGPS=2  (p<0.001) significantly influenced CR rate after 3 cycles of  R-CHOP therapy (Table 3).",Non-OADS,/arxiv_data1/oa_pdf/25/64/ymj-55-1568.PMC4205696.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1572Table 3.,Non-OADS,/arxiv_data1/oa_pdf/25/64/ymj-55-1568.PMC4205696.pdf
"Modified Glasgow Prognostic Scores as a Predictor Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1573is not limited to solid tumors but also shapes the biological  characteristics of B-cell lymphoma, including DLBCL.23,24 CRP is a member of the class of acute-phase reactants,  and due to its sensitivity, specificity, and reproducibility in  hospital laboratories, is commonly used to assess the magni - tude of the systemic inflammatory response.",Non-OADS,/arxiv_data1/oa_pdf/25/64/ymj-55-1568.PMC4205696.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1574sponse in predicting survival in patients with primary operable  cancer.,Non-OADS,/arxiv_data1/oa_pdf/25/64/ymj-55-1568.PMC4205696.pdf
Modified Glasgow Prognostic Scores as a Predictor Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 157531.,Non-OADS,/arxiv_data1/oa_pdf/25/64/ymj-55-1568.PMC4205696.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1576At Least One Cyclic Teriparatide Administration Can Be Helpful  to Delay Initial Onset of a New Osteoporotic Vertebral  Compression Fracture Kyung Soo Suk,1 Hwan Mo Lee,1 Seong-Hwan Moon,1 Hee June Kim,1  Hak Sun Kim,1 Jin-Oh Park,1 and Byung Ho Lee2 1Department of Orthopaedic Surgery, Yonsei University College of Medicine, Seoul; 2Department of Orthopaedic Surgery, International St. Mary ’s Hospital, Catholic Kwandong University College of Medicine, Incheon, Korea.",Non-OADS,/arxiv_data1/oa_pdf/a4/42/ymj-55-1576.PMC4205697.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  Teriparatide markedly increases bone formation and strength, while re - ducing the incidence of new-onset osteoporotic vertebral compression fractures  (OVCFs).",Non-OADS,/arxiv_data1/oa_pdf/a4/42/ymj-55-1576.PMC4205697.pdf
"OVCFs are associated with sig - nificantly decreased quality of life and increased mortality in the elderly.1,2 Nowa -Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.6.1576 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(6):1576-1583, 2014",Non-OADS,/arxiv_data1/oa_pdf/a4/42/ymj-55-1576.PMC4205697.pdf
"Teriparatide and Prevention of New OVCFs Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1577teriparatide administration [20 mcg/day, 250 mcg/mL×2.4  mL for 1 pen (28 days duration), Lilly Korea] were collect - ed from electronic medical records.",Non-OADS,/arxiv_data1/oa_pdf/a4/42/ymj-55-1576.PMC4205697.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1578mg/dL of inorganic phosphate (normal range 2.8‒4.5), and  34.15±19.0 ng/mL of 25-OH vitamin D 3.",Non-OADS,/arxiv_data1/oa_pdf/a4/42/ymj-55-1576.PMC4205697.pdf
Teriparatide and Prevention of New OVCFs Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1579group showed an even distribution of initial OVCFs (11  cases) during follow-up.,Non-OADS,/arxiv_data1/oa_pdf/a4/42/ymj-55-1576.PMC4205697.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1580analysis of clinical trials, patients treated with teriparatide  exhibited a reduced incidence of back pain and also an in - creased quality of life relative to patients receiving a place - bo and anti-resorptive drugs.15-17 One major concern with teriparatide is its high price.",Non-OADS,/arxiv_data1/oa_pdf/a4/42/ymj-55-1576.PMC4205697.pdf
Teriparatide and Prevention of New OVCFs Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1581related to previous bisphosphonate medication use.,Non-OADS,/arxiv_data1/oa_pdf/a4/42/ymj-55-1576.PMC4205697.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1582JR, et al.",Non-OADS,/arxiv_data1/oa_pdf/a4/42/ymj-55-1576.PMC4205697.pdf
Teriparatide and Prevention of New OVCFs Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1583after kyphoplasty and factors involved.,Non-OADS,/arxiv_data1/oa_pdf/a4/42/ymj-55-1576.PMC4205697.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1584Effect of Anteromedial Portal Entrance Drilling Angle   during Anterior Cruciate Ligament Reconstruction:   A Three-Dimensional Computer Simulation  Dong Kyu Moon,1 Chul Ho Yoon,2 Jin Seung Park,3 Bun Jung Kang,3  Seong Hee Cho,3 Ho Seung Jo,3 and Sun Chul Hwang3 1Department of Orthopaedic Surgery, Military Hospital, Hongcheon; 2Department of Rehabilitation Medicine and Institute of Health Sciences, School of Medicine,  Gyeongsang National University, Gyeongsang National University Hospital, Jinju; 3Department of Orthopaedic Surgery and Institute of Health Sciences, School of Medicine,  Gyeongsang National University, Gyeongsang National University Hospital, Jinju, Korea.",Non-OADS,/arxiv_data1/oa_pdf/b5/0d/ymj-55-1584.PMC4205698.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  The object of this study was to evaluate entrance angle effects on femoral  tunnel length and cartilage damage during anteromedial portal drilling using three- dimensional computer simulation.",Non-OADS,/arxiv_data1/oa_pdf/b5/0d/ymj-55-1584.PMC4205698.pdf
"Key Words:    Anterior cruciate ligament, femoral tunnel, medial femoral condyle,  computer simulation, anteromedial portal INTRODUCTION The goal of anterior cruciate ligament (ACL) reconstruction is to return normal ki -Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.6.1584 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(6):1584-1591, 2014",Non-OADS,/arxiv_data1/oa_pdf/b5/0d/ymj-55-1584.PMC4205698.pdf
Effect of AM Portal Entrance Drilling Angle Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1585second hypothesis is that high angle in axial plane with  shorter tunnel length represents higher possibility of medial  femoral condyle damage.,Non-OADS,/arxiv_data1/oa_pdf/b5/0d/ymj-55-1584.PMC4205698.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1586distance between Blumensaat’s line and a tangent to the  distal subchondral bone contour of the condyle parallel to  Blumensaat’s line.,Non-OADS,/arxiv_data1/oa_pdf/b5/0d/ymj-55-1584.PMC4205698.pdf
"Effect of AM Portal Entrance Drilling Angle Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1587Distance between the virtual cylinder of the femoral  tunnel and the medial femoral condyle In tunnels drilled at a coronal angle of 45°, an axial angle of  45°, and a sagittal angle of 45°, the distance between the  virtual cylinder of the femoral tunnel and the medial femo - ral condyle was 9.4±2.6 mm.",OADS,/arxiv_data1/oa_pdf/b5/0d/ymj-55-1584.PMC4205698.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1588lengths from a setting of coronal plane angle at 60° and axi - al plane angle at 30°, and a setting of coronal plane angle at  30° and axial plane angle at 60° showed statistically signifi - cant differences compared to other tunnel lengths in differ - ent settings from ours.",Non-OADS,/arxiv_data1/oa_pdf/b5/0d/ymj-55-1584.PMC4205698.pdf
Effect of AM Portal Entrance Drilling Angle Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1589present study might not represent the anatomical features  and dimensions of the femur in patients undergoing ACL  reconstruction.,Non-OADS,/arxiv_data1/oa_pdf/b5/0d/ymj-55-1584.PMC4205698.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1590ment femoral tunnel drilling through anteromedial portal: axial  plane drill angle affects tunnel length.,Non-OADS,/arxiv_data1/oa_pdf/b5/0d/ymj-55-1584.PMC4205698.pdf
Effect of AM Portal Entrance Drilling Angle Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1591cruciate ligament graft: an in vitro study.,Non-OADS,/arxiv_data1/oa_pdf/b5/0d/ymj-55-1584.PMC4205698.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1592Correlation between Femoral Guidewire Position and   Tunnel Communication in Double Bundle Anterior Cruciate  Ligament Reconstruction Sang Hyuk Lee,1 Jun Young Choi,2 Dong Hee Kim,1 Bun Jung Kang,1 Dae Cheol Nam,1  Hong Kwon Yoon,1 and Sun Chul Hwang1 1Department of Orthopaedic Surgery and Institute of Health Sciences, School of Medicine,  Gyeongsang National University, Gyeongsang National University Hospital, Jinju; 2Department of Thoracic and Cardiovascular Surgery and Institute of Health Sciences, School of Medicine,  Gyeongsang National University, Gyeongsang National University Hospital, Jinju, Korea.",Non-OADS,/arxiv_data1/oa_pdf/e4/b7/ymj-55-1592.PMC4205699.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  The object of this study was to determine the shortest possible distances  of antero-medial (AM) and postero-lateral (PL) guide wire tunnel positions re - quired to prevent femoral bone tunnel communication in double-bundle anterior  cruciate ligament (ACL) reconstruction using human cadaver knees.",Non-OADS,/arxiv_data1/oa_pdf/e4/b7/ymj-55-1592.PMC4205699.pdf
"Key Words:    Anterior cruciate ligament, femoral tunnel, double bundle recon - struction  INTRODUCTION The anterior cruciate ligament (ACL) consists of two bundles, the antero-medial Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.6.1592 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(6):1592-1599, 2014",Non-OADS,/arxiv_data1/oa_pdf/e4/b7/ymj-55-1592.PMC4205699.pdf
Correlation between Femoral Guidewire Position in DB-ACL Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1593struction.,Non-OADS,/arxiv_data1/oa_pdf/e4/b7/ymj-55-1592.PMC4205699.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1594the double bundles was based on an angle of 45° in the axi - al plane.,Non-OADS,/arxiv_data1/oa_pdf/e4/b7/ymj-55-1592.PMC4205699.pdf
Correlation between Femoral Guidewire Position in DB-ACL Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1595the mid-portions of AM and PL femoral bone tunnels with - out communication was 4.45±2.29 mm (range: 4.87‒7.17  mm).,OADS,/arxiv_data1/oa_pdf/e4/b7/ymj-55-1592.PMC4205699.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1596during normal knee range of motion, and that the presence  of the PL bundle can restore normal knee rotation more  readily.14,15 However, DB-ACL reconstruction technique is  technically more demanding and more prone to complica - tions for inexperienced surgeon.",Non-OADS,/arxiv_data1/oa_pdf/e4/b7/ymj-55-1592.PMC4205699.pdf
Correlation between Femoral Guidewire Position in DB-ACL Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1597cal outcomes and strategies of surgical treatments.,Non-OADS,/arxiv_data1/oa_pdf/e4/b7/ymj-55-1592.PMC4205699.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1598observe tunnel communication, and measure distances more  precisely.",OADS,/arxiv_data1/oa_pdf/e4/b7/ymj-55-1592.PMC4205699.pdf
Correlation between Femoral Guidewire Position in DB-ACL Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1599impact of bridge width and different fixation techniques on the  structural properties of the graft/femur complex.,Non-OADS,/arxiv_data1/oa_pdf/e4/b7/ymj-55-1592.PMC4205699.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1600Increase of TRPV1-Immunoreactivity in Dorsal Root Ganglia  Neurons Innervating the Femur in a Rat Model of Osteoporosis Kensuke Yoshino, Miyako Suzuki, Yuya Kawarai, Yoshihiro Sakuma, Gen Inoue, Sumihisa Orita,  Kazuyo Yamauchi, Yasuchika Aoki, Tetsuhiro Ishikawa, Masayuki Miyagi, Hiroto Kamoda,   Gou Kubota, Yasuhiro Oikawa, Kazuhide Inage, Takeshi Sainoh, Jun Sato, Junichi Nakamura,   Tomoaki Toyone, Kazuhisa Takahashi, and Seiji Ohtori Department of Orthopaedic Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.",Non-OADS,/arxiv_data1/oa_pdf/80/cd/ymj-55-1600.PMC4205700.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  Transient receptor potential vanilloid 1 (TRPV1) is a ligand-gated nonse - lective cation channel, which can be activated by capsaicin and other noxious stim - uli.",Non-OADS,/arxiv_data1/oa_pdf/80/cd/ymj-55-1600.PMC4205700.pdf
"Elderly patients with thoracic and lumbar vertebral fractures caused by os -Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.6.1600 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(6):1600-1605, 2014",Non-OADS,/arxiv_data1/oa_pdf/80/cd/ymj-55-1600.PMC4205700.pdf
TRPV1-Immunoreactive DRG Neurons Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1601MATERIALS AND METHODS Osteoporosis model All rats were housed in a vivarium at 21°C on a 12 h light/ dark cycle (08:30‒20:30) and allowed access to food pellets  and to tap water ad libitum.,Non-OADS,/arxiv_data1/oa_pdf/80/cd/ymj-55-1600.PMC4205700.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1602FG-labeled DRG neurons innervating the left femur FG-labeled DRG neurons, indicating where FG was trans - ported from the femur, were present in DRG from L1 through  L6 (Figs.",Non-OADS,/arxiv_data1/oa_pdf/80/cd/ymj-55-1600.PMC4205700.pdf
TRPV1-Immunoreactive DRG Neurons Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1603 Fig.,Non-OADS,/arxiv_data1/oa_pdf/80/cd/ymj-55-1600.PMC4205700.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1604to evoke heat hyperalgesia in vivo  and sensitize nociceptive  nerve fibers to heat in vitro .21 TNF-α enhances the expres - sion of the nociceptor-specific heat transducer TRPV1,21 and  it enhances functional thermal and chemical responses of  TRPV1 channels in human synoviocytes.22 The density of  TRPV1-positive nerve fibers is higher in ovaries from wom - en with complaints of pain from endometriosis than in ova - ries from control patients.23 TRPV1 expression was found to  be elevated significantly when stimulated with inflammatory  mediators such as prostaglandin E2 and TNF-α.23 This sug - gests that inducers of pain such as cytokines and TRPV1  may contribute to pain transmission in osteoporosis.",Non-OADS,/arxiv_data1/oa_pdf/80/cd/ymj-55-1600.PMC4205700.pdf
TRPV1-Immunoreactive DRG Neurons Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1605Joint Surg Br 1997;79:147-53.,Non-OADS,/arxiv_data1/oa_pdf/80/cd/ymj-55-1600.PMC4205700.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1606Feasibility of the Short Hospital Stays after Laparoscopic  Appendectomy for Uncomplicated Appendicitis  Jong Min Lee,1 Ji Young Jang,2 Seung Hwan Lee,1 Hongjin Shim,2 and Jae Gil Lee1   1Department of Surgery, Yonsei University College of Medicine, Seoul; 2Department of Surgery, Yonsei University Wonju College of Medicine, Wonju, Korea.",Non-OADS,/arxiv_data1/oa_pdf/0f/ff/ymj-55-1606.PMC4205701.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  The aim of this study was to evaluate the feasibility of short hospital stays  after laparoscopic appendectomy for uncomplicated appendicitis.",Non-OADS,/arxiv_data1/oa_pdf/0f/ff/ymj-55-1606.PMC4205701.pdf
"Recently, many efforts have been made to reduce hospital costs, and the topic of shortening hospital stay after appendectomy has attracted some interest, espe - cially in the context of one-day surgery, 1-4 because hospital stays after appendecto - my usually exceed 3 days.5-9 The reports issued on this topic have cited hospital  stays of from 2.2 to 6 days after uncomplicated appendectomy.6-11  With regard to reducing costs, non-operative management has been tried and re - ported to be both safe and feasible for uncomplicated appendicitis.12 However, sur -Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.6.1606 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(6):1606-1610, 2014",Non-OADS,/arxiv_data1/oa_pdf/0f/ff/ymj-55-1606.PMC4205701.pdf
"Hospital Stays after Laparoscopic Appendectomy Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1607length of hospital stay, types of antibiotics used, and the re - lation between complication occurrence and duration of an - tibiotic use.",Non-OADS,/arxiv_data1/oa_pdf/0f/ff/ymj-55-1606.PMC4205701.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1608stays than open surgery.,Non-OADS,/arxiv_data1/oa_pdf/0f/ff/ymj-55-1606.PMC4205701.pdf
"Hospital Stays after Laparoscopic Appendectomy Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1609significant difference was observed between patients pre - scribed or not prescribed oral antibiotics with respect to  complication rate ( p=0.654), suggesting that long-term anti - biotic treatment might be unnecessary in preventing post- operative complications.",Non-OADS,/arxiv_data1/oa_pdf/0f/ff/ymj-55-1606.PMC4205701.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 161015.,Non-OADS,/arxiv_data1/oa_pdf/0f/ff/ymj-55-1606.PMC4205701.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1611Underweight Body Mass Index as a Predictive Factor for Surgical  Site Infections after Laparoscopic Appendectomy Mina Cho, Jeonghyun Kang, Im-kyung Kim, Kang Young Lee, and Seung-Kook Sohn Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/ce/d5/ymj-55-1611.PMC4205702.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  Analyses of risk factors associated with surgical site infections (SSIs) af - ter laparoscopic appendectomy (LA) have been limited.",Non-OADS,/arxiv_data1/oa_pdf/ce/d5/ymj-55-1611.PMC4205702.pdf
"1  SSIs are the third most frequently reported nosocomial infections, accounting for  14‒16% of such infections among hospitalized patients and 38% of such infec - tions among surgical patients.1,2 SSIs are associated with a prolonged length of  hospital stay and higher costs.3  Acute appendicitis is a common cause of emergency operations,4 for which lap - aroscopic appendectomy (LA) is being increasingly applied.5 LA provides several Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.6.1611 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(6):1611-1616, 2014",Non-OADS,/arxiv_data1/oa_pdf/ce/d5/ymj-55-1611.PMC4205702.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1612lower abdomen and suprapubic area) was performed for all  enrolled patients.,Non-OADS,/arxiv_data1/oa_pdf/ce/d5/ymj-55-1611.PMC4205702.pdf
Underweight and SSIs after Laparoscopic Appendectomy Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1613BMI were associated with SSIs (Table 2).,Non-OADS,/arxiv_data1/oa_pdf/ce/d5/ymj-55-1611.PMC4205702.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1614an interesting result because a higher rate of SSIs among  obese patients is a well-established finding.12 Due to the  character of Asian populations, our study did not have  enough patients with a BMI of 30 kg/m2 or more, which  may have resulted in selection bias.",Non-OADS,/arxiv_data1/oa_pdf/ce/d5/ymj-55-1611.PMC4205702.pdf
"Underweight and SSIs after Laparoscopic Appendectomy Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1615changes the defense system and its function against infec - tion.30,31 Oh, et al.32 demonstrated that immediate postopera - tive malnutrition status as measured by the nutrition risk index  was correlated with wound complications after gastrectomy.",Non-OADS,/arxiv_data1/oa_pdf/ce/d5/ymj-55-1611.PMC4205702.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 161618.,Non-OADS,/arxiv_data1/oa_pdf/ce/d5/ymj-55-1611.PMC4205702.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1617Problems Associated with Alloplastic Materials in Rhinoplasty Hyun-Soo Kim,1 Su-Sung Park,2 Myung-Hoon Kim,3 Min-Su Kim,3  Seok-Kwun Kim,3 and Keun-Cheol Lee3 1Nose Aesthetic Plastic Surgery Clinic, Busan;  2I & Co Aesthetic Plastic Surgery Clinic, Busan;                   3Department of Plastic and Reconstructive Surgery, Dong-A University School of Medicine, Busan, Korea.",Non-OADS,/arxiv_data1/oa_pdf/5b/cd/ymj-55-1617.PMC4205703.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  Augmentation rhinoplasty using alloplastic materials is a relatively com - mon procedure among Asians.",Non-OADS,/arxiv_data1/oa_pdf/5b/cd/ymj-55-1617.PMC4205703.pdf
"Many materials had been introduced based Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.6.1617 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(6):1617-1623, 2014",Non-OADS,/arxiv_data1/oa_pdf/5b/cd/ymj-55-1617.PMC4205703.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1618plant; 183, Gore-tex®; and 22, Medpor®; 122 (Table 1).",Non-OADS,/arxiv_data1/oa_pdf/5b/cd/ymj-55-1617.PMC4205703.pdf
"Problems Associated with Alloplastic Materials in Rhinoplasty Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1619cification, have been reported at certain rates with the issues  arising from fibrous, calcified capsules.",Non-OADS,/arxiv_data1/oa_pdf/5b/cd/ymj-55-1617.PMC4205703.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1620 Fig.,Non-OADS,/arxiv_data1/oa_pdf/5b/cd/ymj-55-1617.PMC4205703.pdf
"Problems Associated with Alloplastic Materials in Rhinoplasty Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1621solidly to lateral lower cartilage and septal cartilage that its  removal was very difficult, and pHDPE was found to no  longer function as a strong support structure.",Non-OADS,/arxiv_data1/oa_pdf/5b/cd/ymj-55-1617.PMC4205703.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1622noplasty.,Non-OADS,/arxiv_data1/oa_pdf/5b/cd/ymj-55-1617.PMC4205703.pdf
Problems Associated with Alloplastic Materials in Rhinoplasty Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1623els and comparative analysis of activated and inactivated groups.,Non-OADS,/arxiv_data1/oa_pdf/5b/cd/ymj-55-1617.PMC4205703.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1624Modeling of Recovery Profiles in Mentally Disabled and   Intact Patients after Sevoflurane Anesthesia;   A Pharmacodynamic Analysis Teo Jeon Shin,1 Gyu-Jeong Noh,2 Yong-Seo Koo,3 and Dong Woo Han4 1Department of Pediatric Dentistry and Dental Research Institute, School of Dentistry, Seoul National University, Seoul; 2Department of Clinical Pharmacology and Therapeutics/Anesthesiology and Pain Medicine,  Asan Medical Center, University of Ulsan College of Medicine, Seoul; 3Department of Neurology, Korea University College of Medicine, Seoul; 4Department of Anesthesiology and Pain Medicine and Anesthesia and Pain Research Institute,  Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/f0/b9/ymj-55-1624.PMC4205704.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  Mentally disabled patients show different recovery profiles compared to  normal patients after general anesthesia.",Non-OADS,/arxiv_data1/oa_pdf/f0/b9/ymj-55-1624.PMC4205704.pdf
"1 Recently, ambulatory anesthesia has been increasingly  used to tailor the need of rapid discharge after an outpatient’s procedure which is Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.6.1624 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(6):1624-1630, 2014",Non-OADS,/arxiv_data1/oa_pdf/f0/b9/ymj-55-1624.PMC4205704.pdf
Recovery Profiles in Mentally Disabled Patients Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1625ered stop crying as a behavior of LOC during sevoflurane  administration.,Non-OADS,/arxiv_data1/oa_pdf/f0/b9/ymj-55-1624.PMC4205704.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1626OFV calculated from the randomization test and the origi - nal OFV was more than 3.84.,OADS,/arxiv_data1/oa_pdf/f0/b9/ymj-55-1624.PMC4205704.pdf
"A non-parametric bootstrap proce - dure was performed for internal validation using Perl- speaks-NONMEM (PsN) (version 3.6.2, http://psn.source - forge.net).",OADS,/arxiv_data1/oa_pdf/f0/b9/ymj-55-1624.PMC4205704.pdf
"Also we performed a randomization test to test  whether the selected covariate is a significant one using  Wings for NONMEM (version 7.2, http://wfn.source - fourge.net).",OADS,/arxiv_data1/oa_pdf/f0/b9/ymj-55-1624.PMC4205704.pdf
Recovery Profiles in Mentally Disabled Patients Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1627The C 50 for ROC in this study is equivalent to MAC- awake value previously reported.,Non-OADS,/arxiv_data1/oa_pdf/f0/b9/ymj-55-1624.PMC4205704.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1628eral anesthesia.,Non-OADS,/arxiv_data1/oa_pdf/f0/b9/ymj-55-1624.PMC4205704.pdf
Recovery Profiles in Mentally Disabled Patients Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1629th Analg 1993;76:348-52.,Non-OADS,/arxiv_data1/oa_pdf/f0/b9/ymj-55-1624.PMC4205704.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1630$COV ARIANCE PRINT=E $TABLE ID ETA(1) ETA(2)         FILE=20009.ETA NOPRINT ONEHEADER FIRSTONL Y NOAPPEND $TABLE ID CE50 GAM         FILE=20009.PAR NOPRINT ONEHEADER NOAPPEND $TABLE ID DOSE R PROB Y IPRED IRES RES IWRES         FILE=sdtab20009 NOPRINT ONEHEADER  $TABLE ID CE50 GAM ETA(1) ETA(2)         FILE=patab20009 NOPRINT ONEHEADER NOAPPEND,Non-OADS,/arxiv_data1/oa_pdf/f0/b9/ymj-55-1624.PMC4205704.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1631Epidural Dexamethasone Decreased Inflammatory Hyperalgesia  and Spinal cPLA 2 Expression in a Rat Formalin Test Sam-Hong Min, Jung-Sub Soh, Ji-Yong Park, Sung-Uk Choi, Hye-Won Lee,   Jae-Jin Lee, and Jae-Hwan Kim Department of Anesthesiology and Pain Medicine, Korea University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/ae/78/ymj-55-1631.PMC4205705.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  The aim of this study was to investigate the effect of epidural dexametha - sone on analgesia and cytosolic phospholipase A 2 (cPLA 2) expression in the spinal  cord in a rat formalin test.",Non-OADS,/arxiv_data1/oa_pdf/ae/78/ymj-55-1631.PMC4205705.pdf
"Tissue injury and inflammation cause activation of cytosolic phospholipase A 2  (cPLA 2) which yields the release of arachidonic acids from intracellular membrane  phospholipids.2 The released arachidonic acids are processed by cyclooxygenase  to generate eicosanoids including prostaglandins, thromboxanes, prostacyclins, and Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.6.1631 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(6):1631-1639, 2014",Non-OADS,/arxiv_data1/oa_pdf/ae/78/ymj-55-1631.PMC4205705.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1632in Korea University (Approval No.,Non-OADS,/arxiv_data1/oa_pdf/ae/78/ymj-55-1631.PMC4205705.pdf
Epidural Dexamethasone in a Rat Formalin Test Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1633acryl box and was observed for pain behaviors.,Non-OADS,/arxiv_data1/oa_pdf/ae/78/ymj-55-1631.PMC4205705.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1634game, CA, USA)/0.3% Triton X-100/PBS, and followed by  an additional PBS rinse.",Non-OADS,/arxiv_data1/oa_pdf/ae/78/ymj-55-1631.PMC4205705.pdf
"Epidural Dexamethasone in a Rat Formalin Test Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1635laminae I‒II were similar to that of naive group; however,  the cPLA 2 expressions in the laminar III‒IV and V‒VI  were similar to that of control group (Fig.",Non-OADS,/arxiv_data1/oa_pdf/ae/78/ymj-55-1631.PMC4205705.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1636dexamethasone inhibited cPLA 2 expression in the laminae  I‒II of the spinal cord.,Non-OADS,/arxiv_data1/oa_pdf/ae/78/ymj-55-1631.PMC4205705.pdf
"Epidural Dexamethasone in a Rat Formalin Test Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1637glandin E 2 release, and group IV A cPLA 2 expression in the  spinal cord.9,28 Annexin A1 has been reported that modulat - ing nociceptive processing at the spinal level, by reducing  synthesis of prostaglandin E 2 by modulating cPLA 2 in a  mouse.10 This annexin A1 is the second messenger that me - diates the anti-inflammatory actions of dexamethasone.29  These reports are consistent with our results that the inhibi - tion of cPLA 2 in the spinal cord with epidural dexametha - sone was accompanied by a decrease in peripheral inflam - matory tissue injury induced hyperalgesia.",Non-OADS,/arxiv_data1/oa_pdf/ae/78/ymj-55-1631.PMC4205705.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 16384.,Non-OADS,/arxiv_data1/oa_pdf/ae/78/ymj-55-1631.PMC4205705.pdf
Epidural Dexamethasone in a Rat Formalin Test Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 163929.,Non-OADS,/arxiv_data1/oa_pdf/ae/78/ymj-55-1631.PMC4205705.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1640Nonthermal Plasma Induces Apoptosis in ATC Cells:  Involvement of JNK and p38 MAPK-Dependent ROS Sei Young Lee,1 Sung Un Kang,2 Kang Il Kim,3 Sam Kang,2 Yoo Seob Shin,2 Jae Won Chang,2  Sang Sik Yang,3 Keunho Lee,4 Jong-Soo Lee,5 Eunpyo Moon,5 and Chul-Ho Kim2 1Department of Otolaryngology-Head and Neck Surgery, Chung-Ang University College of Medicine, Seoul; 2Department of Otolaryngology, School of Medicine, Ajou University, Suwon; 3Department of Electrical and Computer Engineering, Ajou University, Suwon, Korea; 4PSM America Inc., Colorado Springs, CO, USA;  5Department of Molecular Science and Technology and Life Science, Ajou University, Suwon, Korea.",Non-OADS,/arxiv_data1/oa_pdf/9c/38/ymj-55-1640.PMC4205706.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  To determine the effects of nonthermal plasma (NTP) induced by heli - um (He) alone or He plus oxygen (O 2) on the generation of reactive oxygen spe - cies (ROS) and cell death in anaplastic thyroid cancer cells.",Non-OADS,/arxiv_data1/oa_pdf/9c/38/ymj-55-1640.PMC4205706.pdf
"Key Words:    Nonthermal plasma, ROS, anaplastic thyroid cancer, apoptosis, heli - um, oxygen INTRODUCTION The incidence of thyroid cancer, the most common endocrine malignancy and one Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.6.1640 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(6):1640-1647, 2014",Non-OADS,/arxiv_data1/oa_pdf/9c/38/ymj-55-1640.PMC4205706.pdf
Apoptotic Effect of ROS Generated by Plasma Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1641MATERIALS AND METHODS Experimental system specification and optical emission  spectroscopy The technical specifications of the “torch with spray type”  nonthermal plasma system are schematically presented in  Fig.,Non-OADS,/arxiv_data1/oa_pdf/9c/38/ymj-55-1640.PMC4205706.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1642Western blot Cells were lysed in lysis buffer containing 150 mM NaCl,  1.0% NP40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM  Tris (pH 8.0), and protease inhibitor cocktail (Roche) as pre - viously described.13 The following antibodies were used: an - ti-phospho-JNK, -phopho-p38, -phopho-ERK, -cleaved cas - pase-3, and -α-tubulin (Cell Signaling Technology, Danvers,  MA, USA, 1:1000) for Western blot analysis.",Non-OADS,/arxiv_data1/oa_pdf/9c/38/ymj-55-1640.PMC4205706.pdf
Apoptotic Effect of ROS Generated by Plasma Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 16437 cells; the apoptosis was greater in the He-plus-O 2 plasma  group than in the He-only plasma group.,Non-OADS,/arxiv_data1/oa_pdf/9c/38/ymj-55-1640.PMC4205706.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1644 Fig.,Non-OADS,/arxiv_data1/oa_pdf/9c/38/ymj-55-1640.PMC4205706.pdf
"Apoptotic Effect of ROS Generated by Plasma Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1645cidence of A TC is only 1.7% of all thyroid cancers in the  United States, but the 1-year survival rate is less than 20%.2,3  The most effective treatment of A TC is complete surgical  resection, but many patients with A TC have unresectable  disease when they are initially diagnosed, and only a small  fraction of ATC patients can achieve en bloc resection.14  Accordingly, the effect of conventional combined modality  therapy including surgery, chemotherapy, and radiotherapy  for A TC is very poor.",Non-OADS,/arxiv_data1/oa_pdf/9c/38/ymj-55-1640.PMC4205706.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1646apoptosis induced by plasma is mediated by intracellular  ROS formation (Fig.,Non-OADS,/arxiv_data1/oa_pdf/9c/38/ymj-55-1640.PMC4205706.pdf
Apoptotic Effect of ROS Generated by Plasma Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1647J.,Non-OADS,/arxiv_data1/oa_pdf/9c/38/ymj-55-1640.PMC4205706.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1648Increased Expression of Cathelicidin by Direct Activation   of Protease-Activated Receptor 2: Possible Implications   on the Pathogenesis of Rosacea Ji Young Kim,1* Yoon Jee Kim,1* Beom Jin Lim,2 Hyo Jung Sohn,1  Dongyun Shin,1 and Sang Ho Oh1 1Department of Dermatology, Cutaneous Biology Research Institute, Severance Hospital, Yonsei University College of Medicine, Seoul;  2Department of Pathology, Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/8a/43/ymj-55-1648.PMC4205707.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  Recent findings of increased cathelicidin protein and its proteolytic frag - ments in rosacea suggest a pathogenic role for cathelicidin in this disease.",Non-OADS,/arxiv_data1/oa_pdf/8a/43/ymj-55-1648.PMC4205707.pdf
"Key Words:    Cathelicidin, LL-37, PAR-2, rosacea, VEGF INTRODUCTION Rosacea is a common inflammatory skin disease, most prominent in the central Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.6.1648 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(6):1648-1655, 2014",Non-OADS,/arxiv_data1/oa_pdf/8a/43/ymj-55-1648.PMC4205707.pdf
The Role of Protease-Activated Receptor 2 in Rosacea Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1649MATERIALS AND METHODS Patient samples The Institutional Review Board of Severance Hospital ap - proved this study (No.,Non-OADS,/arxiv_data1/oa_pdf/8a/43/ymj-55-1648.PMC4205707.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1650(threshold cycle) method, where ∆Ct was (target Ct‒GAP - DH Ct), and ∆∆Ct was (∆Ct sample‒∆Ct untreated con - trol).",Non-OADS,/arxiv_data1/oa_pdf/8a/43/ymj-55-1648.PMC4205707.pdf
The Role of Protease-Activated Receptor 2 in Rosacea Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1651treatment with PAR-2 AP (Fig.,Non-OADS,/arxiv_data1/oa_pdf/8a/43/ymj-55-1648.PMC4205707.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1652ciated with Demodex folliculorum  infestation, are suspected  to activate immune responses in patients predisposed to ro -nent vasodilation in the affected skin may explain the persi- stent erythema.19 Microbial agents, notably bacteria asso- Fig.",Non-OADS,/arxiv_data1/oa_pdf/8a/43/ymj-55-1648.PMC4205707.pdf
"The Role of Protease-Activated Receptor 2 in Rosacea Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1653Initially, we found significantly higher cathelicidin expres - sion in rosacea skin tissues than in normal skin, although  PAR-2 expression did not differ significantly between nor - mal skin and rosacea.",Non-OADS,/arxiv_data1/oa_pdf/8a/43/ymj-55-1648.PMC4205707.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1654tissues are needed for such assay.,Non-OADS,/arxiv_data1/oa_pdf/8a/43/ymj-55-1648.PMC4205707.pdf
The Role of Protease-Activated Receptor 2 in Rosacea Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1655dendritic cell differentiation and dendritic cell-induced T cell po - larization.,OADS,/arxiv_data1/oa_pdf/8a/43/ymj-55-1648.PMC4205707.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1656DNA Hypomethylation-Mediated Overexpression   of Carbonic Anhydrase 9 Induces an Aggressive   Phenotype in Ovarian Cancer Cells Hye Youn Sung,1 Woong Ju,2 and Jung-Hyuck Ahn1 Departments of 1Biochemistry and 2Obstetrics and Gynecology, School of Medicine, Ewha Womans University, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/70/b9/ymj-55-1656.PMC4205708.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  Both genetic and epigenetic alterations can lead to abnormal expres - sion of metastasis-regulating genes in tumor cells.",Non-OADS,/arxiv_data1/oa_pdf/70/b9/ymj-55-1656.PMC4205708.pdf
"3 Despite dis - ease-free intervals that may last for months to years after optimal debulking sur - gery and chemotherapy, recurrent OC is inevitable: theoretically, there should be Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.6.1656 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(6):1656-1663, 2014",Non-OADS,/arxiv_data1/oa_pdf/70/b9/ymj-55-1656.PMC4205708.pdf
Epigenetic Regulation of CA9 Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1657no.,Non-OADS,/arxiv_data1/oa_pdf/70/b9/ymj-55-1656.PMC4205708.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1658site), the sites were defined as differentially methylated CpG  sites.",OADS,/arxiv_data1/oa_pdf/70/b9/ymj-55-1656.PMC4205708.pdf
"Epigenetic Regulation of CA9 Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1659a polycarbonate membrane with an 8.0 μm pore size (Corn - ing, New Y ork, USA).",Non-OADS,/arxiv_data1/oa_pdf/70/b9/ymj-55-1656.PMC4205708.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1660 Fig.,Non-OADS,/arxiv_data1/oa_pdf/70/b9/ymj-55-1656.PMC4205708.pdf
Epigenetic Regulation of CA9 Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1661expression was significantly increased in the 5-aza-2’-de - oxycytidine-treated cells (Fig.,Non-OADS,/arxiv_data1/oa_pdf/70/b9/ymj-55-1656.PMC4205708.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1662promote cell motility and invasion by reducing E-cadherin- mediated cell adhesion through interaction with β-catenin.24  Our results also demonstrated that exogenous expression of  CA9 significantly increases the migration and invasion of  SK-OV-3 cells.,OADS,/arxiv_data1/oa_pdf/70/b9/ymj-55-1656.PMC4205708.pdf
"Epigenetic Regulation of CA9 Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1663CC, Gatter KC, et al.",Non-OADS,/arxiv_data1/oa_pdf/70/b9/ymj-55-1656.PMC4205708.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1664ATP-Based Chemotherapy Response Assay in Primary or  Recurrent Ovarian and Peritoneal Cancer Maria Lee,1 Sang Wun Kim,2 Eun Ji Nam,2 Hanbyoul Cho,3 Jae Hoon Kim,3  Young Tae Kim,2 and Sunghoon Kim2 1Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul; 2Institute of Women ’s Life Medical Science, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology,  Yonsei University College of Medicine, Seoul; 3Department of Obstetrics and Gynecology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/c2/5c/ymj-55-1664.PMC4205709.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  To investigate chemosensitivity with an adenosine triphosphate-based  chemotherapy response assay in patients with epithelial ovarian or peritoneal cancer  according to tumor histology, grade, and disease status.",Non-OADS,/arxiv_data1/oa_pdf/c2/5c/ymj-55-1664.PMC4205709.pdf
"Since the development of  the human tumor stem cell assay by Hamburger and Salmon in the 1970s, various Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.6.1664 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(6):1664-1671, 2014",Non-OADS,/arxiv_data1/oa_pdf/c2/5c/ymj-55-1664.PMC4205709.pdf
A TP-Based Chemotherapy Response Assay Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1665mens for the A TP-CRA were removed as part of the normal  treatment procedure.,Non-OADS,/arxiv_data1/oa_pdf/c2/5c/ymj-55-1664.PMC4205709.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1666CI.,Non-OADS,/arxiv_data1/oa_pdf/c2/5c/ymj-55-1664.PMC4205709.pdf
A TP-Based Chemotherapy Response Assay Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1667ma with marginal statistical significance.,Non-OADS,/arxiv_data1/oa_pdf/c2/5c/ymj-55-1664.PMC4205709.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1668platin was higher for recurrent disease (median CI rank: 6)  compared to that of primary disease (median CI rank: 7).,Non-OADS,/arxiv_data1/oa_pdf/c2/5c/ymj-55-1664.PMC4205709.pdf
A TP-Based Chemotherapy Response Assay Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1669recurrent and primary disease.,Non-OADS,/arxiv_data1/oa_pdf/c2/5c/ymj-55-1664.PMC4205709.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1670ing combination may be beneficial as a first-line chemother - apy regimen for primary and recurrent disease.,Non-OADS,/arxiv_data1/oa_pdf/c2/5c/ymj-55-1664.PMC4205709.pdf
A TP-Based Chemotherapy Response Assay Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 167116.,Non-OADS,/arxiv_data1/oa_pdf/c2/5c/ymj-55-1664.PMC4205709.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1672Real Stereopsis Test Using a Three-Dimensional Display   with Tridef Software  Jinu Han,1 So Young Han,1 Seung Koo Lee,2 Jong Bok Lee,1 and Sueng-Han Han1 1Institute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, Seoul; 2Department of Radiology, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/82/e8/ymj-55-1672.PMC4205710.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  To investigate horizontal image disparity in three-dimensional (3-D)  perception using 3-D animations in normal control patients and patients with inter - mittent exotropia, anisometropic amblyopia, and partially accommodative esotro - pia.",Non-OADS,/arxiv_data1/oa_pdf/82/e8/ymj-55-1672.PMC4205710.pdf
"Because stereoacuity is dependent on normal ocular alignment and equal visual acuity by both eyes, stereoacuity tests such as Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.6.1672 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(6):1672-1677, 2014",Non-OADS,/arxiv_data1/oa_pdf/82/e8/ymj-55-1672.PMC4205710.pdf
"Real Stereopsis Using 3-D Animation Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1673viation, 9.99±3.52 years; age range, 4 to 22 years) were  studied, consisting of normal controls and patients with in - termittent exotropia, anisometric amblyopia, and partially  accommodative esotropia.",Non-OADS,/arxiv_data1/oa_pdf/82/e8/ymj-55-1672.PMC4205710.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1674when p-values were less than 0.05.,Non-OADS,/arxiv_data1/oa_pdf/82/e8/ymj-55-1672.PMC4205710.pdf
"Real Stereopsis Using 3-D Animation Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1675stereoacuity was 1.323 log arcsec (95% limits of agree - ment: 0.599 to 2.047), and 124 (93.2%) of the subjects  were within the limits of agreement.",Non-OADS,/arxiv_data1/oa_pdf/82/e8/ymj-55-1672.PMC4205710.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1676fered with the test results would be minimal because the  viewing time was short and the study was conducted at  near distance.,Non-OADS,/arxiv_data1/oa_pdf/82/e8/ymj-55-1672.PMC4205710.pdf
"Real Stereopsis Using 3-D Animation Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1677be a useful tool to detect nil stereopsis in patients with stra - bismus or amblyopia, and could play an important role in  the treatment of strabismus and amblyopia.",Non-OADS,/arxiv_data1/oa_pdf/82/e8/ymj-55-1672.PMC4205710.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1678Meteorological Conditions Related to the Onset of Idiopathic  Sudden Sensorineural Hearing Loss Jae-Hyun Seo, Eun-Ju Jeon, Yong-Soo Park, JunHyun Kim, Ki-Hong Chang, and Sang-Won Yeo Department of Otolaryngology-Head and Neck Surgery, College of Medicine, The Catholic University of Korea, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/2d/53/ymj-55-1678.PMC4205711.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  The objective of this study was to evaluate the effect of meteorological  factors on the onset of idiopathic sudden sensorineural hearing loss (ISSHL).",Non-OADS,/arxiv_data1/oa_pdf/2d/53/ymj-55-1678.PMC4205711.pdf
"The association of weather conditions and the development of diseases have been demonstrated in gouty arthritis, 2 rheu - matoid arthritis,3 systemic lupus erythematosus, Bechet’s disease,4 pneumothorax,5  and various viral infections such as influenza,6 herpes zoster,7 respiratory syncytial  virus,8 and varicella zoster virus.9Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.6.1678 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(6):1678-1682, 2014",Non-OADS,/arxiv_data1/oa_pdf/2d/53/ymj-55-1678.PMC4205711.pdf
Meteorological Conditions and Sudden Deafness Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1679Collection of meteorological data The meteorological data for Incheon city during the same  study period were available from the database at the Kore - an Meteorological Administration Website (http://www.,OADS,/arxiv_data1/oa_pdf/2d/53/ymj-55-1678.PMC4205711.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1680using Mann-Whitney U test demonstrated that mean and  maximal wind velocities were significantly higher for the  days when ISSHL occurred than the days without ISSHL  onset.,OADS,/arxiv_data1/oa_pdf/2d/53/ymj-55-1678.PMC4205711.pdf
"Meteorological Conditions and Sudden Deafness Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1681cause of ISSHL by way of direct viral invasion to the co - chlea or cochlear nerve, reactivation of a latent virus within  the spiral ganglion, or immune-mediated mechanisms.11,18 It  has also been reported that infection due to neurotropic vi - rus such as herpes zoster7 and varicella zoster virus,9 as well  as viral pathogens of acute respiratory tract infection, such  as influenza A, RSV , and adenovirus, were related to weath - er conditions including mean temperature, humidity, and  wind velocity.19 Interruption of vascular flow to the cochlea is thought to  be another major cause of ISSHL.",Non-OADS,/arxiv_data1/oa_pdf/2d/53/ymj-55-1678.PMC4205711.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1682mission is dependent on relative humidity and temperature.,Non-OADS,/arxiv_data1/oa_pdf/2d/53/ymj-55-1678.PMC4205711.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1683Availability of Preoperative Systemic Steroids on Endoscopic  Sinus Surgery for Chronic Rhinosinusitis with Nasal Polyposis Seok Jin Hong,1* Jong Kyu Lee,1* Hyun Sub Lee,1 Jung Yup Lee,1 Jung Soo Pyo,2 and Kyung Chul Lee1 Departments of 1Otorhinolaryngology-Head and Neck Surgery and 2Pathology, Kangbuk Samsung Hospital,  Sungkyunkwan University School of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/b1/85/ymj-55-1683.PMC4205712.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  To analyze the outcome of endoscopic sinus surgery (ESS) after preoper - ative systemic steroid (PSS) treatment for chronic rhinosinusitis (CRS) with nasal  polyposis (NP) and to investigate and compare clinicopathological factors associat - ed with the outcome.",Non-OADS,/arxiv_data1/oa_pdf/b1/85/ymj-55-1683.PMC4205712.pdf
"Key Words:    Steroid, chronic rhinosinusitis, nasal polyp, endoscopic sinus surgery INTRODUCTION Chronic rhinosinusitis (CRS) can be classified by phenotypical presentation as ei - ther CRS without nasal polyps (NP) or CRS with nasal polyps.1 CRS with NP is a  distinct pathologic subtype of CRS, which has a greater burden of symptoms and a  higher relapse rate after management.2-4 Despite the significant morbidity and the  difficulty of treatment, the exact etiology of NP unfortunately has not been eluci - dated, and evidence to guide practitioners is also limited.Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.6.1683 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(6):1683-1690, 2014",Non-OADS,/arxiv_data1/oa_pdf/b1/85/ymj-55-1683.PMC4205712.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1684gation and comparison of the predictive clinicopathological  factors associated with poor outcome of ESS.,Non-OADS,/arxiv_data1/oa_pdf/b1/85/ymj-55-1683.PMC4205712.pdf
Preoperative Steroids on Endoscopic Sinus Surgery Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1685eosinophils divided by the total number of inflammatory  cells counted provided the percentage of eosinophil content  for each sample.,Non-OADS,/arxiv_data1/oa_pdf/b1/85/ymj-55-1683.PMC4205712.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1686the difference between the two groups was not found in the  statistical analysis ( p=0.185).,OADS,/arxiv_data1/oa_pdf/b1/85/ymj-55-1683.PMC4205712.pdf
"Preoperative Steroids on Endoscopic Sinus Surgery Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1687DISCUSSION Sinonasal polyps may develop from the inflammation of  the lateral wall of the nose, and NP has a multifactorial eti - ology, such as allergy, viral or bacterial infection, fungal in - fection, and environmental pollution.23,24 These events dis - rupt the epithelial lining and initiate inflammation, and if  the inflammation does not subside, stromal edema may  consolidate and result in tissue hyperplasia and nasal polyp - osis.23 Even though the pathogenesis of nasal polyp is not  yet well established, steroids are used to reduce mucosal in - flammation and to prevent polyp recurrence after ESS.",Non-OADS,/arxiv_data1/oa_pdf/b1/85/ymj-55-1683.PMC4205712.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1688this study enrolled more patients with CRS with nasal pol - yposis than previous studies.,Non-OADS,/arxiv_data1/oa_pdf/b1/85/ymj-55-1683.PMC4205712.pdf
Preoperative Steroids on Endoscopic Sinus Surgery Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 16899.,Non-OADS,/arxiv_data1/oa_pdf/b1/85/ymj-55-1683.PMC4205712.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 169031.,Non-OADS,/arxiv_data1/oa_pdf/b1/85/ymj-55-1683.PMC4205712.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1691Risk and Protective Factors of Internet Addiction:   A Meta-Analysis of Empirical Studies in Korea Hoon Jung Koo and Jung-Hye Kwon Department of Psychology, College of Liberal Arts, Korea University, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/33/76/ymj-55-1691.PMC4205713.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  A meta-analysis of empirical studies performed in Korea was conducted  to systematically investigate the associations between the indices of Internet addic - tion (IA) and psychosocial variables.",Non-OADS,/arxiv_data1/oa_pdf/33/76/ymj-55-1691.PMC4205713.pdf
"Thus, there is an urgent need to gain a comprehensive un -Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.6.1691 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(6):1691-1711, 2014",Non-OADS,/arxiv_data1/oa_pdf/33/76/ymj-55-1691.PMC4205713.pdf
"Hoon Jung Koo and Jung-Hye Kwon Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1692conflict with their parents,35 report dysfunctional communi - cation with their parents, and experience higher levels of fa - milial conflict1,36 than non-addicts.",Non-OADS,/arxiv_data1/oa_pdf/33/76/ymj-55-1691.PMC4205713.pdf
Risk and Protective Factors of Internet Addiction Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1693MATERIALS AND METHODS Literature search Two methods were used to locate studies for the meta-anal - ysis.,Non-OADS,/arxiv_data1/oa_pdf/33/76/ymj-55-1691.PMC4205713.pdf
"Hoon Jung Koo and Jung-Hye Kwon Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1694personal variables,” in accordance with previous studies.7,37  At the final step, all the variables were classified as either  a risk or protective factor.",Non-OADS,/arxiv_data1/oa_pdf/33/76/ymj-55-1691.PMC4205713.pdf
"Risk and Protective Factors of Internet Addiction Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1695value indicates that the correlations are homogeneous and  the average weighted effect size, r+, represents the popula - tion effect size.",OADS,/arxiv_data1/oa_pdf/33/76/ymj-55-1691.PMC4205713.pdf
Hoon Jung Koo and Jung-Hye Kwon Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1696Table 1.,Non-OADS,/arxiv_data1/oa_pdf/33/76/ymj-55-1691.PMC4205713.pdf
Risk and Protective Factors of Internet Addiction Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1697Table 1.,Non-OADS,/arxiv_data1/oa_pdf/33/76/ymj-55-1691.PMC4205713.pdf
Hoon Jung Koo and Jung-Hye Kwon Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1698was conducted for correlation coefficients for the intraper - sonal versus interpersonal variables.,OADS,/arxiv_data1/oa_pdf/33/76/ymj-55-1691.PMC4205713.pdf
Risk and Protective Factors of Internet Addiction Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1699dent/harm-avoidant ( r=0.28) traits were also significant.,Non-OADS,/arxiv_data1/oa_pdf/33/76/ymj-55-1691.PMC4205713.pdf
"Hoon Jung Koo and Jung-Hye Kwon Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1700es for sociability, social support, peer attachment and social  efficacy respectively were -0.19, -0.15, -0.20, and -0.15, re - spectively, and did not significantly differ in magnitude [ Q  (3)=1.99, n.s.].",Non-OADS,/arxiv_data1/oa_pdf/33/76/ymj-55-1691.PMC4205713.pdf
"Risk and Protective Factors of Internet Addiction Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1701Qb (1)=25.08, p<0.001.",Non-OADS,/arxiv_data1/oa_pdf/33/76/ymj-55-1691.PMC4205713.pdf
Hoon Jung Koo and Jung-Hye Kwon Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1702 Table 5.,Non-OADS,/arxiv_data1/oa_pdf/33/76/ymj-55-1691.PMC4205713.pdf
"Risk and Protective Factors of Internet Addiction Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1703for the Internet-game addiction measure ( r=-0.09 vs. -0.19),  Qb (1)=7.01, p<0.01.",Non-OADS,/arxiv_data1/oa_pdf/33/76/ymj-55-1691.PMC4205713.pdf
"Hoon Jung Koo and Jung-Hye Kwon Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1704faced with a reality that does not meet their high expecta - tions or ideals3,62 could rigidly rely on the Internet in an at - tempt to eliminate their dissatisfaction or distress.",Non-OADS,/arxiv_data1/oa_pdf/33/76/ymj-55-1691.PMC4205713.pdf
"Risk and Protective Factors of Internet Addiction Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1705negative emotional states such as repressed anger, aggres - sion, and hostility.",Non-OADS,/arxiv_data1/oa_pdf/33/76/ymj-55-1691.PMC4205713.pdf
"Hoon Jung Koo and Jung-Hye Kwon Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1706The implementation of analytical methods that can test  causal relationships, rather than merely examining the de - gree of associations, is recommended so that antecedents  and consequences of Internet addiction can be clearly differ - entiated.39 Second, as we have indicated, some of the current  analyses suffered from a relatively small number of avail - able studies.",Non-OADS,/arxiv_data1/oa_pdf/33/76/ymj-55-1691.PMC4205713.pdf
Risk and Protective Factors of Internet Addiction Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 170717.,Non-OADS,/arxiv_data1/oa_pdf/33/76/ymj-55-1691.PMC4205713.pdf
"Hoon Jung Koo and Jung-Hye Kwon Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1708Hills, CA: Sage; 1982.",Non-OADS,/arxiv_data1/oa_pdf/33/76/ymj-55-1691.PMC4205713.pdf
Available from: http://www.psychom.net/ iadcriteria.html/.,Non-OADS,/arxiv_data1/oa_pdf/33/76/ymj-55-1691.PMC4205713.pdf
Risk and Protective Factors of Internet Addiction Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 170997.,Non-OADS,/arxiv_data1/oa_pdf/33/76/ymj-55-1691.PMC4205713.pdf
Hoon Jung Koo and Jung-Hye Kwon Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1710136.,Non-OADS,/arxiv_data1/oa_pdf/33/76/ymj-55-1691.PMC4205713.pdf
Risk and Protective Factors of Internet Addiction Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1711tion of college students.,Non-OADS,/arxiv_data1/oa_pdf/33/76/ymj-55-1691.PMC4205713.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1712Does Age at Onset of First Major Depressive Episode Indicate  the Subtype of Major Depressive Disorder?,Non-OADS,/arxiv_data1/oa_pdf/85/3e/ymj-55-1712.PMC4205714.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  The purpose of this study was to evaluate the effects of age at onset of  the first major depressive episode on the clinical features of individuals with ma - jor depressive disorder (MDD) in a large cohort of Korean depressed patients.",Non-OADS,/arxiv_data1/oa_pdf/85/3e/ymj-55-1712.PMC4205714.pdf
"Key Words:    Major depressive disorder, age at onset, clinical indicator, subtypeOriginal Articlehttp://dx.doi.org/10.3349/ymj.2014.55.6.1712 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(6):1712-1720, 2014",Non-OADS,/arxiv_data1/oa_pdf/85/3e/ymj-55-1712.PMC4205714.pdf
"Age at Onset and Major Depressive Disorder Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1713specifically, the purpose of this study was to answer the fol - lowing questions: • How does age at onset of the first major depressive epi - sode distribute?",Non-OADS,/arxiv_data1/oa_pdf/85/3e/ymj-55-1712.PMC4205714.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1714asked about the age at onset and this was also estimated by  the trained and certified clinical research coordinator.,Non-OADS,/arxiv_data1/oa_pdf/85/3e/ymj-55-1712.PMC4205714.pdf
"Age at Onset and Major Depressive Disorder Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 171514.24; t=16.03, p<0.0001).",Non-OADS,/arxiv_data1/oa_pdf/85/3e/ymj-55-1712.PMC4205714.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1716age at onset are presented in Table 2.,Non-OADS,/arxiv_data1/oa_pdf/85/3e/ymj-55-1712.PMC4205714.pdf
"Age at Onset and Major Depressive Disorder Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1717DISCUSSION In terms of age at onset of first major depressive episode,  the findings of this study were characterized by small pro - portion of child and adolescent subgroup and high propor - tions of adult subgroups (Fig.",Non-OADS,/arxiv_data1/oa_pdf/85/3e/ymj-55-1712.PMC4205714.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1718episodes in this study.,Non-OADS,/arxiv_data1/oa_pdf/85/3e/ymj-55-1712.PMC4205714.pdf
Age at Onset and Major Depressive Disorder Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1719more precise estimates of the association between the vari - ous variables and the age-at-onset subgroups.,Non-OADS,/arxiv_data1/oa_pdf/85/3e/ymj-55-1712.PMC4205714.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 172025.,Non-OADS,/arxiv_data1/oa_pdf/85/3e/ymj-55-1712.PMC4205714.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1721A Comparison of Receptive-Expressive Language Profiles  between Toddlers with Autism Spectrum Disorder and  Developmental Language Delay Kyeong In Seol,1 Seung Ha Song,1 Ka Lim Kim,1 Seung Taek Oh,1 Young Tae Kim,2  Woo Young Im,3 Dong Ho Song,1 and Keun-Ah Cheon1 1Division of Child and Adolescent Psychiatry, Department of Psychiatry and Institute of Behavioral Science in Medicine,  Yonsei University College of Medicine, Seoul; 2Department of Communication Disorder, Ewha Woman ’s University, Seoul;  3Division of Child and Adolescent Psychiatry, Department of Psychiatry, Konyang University College of Medicine, Daejeon, Korea.",Non-OADS,/arxiv_data1/oa_pdf/de/b3/ymj-55-1721.PMC4205715.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  It is well known that expressive language impairment is commonly less  severe than receptive language impairment in children with autism spectrum disor - der (ASD).",Non-OADS,/arxiv_data1/oa_pdf/de/b3/ymj-55-1721.PMC4205715.pdf
"Key Words:    Autism spectrum disorder, toddlers, receptive language, expressive  language INTRODUCTION Autism spectrum disorder (ASD) is a pervasive neurodevelopmental disorder that Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.6.1721 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(6):1721-1728, 2014",Non-OADS,/arxiv_data1/oa_pdf/de/b3/ymj-55-1721.PMC4205715.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1722The results of previous studies have shown considerable  variation in the language ability of individual ASD chil - dren.12 However, the ASD group showed a consistent im - pairment of language ability associated with social area,  with unique features such as echolalia, scripted speech, and  unusual prosody, which is clearly distinguished from other  developmental disorders.13  Furthermore, according to the DSM-IV , language develop - ment of children with Asperger’s disorder is not delayed, but  there are severe impairments in pragmatic language, causing  deficits in the social area.14 Through follow-up of 8 years it  was found that verbal skill is the most powerful prognostic  factor of social adaptive functioning of ASD.15 Not only is  impairment in language ability the earliest symptom of ASD  individuals detected by the parents, but it is also closely re - lated to the long-term social function.16  Generally, receptive language skills are usually much more  advanced than expressive language skills in normally devel - oping children.17 However, some studies found relatively  greater impairment in receptive language skill over expres - sive language skills in toddlers and children with ASD.18,19  The unique feature of ASD such as echolalia, scripted  speech, and unusual prosody reflects the decrease in recep - tive language ability compared to the relatively conserved  expressive language ability in conversations, which is clear - ly distinguished from other developmental disorders.",Non-OADS,/arxiv_data1/oa_pdf/de/b3/ymj-55-1721.PMC4205715.pdf
"Language Profile in Autism Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1723Based on the reference data, language development-for-age  percentile and age-equivalent scores are calculated.",Non-OADS,/arxiv_data1/oa_pdf/de/b3/ymj-55-1721.PMC4205715.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1724no significant difference was found in expressive score and  expressive AE scores.,Non-OADS,/arxiv_data1/oa_pdf/de/b3/ymj-55-1721.PMC4205715.pdf
Language Profile in Autism Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1725study assessed and compared the receptive and expressive  language abilities in two diagnostic groups: ASD and DLD.,Non-OADS,/arxiv_data1/oa_pdf/de/b3/ymj-55-1721.PMC4205715.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1726that compared early language abilities in toddlers with ASD  and toddlers with developmental delay also showed that tod - dlers with ASD had relatively more severe receptive than ex - pressive language delays.,Non-OADS,/arxiv_data1/oa_pdf/de/b3/ymj-55-1721.PMC4205715.pdf
"Language Profile in Autism Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1727guage impairment both ASD and DLD groups is critical  and that the direction and the approach to language therapy  of the two groups is different, results of current study could  play a vital role.",Non-OADS,/arxiv_data1/oa_pdf/de/b3/ymj-55-1721.PMC4205715.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1728guage Scale for Infants (SELSI).,Non-OADS,/arxiv_data1/oa_pdf/de/b3/ymj-55-1721.PMC4205715.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1729Home Mechanical Ventilation in South Korea Dong Hyun Kim,1 Seong-Woong Kang,2 and Won Ah Choi2 1Department of Rehabilitation Medicine, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul; 2Department of Rehabilitation Medicine, Gangnam Severance Hospital and Rehabilitation Institute of Neuromusular Disease,  Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/f0/10/ymj-55-1729.PMC4205716.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  To survey the use of invasive and noninvasive home mechanical ventila - tion (HMV) methods in South Korea from the perspective of physical medicine and  rehabilitation (PM&R).",Non-OADS,/arxiv_data1/oa_pdf/f0/10/ymj-55-1729.PMC4205716.pdf
"In  addition, the use of inspiratory and expiratory muscle aids, including noninvasive  mechanical ventilation (NIV) and mechanically assisted coughing (MAC), can fa - cilitate the decannulation of invasively managed ventilator users to more desirable Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.6.1729 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(6):1729-1735, 2014",Non-OADS,/arxiv_data1/oa_pdf/f0/10/ymj-55-1729.PMC4205716.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1730subjects air stacking,7 and the expiratory phase assisted by  application of an abdominal thrust.8 5) The ventilatory status was monitored by arterial blood  gas analysis (ABGA) or by monitoring oxyhemoglobin sat - uration (SpO 2) and end tidal carbon dioxide (EtCO 2) via  oximetry and capnometry (Microcap plus, Oridion Ltd., Je - rusalem, Israel) just before HMV prescription, while using  mechanical ventilation.",Non-OADS,/arxiv_data1/oa_pdf/f0/10/ymj-55-1729.PMC4205716.pdf
HMV in South Korea Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1731failure to NIV were accompanying bulbar muscle weakness  and insufficient cooperation due to either young age (<7 yrs  old) or mental retardation (Table 5-2).,Non-OADS,/arxiv_data1/oa_pdf/f0/10/ymj-55-1729.PMC4205716.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1732 Table 3.,Non-OADS,/arxiv_data1/oa_pdf/f0/10/ymj-55-1729.PMC4205716.pdf
"HMV in South Korea Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1733public subsidy for NMDs, and the characteristics of a center  at which the survey was conducted may contribute to this.",Non-OADS,/arxiv_data1/oa_pdf/f0/10/ymj-55-1729.PMC4205716.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1734tures,14,15 aggressive use of continuous NIV and MAC can  result in more favorable outcomes and better survival.",Non-OADS,/arxiv_data1/oa_pdf/f0/10/ymj-55-1729.PMC4205716.pdf
"HMV in South Korea Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1735R, Fauroux B, et al.",Non-OADS,/arxiv_data1/oa_pdf/f0/10/ymj-55-1729.PMC4205716.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1736Effects of Hippotherapy on Gross Motor Function and  Functional Performance of Children with Cerebral Palsy Eun Sook Park,1 Dong-Wook Rha,1 Jung Soon Shin,2 Soohyeon Kim,3 and Soojin Jung1 1Department of Rehabilitation Medicine, Severance Hospital, Research Institute of Rehabilitation Medicine,  Yonsei University College of Medicine, Seoul; 2Horse Riding Academy of Korea Racing Authority, Gwacheon; 3Horse Riding Promotion Team of Korea Racing Authority, Gwacheon, Korea.",Non-OADS,/arxiv_data1/oa_pdf/d0/ea/ymj-55-1736.PMC4205717.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  The purpose of our study was to investigate the effects of hippotherapy  on gross motor function and functional performance in children with spastic cere - bral palsy (CP).",Non-OADS,/arxiv_data1/oa_pdf/d0/ea/ymj-55-1736.PMC4205717.pdf
"Key Words:    Cerebral palsy, spastic, hippotherapy, function, physical activity, dis - ability evaluation  INTRODUCTION Cerebral palsy (CP) refers to a group of permanent motor disorders attributed to a  non-progressive lesion that occurs in the immature brain.1 Children with CP have  various degrees of impairment of movement and posture, which can limit physical Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.6.1736 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(6):1736-1742, 2014",Non-OADS,/arxiv_data1/oa_pdf/d0/ea/ymj-55-1736.PMC4205717.pdf
Effects of Hippotherapy on Children with CP Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1737MATERIALS AND METHODS Participants Children with spastic CP who met the inclusion and exclu - sion criteria were recruited for this study.,Non-OADS,/arxiv_data1/oa_pdf/d0/ea/ymj-55-1736.PMC4205717.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1738the parent or caregiver.,Non-OADS,/arxiv_data1/oa_pdf/d0/ea/ymj-55-1736.PMC4205717.pdf
Effects of Hippotherapy on Children with CP Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1739of any domain between groups.,Non-OADS,/arxiv_data1/oa_pdf/d0/ea/ymj-55-1736.PMC4205717.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1740CP .,Non-OADS,/arxiv_data1/oa_pdf/d0/ea/ymj-55-1736.PMC4205717.pdf
Effects of Hippotherapy on Children with CP Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1741REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d0/ea/ymj-55-1736.PMC4205717.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1742equine-movement therapy program on gait, energy expenditure,  and motor function in children with spastic cerebral palsy: a pilot  study.",Non-OADS,/arxiv_data1/oa_pdf/d0/ea/ymj-55-1736.PMC4205717.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1743Usefulness of Permanent Tracheostoma in Chronic   Brain Injured Patients: A Case Series Yu Hui Won,1 Seo Young Jeon,2 Han Su Kim,3 and Hasuk Bae4 1Department of Physical Medicine and Rehabilitation, Chonbuk National University Medical School, Jeonju; 2Department of Rehabilitation, Hanyang University Medical Center, Seoul; Departments of 3Otorhinolaryngology-Head and Neck Surgery and 4Rehabilitation Medicine,  School of Medicine, Ewha Womans University, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/7c/2f/ymj-55-1743.PMC4205718.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Patients with severe neurological deficit, such as hypoxic ischemic injury, cerebral  infarction, and traumatic brain injury, often show comatose mental status and re - quire maintenance of long-term tracheostomy for pulmonary toileting.",Non-OADS,/arxiv_data1/oa_pdf/7c/2f/ymj-55-1743.PMC4205718.pdf
"Case Reporthttp://dx.doi.org/10.3349/ymj.2014.55.6.1743 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(6):1743-1746, 2014",Non-OADS,/arxiv_data1/oa_pdf/7c/2f/ymj-55-1743.PMC4205718.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1744good alternative method for conventional tracheostomy and  were free of tube-related complications after the procedure.,Non-OADS,/arxiv_data1/oa_pdf/7c/2f/ymj-55-1743.PMC4205718.pdf
"Permanent Tracheostoma in Brain Injured Patients Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1745which was fourth common complication of the tracheosto - my, according to a previous study.3 If the stoma is sustained  without the tube, caregivers and patients may feel comfort - able with stoma care, as also found in this study.",Non-OADS,/arxiv_data1/oa_pdf/7c/2f/ymj-55-1743.PMC4205718.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1746aspiration, this tube-free permanent tracheostoma is a rea - sonable alternative way for chronic brain injured patients,  who need the long-term artificial airway, by brining the  aforementioned benefits.",Non-OADS,/arxiv_data1/oa_pdf/7c/2f/ymj-55-1743.PMC4205718.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1747Erratumhttp://dx.doi.org/10.3349/ymj.2014.55.6.1747 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(6):1747-1747, 2014 Erratum to “Toll-Like Receptor 4 Signaling is Involved   in IgA-Stimulated Mesangial Cell Activation” by Lim BJ, et al.",OADS,/arxiv_data1/oa_pdf/17/8e/ymj-55-1747.PMC4205719.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1748Erratumhttp://dx.doi.org/10.3349/ymj.2014.55.6.1748 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(6):1748-1748, 2014 Erratum to “LRIG1 Enhances Chemosensitivity   by Modulating BCL-2 Expression and Receptor Tyrosine   Kinase Signaling in Glioma Cells”   by Guo Z, et al.",OADS,/arxiv_data1/oa_pdf/1f/94/ymj-55-1748.PMC4205720.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1749Erratumhttp://dx.doi.org/10.3349/ymj.2014.55.6.1749 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(6):1749-1749, 2014 Erratum to “Fresh Frozen Plasma in Pump Priming for  Congenital Heart Surgery: Evaluation of Effects on Postoperative  Coagulation Profiles Using a Fibrinogen Assay and Rotational  Thromboelastometry” by Lee JW , et al.",Non-OADS,/arxiv_data1/oa_pdf/52/1e/ymj-55-1749.PMC4205721.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1750Erratumhttp://dx.doi.org/10.3349/ymj.2014.55.6.1750 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(6):1750-1750, 2014 Erratum to “Effect of 6% Hydroxyethyl Starch 130/0.4 as a  Priming Solution on Coagulation and Inflammation Following  Complex Heart Surgery”   by Cho JE, et al.",Non-OADS,/arxiv_data1/oa_pdf/42/44/ymj-55-1750.PMC4205722.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non -Commercial License (http://creativecommons.org/licenses/   by-nc/3.0/) which permits unrestricted, non -commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/59/f3/TOCMJ-8-94.PMC4205776.pdf
http://dx.doi.org/10.1146/annurev-med-042711 -140023 .,Non-OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
http://dx.doi.org/10.1056/NEJM199808203390806 .,OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
http://dx.doi.org/10.1086/653519 .,Non-OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
http://dx.doi.org/10.1056/ NEJMra035415 .,OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
http://dx.doi.org/10.1128/IAI.69.5.3423 -3426.2001 .,Non-OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
6:484 – 488. http://dx.doi.org/10.1016/S0966 -842X(98)01400-0 .,OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
http://dx.doi.org/10.1128/AEM.00395-13 .,Non-OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
http://dx.doi.org/10.1371/ journal.pone.0005822 .,Non-OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
http://dx.doi.org/10.1128/IAI.00377-13 .,Non-OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
http://dx.doi.org/10.1371/ journal.pone.0026714 .,Non-OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
74:470 – 476. http://dx.doi.org/10.1128/ AEM.02073-07 .,Non-OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
http://dx.doi.org/10.1371/ journal.ppat.1000052 .,Non-OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
76:4136 – 4142. http://dx.doi.org/10.1128/ AEM.03065-09 .,Non-OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
http://dx.doi.org/10.1128/JCM.43.4.1973-1976.2005 .,OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
http://dx.doi.org/10.1128/ JCM.02280-06 .,Non-OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
http://dx.doi.org/ 10.1128/IAI.01036-08 .,Non-OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
U.S.A. 104: 8113– 8118. http://dx.doi.org/10.1073/ pnas.0610226104 .,Non-OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
191:4767– 4775. http://dx.doi.org/10.1128/JB.00348-09 .,Non-OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
mBio 4(1):e00537- 12.http://dx.doi.org/10.1128/mBio.00537-12 .,Non-OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
http://dx.doi.org/10.1128/JB.00167-08 .,Non-OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
http://dx.doi.org/10.1111/j.1365 -2958.2009.06981.x .,Non-OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
http://dx.doi.org/10.1111/j.1365 -2958.1994.tb00304.x .,Non-OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
191:832– 843. http://dx.doi.org/10.1128/JB.01222-08 .,Non-OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
Mi- crobiology 149:643– 654. http://dx.doi.org/10.1099/mic.0.25996-0 .,Non-OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
http://dx.doi.org/10.1099/mic.0.26412-0 .,Non-OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
9:22.http://dx.doi.org/10.1186/1471 -2180-9-22 .,Non-OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
http://dx.doi.org/10.1099/00221287-144-12-3387 .,Non-OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
http://dx.doi.org/10.1126/science.285.5428.760 .,Non-OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
http://dx.doi.org/ 10.1073/pnas.0911032107 .,Non-OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
http://dx.doi.org/10.1128/JB.186.6.1838-1850.2004 .,Non-OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
http://dx.doi.org/ 10.1002/mbo3.55 .,Non-OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
http://dx.doi.org/ 10.1128/JB.00369-11 .,Non-OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
http://dx.doi.org/10.1128/IAI.06134-11 .,Non-OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
http://dx.doi.org/10.1128/IAI.01242-12 .,Non-OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
http://dx.doi.org/ 10.1128/JB.183.24.7341-7353.2001 .,OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
http://dx.doi.org/10.1086/317606 .,OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
http://dx.doi.org/10.1111/j.1574-6968.2006.00281.x .,Non-OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
http://dx.doi.org/10.1128/mBio.01667-14 .,Non-OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
http://dx.doi.org/10.1371/journal.pone.0067629 .,Non-OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
http://dx.doi.org/10.1371/journal.pone.0019172 .,Non-OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
http://dx.doi.org/ 10.1016/j.mib.2011.09.016 .,OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
http://dx.doi.org/10.1128/IAI.00046-11 .,Non-OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
http://dx.doi.org/10.1086/598967 .,OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
http://dx.doi.org/10.1128/JB.00555-06 .,Non-OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
http://dx.doi.org/10.1016/j.chom.2013.05.003 .,OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
192: 613– 623. http://dx.doi.org/ 10.1128/JB.01242-09 .,Non-OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
http://dx.doi.org/10.1371/ journal.ppat.1004205 .,Non-OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
http://dx.doi.org/10.1126/ science.280.5361.295 .,Non-OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
http://dx.doi.org/10.1371/ journal.ppat.1000354 .,Non-OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
http://dx.doi.org/10.1016/0012-1606(79)90228-8 .,OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
Cell 132:55– 66. http://dx.doi.org/10.1016/j.cell.2007.11.044 .,OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
http://dx.doi.org/10.1038/305709a0 .,Non-OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
http://dx.doi.org/10.1371/ journal.pone.0003361 .,Non-OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
70:470 – 480. http://dx.doi.org/ 10.1128/IAI.70.2.470-480.2002 .,Non-OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
http://dx.doi.org/10.1371/ journal.pone.0010146 .Moormeier et al.,OADS,/arxiv_data1/oa_pdf/71/46/mBio.01341-14.PMC4205790.pdf
The 15 putative A. ﬂavus GPCRs were identiﬁed by a BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi) search of the A. nidulans GPCRs (7) against the A. ﬂavus ge- nome.,OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
"Publicly available RNA-seq and microarray ex- pression data for A. ﬂavus under various conditions was accessed from the publication itself or from the Gene Expression Omnibus (GEO) database(http://www.ncbi.nlm.nih.gov/geo/), depending on where the data weredeposited.",OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
http://dx.doi.org/10.1081/TXR-120024089 .,Non-OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
http://dx.doi.org/10.1099/ mic.0.2007/007641-0 .,Non-OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
http://dx.doi.org/10.1111/j.1574-6976.2008.00131.x .,Non-OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
http://dx.doi.org/ 10.1093/embo-reports/kve132 .,OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
http://dx.doi.org/ 10.1007/s11046-012-9600-5 .,Non-OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
http://dx.doi.org/10.1016/j.fgb.2006.02.001 .,OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
http://dx.doi.org/10.1186/gb-2005-6-3 -r24.,Non-OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
Cell 17:667– 679. http://dx.doi.org/ 10.1091/mbc.E05-07-0699 .,OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
61:423– 452. http://dx.doi.org/10.1146/annurev.micro.61.080706.093432 .,Non-OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
http://dx.doi.org/10.1016/ j.funbio.2010.02.008 .,OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
13:108. http://dx.doi.org/10.1186/ 1471-2180-13-108 .,Non-OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
http://dx.doi.org/ 10.1006/jmbi.2000.4315 .,OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
225:487– 494. http://dx.doi.org/10.1016/0022-2836(92)90934-C .,OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
http://dx.doi.org/10.2307/3807436 .,Non-OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
http://dx.doi.org/ 10.1126/science.1087790 .,Non-OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
http://dx.doi.org/10.1016/S0076 -6879(04)89020-7 .,OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
http://dx.doi.org/10.1073/ pnas.0704751104 .,Non-OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
http://dx.doi.org/10.1111/j.1365-2958.2003.03940.x .,Non-OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
7:539. http://dx.doi.org/ 10.1038/msb.2011.75 .,Non-OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
http://dx.doi.org/10.1093/nar/ gkn180.,Non-OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
http://dx.doi.org/10.1046/j.1365-2958.2002.02933.x .,Non-OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
http://dx.doi.org/10.1111/j.1365 -2958.2004.04163.x .,Non-OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
Genetics 171:71– 80. http://dx.doi.org/10.1534/genetics.105.040584 .,Non-OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
http://dx.doi.org/10.1128/AEM.00052-10 .,Non-OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
http://dx.doi.org/10.1128/AEM.00565-08 .,Non-OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
http://dx.doi.org/10.3390/toxins4090695 .,Non-OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
http://dx.doi.org/10.1023/ B:MYCO.0000041841.71648.6e .,OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
http://dx.doi.org/ 10.1046/j.1365-2958.1999.01413.x .,Non-OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
http://dx.doi.org/10.1016/j.molcel.2004.10.004 .,OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
http://dx.doi.org/ 10.1128/EC.3.4.919-931.2004 .,Non-OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
http://dx.doi.org/10.1091/mbc.E04-09-0780 .,Non-OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
http://dx.doi.org/10.1111/j.1365-2621.1982.tb11021.x .,Non-OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
276: 40190 – 40201. http://dx.doi.org/10.1074/jbc.M100341200 .,Non-OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
http://dx.doi.org/10.3390/ toxins2040367 .,Non-OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
http://dx.doi.org/10.1038/nprot.2006.397 .,Non-OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
http://dx.doi.org/10.1016/ j.fgb.2010.05.005 .,OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
2009: 842626. http://dx.doi.org/10.1155/2009/842626 .,Non-OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
http://dx.doi.org/10.1021/jf010074 /H11001.,Non-OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
http://dx.doi.org/10.1111/j.1364 -3703.2009.00594.x .,Non-OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
Phytopathol- ogy84:483– 488. http://dx.doi.org/10.1094/Phyto-84-483 .,Non-OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
http://dx.doi.org/10.1371/journal.pone.0097814 .,Non-OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
http://dx.doi.org/10.1007/s13213-012-0531-7 .,Non-OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
56:78 – 86. http://dx.doi.org/10.1016/j.fgb.2013.04.007 .,OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
http://dx.doi.org/10.1111/j.1365 -2958.2004.04232.x .,Non-OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
Mycologia 101:423– 429. http://dx.doi.org/10.3852/09-011 .,Non-OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
15:8570 – 8590. http://dx.doi.org/10.3390/ijms15058570 .,Non-OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
96:8034 – 8039. http://dx.doi.org/10.1073/ pnas.96.14.8034 .,Non-OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
http://dx.doi.org/10.1007/s00294-007-0148-8 .,Non-OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
http://dx.doi.org/10.1016/j.jmb.2009.01.057 .,OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
http://dx.doi.org/10.1039/b315527g .,Non-OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
http://dx.doi.org/10.1126/science.287.5460.1960 .,Non-OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
http://dx.doi.org/10.1016/ j.mimet.2010.03.010 .,OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
7:104. http://dx.doi.org/10.1186/1471 -2180-7-104 .,Non-OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
Methods 9:671– 675. http://dx.doi.org/ 10.1038/nmeth.2089 .Global Survey of Canonical Aspergillus ﬂavus GPCRs September/October 2014 Volume 5 Issue 5 e01501-14®mbio.asm.org 11,Non-OADS,/arxiv_data1/oa_pdf/ad/72/mBio.01501-14.PMC4205791.pdf
"In contrast, human infectionswith very little onward transmission to humans have been de-scribed for avian H7N2 (6 human cases), H7N3 (58 cases), andH7N7 (90 cases; see reference 4) viruses and of course for theongoing H7N9 outbreak (450 cases; http://www.who.int /inﬂuenza/human_animal_interface/inﬂuenza_h7n9/Risk_Assessment/en/ ).",Non-OADS,/arxiv_data1/oa_pdf/05/17/mBio.01882-14.PMC4205792.pdf
"To date, avian H5N1 viruses have caused 650 symptom-atic human infections, with 386 deaths (case fatality rate [CFR],~60%; http://www.who.int/inﬂuenza/human_animal_interface /EN_GIP_20140124CumulativeNumberH5N1cases.pdf?ua /H110051).",Non-OADS,/arxiv_data1/oa_pdf/05/17/mBio.01882-14.PMC4205792.pdf
"In 2010, the Max Planck Societyissued a code of rules that gives the president of each Max PlanckInstitute the power to stop publication of a manuscript if the ﬁnd-ings are deemed to hurt the Society at large or the institute wherethe work was performed ( http://www.mpg.de/232129/research FreedomRisks.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/05/17/mBio.01882-14.PMC4205792.pdf
"Equally, in early 2014, the German Ethics Council, at the request ofthe German Parliament, came out with a very complete report withan executive summary in English ( http://www.ethikrat.org/ﬁles /opinion-biosecurity-summary-and-recommendations.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/05/17/mBio.01882-14.PMC4205792.pdf
88:6623– 6635. http://dx.doi.org/ 10.1128/JVI.02765-13 .,Non-OADS,/arxiv_data1/oa_pdf/05/17/mBio.01882-14.PMC4205792.pdf
88:6533– 6534. http://dx.doi.org/10.1128/JVI.00886-14 .,Non-OADS,/arxiv_data1/oa_pdf/05/17/mBio.01882-14.PMC4205792.pdf
88:6535– 6537. http://dx.doi.org/10.1128/JVI.00875-14 .,Non-OADS,/arxiv_data1/oa_pdf/05/17/mBio.01882-14.PMC4205792.pdf
13:809 – 821. http://dx.doi.org/10.1016/ S1473-3099(13)70167-1 .,OADS,/arxiv_data1/oa_pdf/05/17/mBio.01882-14.PMC4205792.pdf
Nature 511: 475– 477. http://dx.doi.org/10.1038/ nature13443 .,Non-OADS,/arxiv_data1/oa_pdf/05/17/mBio.01882-14.PMC4205792.pdf
http://dx.doi.org/10.1016/j.cell.2013.05.034 .,OADS,/arxiv_data1/oa_pdf/05/17/mBio.01882-14.PMC4205792.pdf
http://dx.doi.org/10.1016/ j.cell.2013.05.035 .,OADS,/arxiv_data1/oa_pdf/05/17/mBio.01882-14.PMC4205792.pdf
http://dx.doi.org/ 10.1016/j.meegid.2012.05.013 .,OADS,/arxiv_data1/oa_pdf/05/17/mBio.01882-14.PMC4205792.pdf
87: 8235– 8240. http://dx.doi.org/10.1128/JVI.01085-13 .,Non-OADS,/arxiv_data1/oa_pdf/05/17/mBio.01882-14.PMC4205792.pdf
Nature 486:420 – 428. http://dx.doi.org/10.1038/nature10831 .,Non-OADS,/arxiv_data1/oa_pdf/05/17/mBio.01882-14.PMC4205792.pdf
http://dx.doi.org/ 10.1126/science.1213362 .,Non-OADS,/arxiv_data1/oa_pdf/05/17/mBio.01882-14.PMC4205792.pdf
http://dx.doi.org/10.1371/journal.pone.0055358 .,Non-OADS,/arxiv_data1/oa_pdf/05/17/mBio.01882-14.PMC4205792.pdf
Nature 495:411. http://dx.doi.org/10.1038/495411a .,Non-OADS,/arxiv_data1/oa_pdf/05/17/mBio.01882-14.PMC4205792.pdf
http://dx.doi.org/10.1126/science.342.6156.310-b .,Non-OADS,/arxiv_data1/oa_pdf/05/17/mBio.01882-14.PMC4205792.pdf
Public Health 2:77. http://dx.doi.org/10.3389/ fpubh.2014.00077 .,Non-OADS,/arxiv_data1/oa_pdf/05/17/mBio.01882-14.PMC4205792.pdf
"Transmembrane domain prediction was performed using TMHHM 2.0, putative N-glycosylation sites were predicted with NetNGlyc 1.0, andthe presence of N-terminal signal peptides was predicted using SignalP4.1, all of which were accessed through the ExPASy web portal (http://www.expasy.org).",OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
http://dx.doi.org/10.1038/nature06536 .,Non-OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
Rev.72:457– 470. http://dx.doi.org/10.1128/MMBR.00004-08 .,Non-OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
http://dx.doi.org/10.1016/j.tree.2005.02.009 .,OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
BioScience 52:883– 890. http://dx.doi.org/10.1641/0006- 3568(2002)052[0883:UBAC]2.0.CO;2 .,OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
http://dx.doi.org/ 10.1111/j.1948-7134.2012.00201.x .,Non-OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
"http://dx.doi.org/10.1016/j.landurbplan.2008.10.017 8.Gardner-Santana LC, Norris DE, Fornadel CM, Hinson ER, Klein SL, Glass GE.",OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
http://dx.doi.org/10.1111/j.1365- 294X.2009.04232.x .,Non-OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
http://dx.doi.org/ 10.1289/ehp.0901389 .,Non-OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
http://dx.doi.org/10.1017/ S0950268806007746 .,Non-OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
18: 631– 633. http://dx.doi.org/10.3201/eid1804.110816 .14.,Non-OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
http://dx.doi.org/10.1089/ vbz.2012.1195 .,Non-OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
http://dx.doi.org/10.1371/journal.ppat.1003438 .,Non-OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
http://dx.doi.org/10.1016/j.str.2013.04.003 .,OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
http://dx.doi.org/10.1128/JVI.00601- 10.,Non-OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
86:395– 405. http://dx.doi.org/ 10.1128/JVI.06253-11 .,Non-OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
74: 6269 – 6277. http://dx.doi.org/10.1128/JVI.74.14.6269-6277.2000 .,Non-OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
http://dx.doi.org/10.1128/JVI.01142-12 .,Non-OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
http://dx.doi.org/ 10.1007/s11262-013-0968-1 .,Non-OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
http://dx.doi.org/10.1007/ s10393-012-0763-9 .,Non-OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
http://dx.doi.org/10.1086/ 527443 .,Non-OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
http://dx.doi.org/10.1128/CMR.00016-06 .,Non-OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
http://dx.doi.org/10.1186/1752-1947-5-7 .,Non-OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
2:8. http://dx.doi.org/ 10.3389/fcimb.2012.00008 .,Non-OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
http://www.ny1.com/content/news /67517/health-commissioner--rats-are-not-a-health-risk .,Non-OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
http://dx.doi.org/10.1007/s00436-007-0488-9 .,Non-OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
2011:686923. http://dx.doi.org/10.4061/2011/ 686923 .,Non-OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
79:6337– 6344. http://dx.doi.org/10.1128/AEM.01503-13 .,Non-OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
http://dx.doi.org/10.1128/AEM.03609-13 .,Non-OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
http://dx.doi.org/10.1086/345377 .,Non-OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
http://dx.doi.org/10.1056/ NEJMoa065987 .,OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
http://dx.doi.org/10.1056/NEJM199901213400303 .,Non-OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
http://dx.doi.org/10.3201/eid0402.980225 .,Non-OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
http://dx.doi.org/10.1371/journal.ppat.1002218 .,Non-OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
21:32– 41. http://dx.doi.org/10.1002/rmv.677 .,Non-OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
http://dx.doi.org/10.1128/JCM.02427-09 .,Non-OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
18:873– 876. http://dx.doi.org/ 10.3201/eid1805.111843 .,Non-OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
http://dx.doi.org/10.1128/JVI.05217-11 .,Non-OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
http://dx.doi.org/10.1128/JVI.05026-11 .,Non-OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
http://dx.doi.org/ 10.1038/nature12427 .,Non-OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
Hepa-tology 59:789 – 802. http://dx.doi.org/10.1002/hep.26750 .,Non-OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
http://dx.doi.org/10.1126/science.1113329 .,Non-OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
http://dx.doi.org/10.1111/jvh.12150 .,Non-OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
http://www.census.gov/prod/cen2010 /doc/sf1.pdf .,OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
http://dx.doi.org/10.1674/0003- 0031(2006)155[0221:GEOARP]2.0.CO;2 .,Non-OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
http://dx.doi.org/ 10.1016/j.cgh.2013.03.037 .,OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
http://dx.doi.org/10.1101/gr.1917404 .,Non-OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
http://dx.doi.org/10.1038/nature03959 .,Non-OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
http://dx.doi.org/10.1371/journal.pone.0036323 .,Non-OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
http://dx.doi.org/10.1016/S0966- 842X(03)00143-4 .,OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
http://dx.doi.org/10.1093/molbev/mss075 .,Non-OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
http://dx.doi.org/ 10.1093/nar/gkg595 .,Non-OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
http://dx.doi.org/10.1093/bioinformatics/btp252 .,Non-OADS,/arxiv_data1/oa_pdf/cd/be/mBio.01933-14.PMC4205793.pdf
http://dx.doi.org/ 10.1128/mBio.01882-14 .,Non-OADS,/arxiv_data1/oa_pdf/a2/9e/mBio.01985-14.PMC4205794.pdf
88:6623– 6635. http://dx.doi.org/ 10.1128/JVI.02765-13 .,Non-OADS,/arxiv_data1/oa_pdf/a2/9e/mBio.01985-14.PMC4205794.pdf
http://dx.doi.org/10.1128/ mBio.01875-14 .,Non-OADS,/arxiv_data1/oa_pdf/a2/9e/mBio.01985-14.PMC4205794.pdf
http://www.phe.gov/s3/dualuse/Documents/us-policy-durc -032812.pdf .,Non-OADS,/arxiv_data1/oa_pdf/a2/9e/mBio.01985-14.PMC4205794.pdf
88:6535– 6537. http://dx.doi.org/10.1128/JVI.00875-14 .,Non-OADS,/arxiv_data1/oa_pdf/a2/9e/mBio.01985-14.PMC4205794.pdf
Nature 486: 420 – 428. http://dx.doi.org/10.1038/nature10831 .,Non-OADS,/arxiv_data1/oa_pdf/a2/9e/mBio.01985-14.PMC4205794.pdf
http://dx.doi.org/ 10.1126/science.1213362 .,Non-OADS,/arxiv_data1/oa_pdf/a2/9e/mBio.01985-14.PMC4205794.pdf
http://dx.doi.org/10.1016/j.chom.2014.05.006 .,OADS,/arxiv_data1/oa_pdf/a2/9e/mBio.01985-14.PMC4205794.pdf
88:6533– 6534. http://dx.doi.org/10.1128/JVI.00886-14 .Editorial 2®mbio.asm.org September/October 2014 Volume 5 Issue 5 e01985-14,Non-OADS,/arxiv_data1/oa_pdf/a2/9e/mBio.01985-14.PMC4205794.pdf
http://dx.doi.org/10.1128/ mBio.01875-14 .,Non-OADS,/arxiv_data1/oa_pdf/4b/71/mBio.01993-14.PMC4205795.pdf
http://dx.doi.org/ 10.1126/science.1213362 .,Non-OADS,/arxiv_data1/oa_pdf/4b/71/mBio.01993-14.PMC4205795.pdf
http://dx.doi.org/10.1136/medethics- 2012-100712 .,Non-OADS,/arxiv_data1/oa_pdf/4b/71/mBio.01993-14.PMC4205795.pdf
Hastings Center Rep. 37:35– 43. http://dx.doi.org/ 10.1353/hcr.2007.0046 .,Non-OADS,/arxiv_data1/oa_pdf/4b/71/mBio.01993-14.PMC4205795.pdf
Wall Street J. http://online.wsj.com/articles/decades-after -nuclear-test-u-s-studies-cancer-fallout-1410802085 .Letter to the Editor 2®mbio.asm.org September/October 2014 Volume 5 Issue 5 e01993-14,Non-OADS,/arxiv_data1/oa_pdf/4b/71/mBio.01993-14.PMC4205795.pdf
http://dx.doi.org/ 10.1128/mBio.01875-14 .,Non-OADS,/arxiv_data1/oa_pdf/54/a5/mBio.02008-14.PMC4205796.pdf
http://dx.doi.org/ 10.1001/jama.296.14.1731 .,Non-OADS,/arxiv_data1/oa_pdf/54/a5/mBio.02008-14.PMC4205796.pdf
Nature 501: 33.http://dx.doi.org/10.1038/501033e .,Non-OADS,/arxiv_data1/oa_pdf/54/a5/mBio.02008-14.PMC4205796.pdf
http://dx.doi.org/ 10.1038/nature12476 .,Non-OADS,/arxiv_data1/oa_pdf/54/a5/mBio.02008-14.PMC4205796.pdf
http://dx.doi.org/10.1126/science.1239844 .,Non-OADS,/arxiv_data1/oa_pdf/54/a5/mBio.02008-14.PMC4205796.pdf
Science 341: 410 – 414. http://dx.doi.org/10.1126/science.1240532 .,Non-OADS,/arxiv_data1/oa_pdf/54/a5/mBio.02008-14.PMC4205796.pdf
http://dx.doi.org/10.1016/ j.cell.2013.05.035 .,OADS,/arxiv_data1/oa_pdf/54/a5/mBio.02008-14.PMC4205796.pdf
http://dx.doi.org/10.1093/cid/ 10.Supplement_2.S274 .,OADS,/arxiv_data1/oa_pdf/54/a5/mBio.02008-14.PMC4205796.pdf
http://www.cdc.gov/about/pdf/lab-safety/Final_Anthrax_Report.pdf .,Non-OADS,/arxiv_data1/oa_pdf/54/a5/mBio.02008-14.PMC4205796.pdf
Cell http://www.cell.com/cell/ comments/S0092-8674(14)00281-5 .,Non-OADS,/arxiv_data1/oa_pdf/54/a5/mBio.02008-14.PMC4205796.pdf
http://dx.doi.org/ 10.1128/mBio.02008-14 .,Non-OADS,/arxiv_data1/oa_pdf/d5/84/mBio.02053-14.PMC4205797.pdf
http://dx.doi.org/ 10.1126/science.1213362 .,Non-OADS,/arxiv_data1/oa_pdf/d5/84/mBio.02053-14.PMC4205797.pdf
http://dx.doi.org/10.2217/ fmb.13.64 .,Non-OADS,/arxiv_data1/oa_pdf/d5/84/mBio.02053-14.PMC4205797.pdf
88:6623– 6635. http://dx.doi.org/ 10.1128/JVI.02765-13 .,Non-OADS,/arxiv_data1/oa_pdf/d5/84/mBio.02053-14.PMC4205797.pdf
http://dx.doi.org/10.1128/ mBio.01875-14 .,Non-OADS,/arxiv_data1/oa_pdf/d5/84/mBio.02053-14.PMC4205797.pdf
http://dx.doi.org/ 10.1128/mBio.01730-14 .Author Reply 2®mbio.asm.org September/October 2014 Volume 5 Issue 5 e02053-14,Non-OADS,/arxiv_data1/oa_pdf/d5/84/mBio.02053-14.PMC4205797.pdf
mBio 5(5):e01993- 14.http://dx.doi.org/10.1128/mBio.01993-14 .,Non-OADS,/arxiv_data1/oa_pdf/41/12/mBio.02054-14.PMC4205798.pdf
http://dx.doi.org/10.1128/ mBio.01875-14 .,Non-OADS,/arxiv_data1/oa_pdf/41/12/mBio.02054-14.PMC4205798.pdf
http://dx.doi.org/10.1073/ pnas.72.6.1981 .,Non-OADS,/arxiv_data1/oa_pdf/99/ef/mBio.02062-14.PMC4205799.pdf
http://dx.doi.org/ 10.1128/mBio.01730-14 .,Non-OADS,/arxiv_data1/oa_pdf/99/ef/mBio.02062-14.PMC4205799.pdf
http://dx.doi.org/10.1128/ mBio.01875-14 .,Non-OADS,/arxiv_data1/oa_pdf/99/ef/mBio.02062-14.PMC4205799.pdf
http://en.wikipedia.org/wiki/Rhetorical_device .,Non-OADS,/arxiv_data1/oa_pdf/99/ef/mBio.02062-14.PMC4205799.pdf
"This is an open-access article distributed under the  terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and  redistribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/9c/11/aapm-04-04-19384.PMC4205801.pdf
"This is an open-access article distributed under the  terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and  redistribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/d6/4c/aapm-04-04-19423.PMC4205802.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6719 | DOI: 10.1038/srep06719 5",Non-OADS,/arxiv_data1/oa_pdf/16/10/srep06719.PMC4205835.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/69/4f/srep06714.PMC4205837.pdf
http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_full.pdf (2008) (Date of access: 30/06/2014).,Non-OADS,/arxiv_data1/oa_pdf/55/93/srep06716.PMC4205838.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: Yes there is potential Competing Interest.,Non-OADS,/arxiv_data1/oa_pdf/55/93/srep06716.PMC4205838.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6716 | DOI: 10.1038/srep06716 7",Non-OADS,/arxiv_data1/oa_pdf/55/93/srep06716.PMC4205838.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/61/32/srep06644.PMC4205840.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d9/76/srep06672.PMC4205841.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6672 | DOI: 10.1038/srep06672 6",Non-OADS,/arxiv_data1/oa_pdf/d9/76/srep06672.PMC4205841.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/b6/f7/srep06712.PMC4205842.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6712 | DOI: 10.1038/srep06712 7",Non-OADS,/arxiv_data1/oa_pdf/b6/f7/srep06712.PMC4205842.pdf
All authors reviewed the manuscript.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/fd/22/srep06661.PMC4205843.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6661 | DOI: 10.1038/srep06661 12",Non-OADS,/arxiv_data1/oa_pdf/fd/22/srep06661.PMC4205843.pdf
In Silico Organisms http://systemsbiology.ucsd.edu/InSilicoOrganisms/ OtherOrganisms (2013).,OADS,/arxiv_data1/oa_pdf/f6/95/ncomms5893.PMC4205847.pdf
NEOS Server for Optimization http://www.neos-server.org/ (2013).25.,OADS,/arxiv_data1/oa_pdf/f6/95/ncomms5893.PMC4205847.pdf
CPLEX Optimizer http://www-01.ibm.com/software/integration/optimization/ cplex-optimizer (2014).,OADS,/arxiv_data1/oa_pdf/f6/95/ncomms5893.PMC4205847.pdf
The Systems Biology Markup Language http://sbml.org/ (2014).,OADS,/arxiv_data1/oa_pdf/f6/95/ncomms5893.PMC4205847.pdf
Library for developers to extract data from Microsoft Excel spreadsheet ﬁles http://pypi.python.org/pypi/xlrd (2014).,OADS,/arxiv_data1/oa_pdf/f6/95/ncomms5893.PMC4205847.pdf
GLPK: GNU Linear Programming Kit http://www.gnu.org/software/glpk (2012).,Non-OADS,/arxiv_data1/oa_pdf/f6/95/ncomms5893.PMC4205847.pdf
42. sybilSBML: SBML Integration in Package sybil http://cran.r-project.org/web/ packages/sybilSBML/ (2014).,OADS,/arxiv_data1/oa_pdf/f6/95/ncomms5893.PMC4205847.pdf
The R Project for Statistical Computinghttp://www.r-project.org (2014).,Non-OADS,/arxiv_data1/oa_pdf/f6/95/ncomms5893.PMC4205847.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/f6/95/ncomms5893.PMC4205847.pdf
Reprints and permission information is available online at http://www.nature.com/ reprints/index.html.,Non-OADS,/arxiv_data1/oa_pdf/f6/95/ncomms5893.PMC4205847.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e9/7f/srep06709.PMC4205854.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6720 | DOI: 10.1038/srep06720 7",Non-OADS,/arxiv_data1/oa_pdf/ca/c2/srep06720.PMC4205881.pdf
"at ,http://www.R-project.org/ .",Non-OADS,/arxiv_data1/oa_pdf/2a/17/srep06727.PMC4205883.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6727 | DOI: 10.1038/srep06727 4",Non-OADS,/arxiv_data1/oa_pdf/2a/17/srep06727.PMC4205883.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/47/8a/srep06725.PMC4205888.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/38/c2/ncomms6101.PMC4205890.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Tullius, S. G. et al.",Non-OADS,/arxiv_data1/oa_pdf/38/c2/ncomms6101.PMC4205890.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms6101 ARTICLE NATURE COMMUNICATIONS | 5:5101 | DOI: 10.1038/ncomms6101 | www.nature.com/naturecommunications 17 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/38/c2/ncomms6101.PMC4205890.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/fa/b4/srep06660.PMC4205892.pdf
Geneva http://www.unaids.org/globalreport/global_ report.htm.,Non-OADS,/arxiv_data1/oa_pdf/92/fa/icb201450a.PMC4205896.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ The Supplementary Information that accompanies this paper is available on the Immunology and Cell Biology website (http://www.nature.com/icb)Hyaluronic acid reduces HIV infection PL i et al 780",Non-OADS,/arxiv_data1/oa_pdf/92/fa/icb201450a.PMC4205896.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/af/99/pgpm-7-297.PMC4205933.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPharmacogenomics and Personalized Medicine 2014:7 297–305Pharmacogenomics and Personalized Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  297Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/PGPM.S6787 6Pharmacogenetic information for patients   on drug labels susanne B haga rachel Mills Jivan Moaddeb center for applied genomics and  Precision Medicine, Department of  Medicine, Duke University, Durham,   nc, Usa correspondence: susanne B haga   center for applied genomics and  Precision Medicine, Department of  Medicine, Duke University,  304 research  Drive, Box  90141, Durham, nc  27708,  Usa  Tel +1 919 684 0325  Fax +1 919 613 6448  email susanne.haga@duke.ed uAbstract :  Advances in pharmacogenetic research have improved our understanding of adverse  drug responses and have led to the development of pharmacogenetic tests and targeted drugs.",Non-OADS,/arxiv_data1/oa_pdf/af/99/pgpm-7-297.PMC4205933.pdf
"Available from: http://www.fda.gov/Drugs/ ScienceResearch/ResearchAreas/Pharmacogenetics/ucm083378.ht m.  Accessed May  13, 2014.",Non-OADS,/arxiv_data1/oa_pdf/af/99/pgpm-7-297.PMC4205933.pdf
"Available from: http://www.fda.gov/ohrms/ dockets/98fr/06-545.pd f. Accessed July  22, 2014.",Non-OADS,/arxiv_data1/oa_pdf/af/99/pgpm-7-297.PMC4205933.pdf
Available from: http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/af/99/pgpm-7-297.PMC4205933.pdf
"Available from: http://www.fda.gov/downloads/Drugs/ Guidance ComplianceRegulatoryInformation /Guidances/UCM368602.pd f.  Accessed May  13, 2014.",Non-OADS,/arxiv_data1/oa_pdf/af/99/pgpm-7-297.PMC4205933.pdf
Available from: http://www.accessdata.fda.gov/scripts/ cdrh/cfdocs/cfCFR/CFRSearch.cfm?fr =310.50121CFR310.50 1.,OADS,/arxiv_data1/oa_pdf/af/99/pgpm-7-297.PMC4205933.pdf
Available from: http://www.accessdata.fda.gov/scripts/ cdrh/cfdocs/cfCFR/CFRSearch.cfm?fr =310.51 5.,OADS,/arxiv_data1/oa_pdf/af/99/pgpm-7-297.PMC4205933.pdf
Available from: http://www.accessdata.fda.,OADS,/arxiv_data1/oa_pdf/af/99/pgpm-7-297.PMC4205933.pdf
"Available  from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/   018081s056lbl.pd f. Accessed July  22, 2014.",Non-OADS,/arxiv_data1/oa_pdf/af/99/pgpm-7-297.PMC4205933.pdf
"Available  from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/   020896s026lbl.pd f. Accessed July  22, 2014.",Non-OADS,/arxiv_data1/oa_pdf/af/99/pgpm-7-297.PMC4205933.pdf
"Available  from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/   20985slr004_carac_lbl.pd f. Accessed July  22, 2014.",Non-OADS,/arxiv_data1/oa_pdf/af/99/pgpm-7-297.PMC4205933.pdf
"Available from:  http://www.fda.gov/downloads/Drugs/DrugSafety/UCM227568.pd f.  Accessed July  22, 2014.",Non-OADS,/arxiv_data1/oa_pdf/af/99/pgpm-7-297.PMC4205933.pdf
"Available  from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/   202429s002s003lbl.pd f. Accessed July  22, 2014.",Non-OADS,/arxiv_data1/oa_pdf/af/99/pgpm-7-297.PMC4205933.pdf
"Available from: http://www.fda.gov/Drugs/ResourcesForY ou/ Consumers/default.ht m. Accessed May  13, 2014.",Non-OADS,/arxiv_data1/oa_pdf/af/99/pgpm-7-297.PMC4205933.pdf
"Available from: http://www.fda.gov/drugs/ newsevents/ucm219716.ht m. Accessed July  22, 2014.",Non-OADS,/arxiv_data1/oa_pdf/af/99/pgpm-7-297.PMC4205933.pdf
"Pharmacogenomics and Personalized Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/pharmacogenomics-and-personalized-medicine-journa lPharmacogenomics and Personalized Medicine is an international, peer- reviewed, open access journal characterizing the influence of genotype  on pharmacology leading to the development of personalized treatment  programs and individualized drug selection for improved safety, efficacy  and sustainability.",Non-OADS,/arxiv_data1/oa_pdf/af/99/pgpm-7-297.PMC4205933.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/af/99/pgpm-7-297.PMC4205933.pdf
"Pharmacogenomics and Personalized Medicine 2014:7submit your manuscript | www.dovepress.co m Dove press Dove press Dove pres s 305Pharmacogenetic information for patients on drug labels Supplementary material Table S1  Patient-targeted sections of drug labels used for content analysis (due to copyright restrictions , we are not able to provide  the full text used in the content analysis but refer the reader to the noted section in the drug label at the provided Url accessible  through the Us Food and Drug administration) Drug Source URL for drug label abacavir Mg http://www.fda.gov/downloads/Drugs/Drugsafety/ucm224556.pd f afatinib Pi http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/201292s002lbl.pd f Bosutinib Pi http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/203341s001lbl.pd f capecitabine Pi http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020896s026lbl.pd f carbamazepine Mg http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/016608s103,018281s051,018927s044,020234s035lbl.pd f codeine Pci http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022402s006lbl.pd f clopidogrel Mg http://www.fda.gov/downloads/Drug/Drugsafety/UcM243349.pd f crizotinib Pi http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/202570s006lbl.pd f Dabrafenib Mg, Pci http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/202806s002lbl.pd f Dapsone Pi http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021794s006lbl.pd f Dasatinib Pi http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021986s014lbl.pd f everolimus Pi http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022334s021s023s024,203985s002s004s005lbl.pd f Fluorouracil Pi http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/20985slr004_carac_lbl.pd f ivacaftor Pi http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/203188s008lbl.pd f lapatinib Pi http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022059s016s017lbl.pd f lenalidomide Mg http://www.fda.gov/downloads/Drugs/Drugsafety/ucm111335.pd f lomitapide Mg http://www.fda.gov/downloads/Drugs/Drugsafety/UcM333530.pd f Maraviroc Mg http://www.fda.gov/downloads/Drugs/Drugsafety/ucm089122.pd f Mipomersen Mg http://www.fda.gov/downloads/Drugs/Drugsafety/UcM337730.pd f Mycophenolic acid Mg http://www.fda.gov/downloads/Drugs/Drugsafety/UcM172735.pd f nilotinib Mg http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022068s017lbl.pd f Peg-3350 Mg http://www.fda.gov/downloads/Drugs/Drugsafety/UcM253840.pd f Pegloticase Mg, Pci http://www.fda.gov/downloads/Drugs/Drugsafety/UcM227568.pd f Ponatinib Mg http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203469s000mg.pd f Quinine sulfate Mg http://www.fda.gov/downloads/Drugs/Drugsafety/UcM192698.pd f sofosbuvir Pci http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/204671s000lbl.pd f Trametinib Mg, Pci http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/204114s001lbl.pd f Valproic acid Mg http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/018081s056lbl.pd f Vemurafenib Mg, Pci http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/202429s004lbl.pd f Abbreviations:  Mg, medication guide; Pi, patient information; Pci, patient counseling information section (section 17).",Non-OADS,/arxiv_data1/oa_pdf/af/99/pgpm-7-297.PMC4205933.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/21/25/pgpm-7-307.PMC4205934.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPharmacogenomics and Personalized Medicine 2014:7 307–316Pharmacogenomics and Personalized Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  307Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PGPM.S3976 5Novel treatment strategies in triple-negative  breast cancer: specific role of poly(adenosine  diphosphate-ribose) polymerase inhibition M william Audeh Division of Medical Oncology, Samuel  Oschin Cancer Institute, Cedars-Sinai  Medical Center, Los Angeles, CA, USA Correspondence: M william Audeh   Division of Medical Oncology, Samuel  Oschin Cancer Institute, Cedars-Sinai  Medical Center, 8700 Beverly Boulevard,  Los Angeles, CA 90048 USA   email william.audeh@cshs.or gAbstract:  Inhibitors of the poly(adenosine triphosphate-ribose) polymerase (PARP)-1 enzyme  induce synthetic lethality in cancers with ineffective DNA (DNA) repair or homologous repair  deficiency, and have shown promising clinical activity in cancers deficient in DNA repair due to  germ-line mutation in BRCA1  and BRCA2 .",Non-OADS,/arxiv_data1/oa_pdf/21/25/pgpm-7-307.PMC4205934.pdf
"Pharmacogenomics and Personalized Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/pharmacogenomics-and-personalized-medicine-journa lPharmacogenomics and Personalized Medicine is an international, peer- reviewed, open access journal characterizing the influence of genotype  on pharmacology leading to the development of personalized treatment  programs and individualized drug selection for improved safety, efficacy  and sustainability.",Non-OADS,/arxiv_data1/oa_pdf/21/25/pgpm-7-307.PMC4205934.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/21/25/pgpm-7-307.PMC4205934.pdf
"2014;46(4) :403-410 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2013.168    │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │403 Copyright ⓒ2014    by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f9/13/crt-2013-168.PMC4206062.pdf
"2014;46(4) :323-330 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2013.120  Open Access  Nomogram Predicting Clinical Outcomes in Non-small Cell Lung  Cancer Patients Treated with Epidermal Growth Factor Receptor  Tyrosine Kinase Inhibitors  Purpose The aim of this study was to develop a pragmatic nomogram for prediction of progression-  free survival (PFS) for the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor  (TKI) in EGFR mutant non-small cell lung cancer (NSCLC).",Non-OADS,/arxiv_data1/oa_pdf/95/2b/crt-2013-120.PMC4206063.pdf
"+  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + Correspondence: Dong-Wan Kim, MD, PhD  Department of Internal Medicine,  Seoul National University Hospital,  101 Daehak-ro, Jongno-gu, Seoul 110-744, Korea  Tel: 82-2-2072-2995  Fax: 82-2-764-2199  E-mail: kimdw@snu.ac.kr  Received  July 23, 2013  Accepted  October 1, 2013 Bhumsuk Keam, MD, PhD 1,2  Dong-Wan Kim, MD, PhD 1,2  Jin Hyun Park, MD 1 Jeong-Ok Lee, MD 1 Tae Min Kim, MD, PhD 1,2  Se-Hoon Lee, MD, PhD 1,2  Doo Hyun Chung, MD, PhD 3 Dae Seog Heo, MD, PhD 1,2  1Department of Internal Medicine,  Seoul National University Hospital, Seoul,  2Cancer Research Institute,  Seoul National University  College of Medicine, Seoul,  3Department of Pathology,  Seoul National University Hospital,  Seoul, Korea Original Article  │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │323 Copyright ⓒ2014    by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/95/2b/crt-2013-120.PMC4206063.pdf
2.13.2 (http://www.r-project.org).,Non-OADS,/arxiv_data1/oa_pdf/95/2b/crt-2013-120.PMC4206063.pdf
"R  package with the Design, and survcomp libraries (available  at URL: http://cran.r-project.org/web/packages/) were  used.",OADS,/arxiv_data1/oa_pdf/95/2b/crt-2013-120.PMC4206063.pdf
http://dx.doi.org/10.1007/s10147-013-0602-1.,Non-OADS,/arxiv_data1/oa_pdf/95/2b/crt-2013-120.PMC4206063.pdf
"2014;46(4) :425 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2014.123C  │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │425 Copyright ⓒ2014    by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3e/42/crt-2014-123C.PMC4206064.pdf
"2014;46(4) :366-373 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2013.185    Open Access  Clinical Characteristics and Adequate Treatment of  Familial Adenomatous Polyposis Combined with Desmoid Tumors  Purpose The objective of this study was to examine the clincopathologic characteristics and  outcomes of familial adenomatous polyposis (FAP) patients with and without desmoid  tumors (DTs), including the risk factors for progression of FAP-related DTs.",Non-OADS,/arxiv_data1/oa_pdf/49/83/crt-2013-185.PMC4206065.pdf
"Won Beom Jung, MD  Chan Wook Kim, MD  Jin Cheon Kim, MD  Department of Surgery,  Institute of Innovative Cancer Research,  Asan Medical Center,  University of Ulsan College of Medicine,  Seoul, Korea Original Article  │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │366 Copyright ⓒ2014 by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/49/83/crt-2013-185.PMC4206065.pdf
"2014;46(4) :331-338 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2013.130    │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │331 Copyright ⓒ2014    by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/52/5c/crt-2013-130.PMC4206066.pdf
"2014;46(4) :426 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2014.123R  Reply to Commentary on “A Nationwide Survey of Knowledge of  and Compliance with Cancer Pain Management Guidelines by  Korean Physicians”  Do Yeun Kim, MD 1, Si-Young Kim, MD 2 1Department of Internal Medicine, Dongguk University Ilsan Hospital, Dongguk University College of Medicine, Goyang,  2Department of Internal Medicine, Kyung Hee University Medical Center, Kyung Hee University School of Medicine, Seoul, Korea  We appreciate the comments, and appropriate questions raised by Dr. Walsh K [1].",Non-OADS,/arxiv_data1/oa_pdf/6a/6a/crt-2014-123R.PMC4206067.pdf
"Letter to the Editor  Correspondence: Si-Young Kim, MD  Division of Hematology and Medical Oncology, Department of Internal Medicine, Kyung Hee University Medical Center,  23 Kyungheedae-ro, Dongdaemun-gu, Seoul 130-872, Korea  Tel: 82-2-958-8204,  E-mail: sykim@khu.ac.kr  Received July 2, 2014  Accepted July 16, 2014 Open Access  │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │426 Copyright ⓒ2014 by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6a/6a/crt-2014-123R.PMC4206067.pdf
"2014;46(4) :358-365 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2013.047    Original Article Open Access  Clinical Outcome of Relapsed or Refractory Burkitt Lymphoma and  Mature B-Cell Lymphoblastic Leukemia in Children and Adolescents  1Department of Pediatrics,  SMG-SNU Boramae Medical Center,  Seoul National University College of Medicine,  Seoul, 2Department of Pediatrics,  Gyeongsang National University School of Medicine,  Jinju, 3Gyeongsang Institute of Health Sciences,  Gyeongsang National University, Jinju,  4Department of Pediatrics,  Samsung Medical Center, Sungkyunkwan University  School of Medicine, Seoul,  5Department of Pediatrics,  Yonsei University College of Medicine, Seoul,  6Department of Pediatrics,  Pusan National University School of Medicine,  Busan, 7Department of Pediatrics,  Chonnam National University Hwasun Hospital,  Chonnam National University Medical School,  Hwasun, 8Department of Pediatrics,  Seoul National University College of Medicine, Seoul,  9Cancer Research Institute  Seoul National University, Seoul, Korea Purpose Despite the rapid improvement in survival rate from Burkitt lymphoma and mature B-cell  lymphoblastic leukemia (B-ALL) in children, a small subset of patients do not respond to  first-line chemotherapy or experience relapse (RL).",Non-OADS,/arxiv_data1/oa_pdf/ab/0f/crt-2013-047.PMC4206068.pdf
"In an international  cooperative study, patients with central nervous system  (CNS)-positive and/or mature B-cell acute lymphoblastic Hyery Kim, MD 1 Eun Sil Park, MD, PhD 2,3  Soo Hyun Lee, MD, PhD 4 Hong Hoe Koo, MD, PhD 4 Hyo Sun Kim, MD 5 Chuhl Joo Lyu, MD, PhD 5 So Eun Jun, MD 6 Young Tak Lim, MD, PhD 6 Hee Jo Baek, MD, PhD 7 Hoon Kook, MD, PhD 7 Ji Won Lee, MD 8,9  Hyoung Jin Kang, MD, PhD 8,9  Kyung Duk Park, MD, PhD 8,9  Hee Young Shin, MD, PhD 8,9  Hyeo Seop Ahn, MD, PhD 8,9  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + Correspondence: Eun Sil Park, MD, PhD  Department of Pediatrics, Gyeongsang Institute  of Health Sciences, Gyeongsang National  University School of Medicine, 79 Gangnam-ro,  Jinju 660-702, Korea  Tel: 82-55-750-8829  Fax: 82-55-752-9339  E-mail: espark@gsnu.ac.kr  Received  March 20, 2013  Accepted  October 31, 2013  │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │358 Copyright ⓒ2014 by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ab/0f/crt-2013-047.PMC4206068.pdf
"2014;46(4) :415-418 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2013.068  │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │415 Copyright ⓒ2014    by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/90/aa/crt-2013-068.PMC4206069.pdf
"2014;46(4) :411-414 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2013.093  │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │411 Copyright ⓒ2014    by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a5/63/crt-2013-093.PMC4206070.pdf
"2014;46(4) :374-382 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2013.084  Open Access  Is Prophylactic Irradiation to Para-aortic Lymph Nodes in  Locally Advanced Cervical Cancer Necessary?",Non-OADS,/arxiv_data1/oa_pdf/c1/fb/crt-2013-084.PMC4206071.pdf
"In a comparison between EFI without chemotherapy +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + Correspondence: Jin Hee Kim, MD, PhD  Department of Radiation Oncology,  Keimyung University Dongsan Medical Center,  Keimyung University School of Medicine,  56 Dalseong-ro, Jung-gu, Daegu 700-712, Korea  Tel: 82-53-250-7665  Fax: 82-53-250-7984  E-mail: jhkim@dsmc.or.kr  Received  May 28, 2013  Accepted  October 31, 2013 Seung Gyu Park, MD 1 Jin Hee Kim, MD, PhD 1 Young Kee Oh, PhD 1 Sang Jun Byun, MD 1 Mi Young Kim, MD 1 Sang Hoon Kwon, MD, PhD 2 Ok Bae Kim, MD, PhD 1 Departments of 1Radiation Oncology and  2Obstetrics and Gynecology,  Keimyung University  Dongsan Medical Center,  Keimyung University School of Medicine,  Daegu, Korea Original Article  │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │374 Copyright ⓒ2014 by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c1/fb/crt-2013-084.PMC4206071.pdf
"2014;46(4) :393-402 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2013.132  │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │393 Copyright ⓒ2014    by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a8/b4/crt-2013-132.PMC4206072.pdf
"2014;46(4) :383-392 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2013.102  │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │383 Copyright ⓒ2014    by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f6/f8/crt-2013-102.PMC4206073.pdf
"│http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │348 Copyright ⓒ2014 by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/46/fe/crt-2013-142.PMC4206074.pdf
"2014;46(4) :348-357 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2013.142  Open Access  Multicenter Validation Study of a Prognostic Index for  Portal Vein Tumor Thrombosis in Hepatocellular Carcinoma  Purpose We previously reported on a staging system and prognostic index (PITH) for portal vein tumor  thrombosis (PVTT) in hepatocellular carcinoma (HCC) patients treated with radiotherapy  (RT) at a single institution.",Non-OADS,/arxiv_data1/oa_pdf/46/fe/crt-2013-142.PMC4206074.pdf
"2014;46(4) :419-424 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2013.104  │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │419 Copyright ⓒ2014    by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/02/65/crt-2013-104.PMC4206075.pdf
"2014;46(4) :339-347 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2013.154    │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │339 Copyright ⓒ2014    by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b2/76/crt-2013-154.PMC4206076.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJune 2014 |  88  | e51649 | Page 1 of 9Video Article Establishment and Optimization of a High Throughput Setup to Study Staphylococcus epidermidis  and Mycobacterium marinum  Infection as a Model for Drug Discovery Wouter J. Veneman*1, Rubén Marín-Juez*2, Jan de Sonneville3, Anita Ordas1, Susanne Jong-Raadsen2, Annemarie H. Meijer1, Herman P. Spaink1 1Institute of Biology, Leiden University 2ZF-screens BV 3Life Science Methods BV *These authors contributed equally Correspondence to: Wouter J. Veneman at w.j.veneman@biology.leidenuniv.nl, Herman P. Spaink at h.p.spaink@biology.leidenuniv.nl URL: http://www.jove.com/video/51649 DOI: doi:10.3791/51649 Keywords: Infection, Issue 88, Zebrafish, Staphylococcus epidermidis , Mycobacterium marinum , automated injection, high throughput screening, COPAS XL, VAST BioImager, host pathogen interaction, drug screen, CLSM Date Published: 6/26/2014 Citation: Veneman, W.J., Marín-Juez, R., de Sonneville, J., Ordas, A., Jong-Raadsen, S., Meijer, A.H., Spaink, H.P.",Non-OADS,/arxiv_data1/oa_pdf/30/32/jove-88-51649.PMC4206090.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/51649/ Introduction To date the zebrafish (Danio rerio ) has been successfully established as an efficient model to study a variety of infectious diseases1.,Non-OADS,/arxiv_data1/oa_pdf/30/32/jove-88-51649.PMC4206090.pdf
"Available from: http://www.mds.gov.br/assistenciasocial/secretaria-nacional-de-assistencia-social-snas/cadernos/cadernos-suas- evolucao-dos-recursos-dos-programas-de-transferencia-de-renda b Ministério do Desenvolvimento Social e Combate à Fome, Secretaria de Avaliação e Gestão da Informação.",OADS,/arxiv_data1/oa_pdf/90/8e/rsp-47-06-1159.PMC4206093.pdf
"Available from: http://aplicacoes.mds.gov.br/sagi/RIv3/geral/ c Ministério da Saúde, Secretaria de Atenção à Saúde, Departamento de Atenção Básica, Coordenação Geral de Alimentação e Nutrição.",OADS,/arxiv_data1/oa_pdf/90/8e/rsp-47-06-1159.PMC4206093.pdf
"Available from: http://siteresources.worldbank.org/EXTLACREGTOPPOVANA/Resources/OlintoFloresMorrisVeigaimpactcofbolsadeali entacaoprogram.pdf h Santos LMP, Guanais F, Porto DL, Morais Neto OL, Stevens A, Escalante JJC, et al.",OADS,/arxiv_data1/oa_pdf/90/8e/rsp-47-06-1159.PMC4206093.pdf
Disponível em: http://www.fao.org/docrep/005/ Y4249E/y4249e0a.htm#bm10 5.,Non-OADS,/arxiv_data1/oa_pdf/90/8e/rsp-47-06-1159.PMC4206093.pdf
Disponível em: http://www.fao.org/docrep/005/ Y4249E/y4249e0d.htm#bm13 13.,Non-OADS,/arxiv_data1/oa_pdf/90/8e/rsp-47-06-1159.PMC4206093.pdf
Disponível em: http://www.who.int/childgrowth/publications/physical_status/en/index.html,Non-OADS,/arxiv_data1/oa_pdf/90/8e/rsp-47-06-1159.PMC4206093.pdf
Available from: http://riskfactor.cancer.gov/diet/usualintakes,Non-OADS,/arxiv_data1/oa_pdf/c7/cc/rsp-47-06-1021.PMC4206095.pdf
Available from: http://www.ibge.gov.br/home/xml/pof_2008_2009.shtm,Non-OADS,/arxiv_data1/oa_pdf/c7/cc/rsp-47-06-1021.PMC4206095.pdf
Available from: http://www.seade.gov.br/ produtos/perfil/perfil.php h Sistema de Informações de Nascidos Vivos.,OADS,/arxiv_data1/oa_pdf/d6/fe/rsp-47-06-1141.PMC4206096.pdf
Available from: http://www.ribeiraopreto.sp.gov.br/ssaude/vigilancia/vigep/tabnet/ i16nascidos.php,Non-OADS,/arxiv_data1/oa_pdf/d6/fe/rsp-47-06-1141.PMC4206096.pdf
Available from: http://bvsms.saude.gov.br/bvs/publicacoes/inca/PET_ab_2011.pdf b Agência Nacional de Vigilância Sanitária (Anvisa).,Non-OADS,/arxiv_data1/oa_pdf/1d/cf/rsp-47-06-1123.PMC4206097.pdf
Available from: http://portal.anvisa.gov.br/wps/portal/anvisa/anvisa/busca/!ut/p/c5/04_SB8K8xLLM9MSSzPy8xBz9CP0os3jvQA9PdwMDI0v_EAsXA0-TkCAPS29nfzdDQ6B8pFm8AQ7gaADS7ezu6GFi7gPkmzk5G3i6m_qZmQb6Gxj4Q3XjlDcixm48puPXHQ7yK37bQfJ4_ObnkZ-bql-QGxoaYZBlAgC5fbbW/?1dmy&urile=wcm%3apath%3a//Anvisa Portal/Anvisa/Sala de Imprensa/Assunto de Interesse/Noticias/Cigarros com sabor deverao ser retirados do mercado brasileiro,Non-OADS,/arxiv_data1/oa_pdf/1d/cf/rsp-47-06-1123.PMC4206097.pdf
Available from: http://www.who.int/tobacco/mpower/mpower_report_full_2008.pdf e Instituto Brasileiro de Geografia e Estatística.,OADS,/arxiv_data1/oa_pdf/1d/cf/rsp-47-06-1123.PMC4206097.pdf
"Available from: http://www.ibge.gov.br/home/estatistica/populacao/trabalhoerendimento/pnad2008/suplementos/tabagismo/default.shtmArticle 12 of the World Health Organization Framework  Convention on Tobacco Control (WHO FCTC) advo- cates education, communication, training, and public awareness “… on the health risks including the addic - tive characteristics of tobacco consumption and expo- sure to tobacco smoke”.",Non-OADS,/arxiv_data1/oa_pdf/1d/cf/rsp-47-06-1123.PMC4206097.pdf
Available from: http://www.paho.org/English/DD/PUB/profits_over_people.pdf 2.,Non-OADS,/arxiv_data1/oa_pdf/1d/cf/rsp-47-06-1123.PMC4206097.pdf
Available from: http://www-wds.worldbank.org/servlet/WDSContentServer/WDSP/IB/2012/10/23/000158349_20121023093211/Rendered/PDF/wps6248.pdf,Non-OADS,/arxiv_data1/oa_pdf/7c/4d/rsp-47-06-1039.PMC4206098.pdf
Available from: http://tabnet.datasus.gov.br/cgi/tabcgi.exe?sih/cnv/nrsp.def b União da Indústria de Cana de Açúcar.,OADS,/arxiv_data1/oa_pdf/81/9f/rsp-47-06-1209.PMC4206099.pdf
Available  from: http://www.unicadata.com.br/historico-de-producao-e-moagem.php?idMn=32&tipoHistorico=4&acao=visualizar&idTabela=1424&safra =2012%2F2013&estado=RS%2CSC%2CPR%2CSP%2CRJ%2CMG%2CES%2CMS%2CMT%2CGO%2CDF%2CBA%2CSE%2CAL%2CPE%2CPB%2CRN%2CCE%2CPI%2CMA%2CTO%2CPA%2CAP%2CRO%2CAM%2CAC%2CRR c Universidade de São Paulo.,Non-OADS,/arxiv_data1/oa_pdf/81/9f/rsp-47-06-1209.PMC4206099.pdf
Available from: http://www.leb.esalq.usp.br/posto.html d Instituto Brasileiro de Geografia e Estatística.,Non-OADS,/arxiv_data1/oa_pdf/81/9f/rsp-47-06-1209.PMC4206099.pdf
Available from:  http://www.cetesb.sp.gov.br/ar/Informa?,Non-OADS,/arxiv_data1/oa_pdf/81/9f/rsp-47-06-1209.PMC4206099.pdf
Available  from: http://www.minsalud.gov.co/salud/Paginas/ProgramaAmpliadodeInmunizaciones(PAI).aspx b Departamento Administrativo Nacional de Estadística de Colombia.,Non-OADS,/arxiv_data1/oa_pdf/a5/8a/rsp-47-06-1080.PMC4206100.pdf
Available from:  http://www.dane.gov.co/index.php?option=com_content&view=article&id=75&Itemid=72,Non-OADS,/arxiv_data1/oa_pdf/a5/8a/rsp-47-06-1080.PMC4206100.pdf
Available from: http://www.saude.sp.gov.,Non-OADS,/arxiv_data1/oa_pdf/a6/32/rsp-47-06-1030.PMC4206101.pdf
Available from: http://www.measuredhs.com/pubs/pdf/SR160/SR160.pdf b Sociedade Civil Bem-Estar Familiar no Brasil.,OADS,/arxiv_data1/oa_pdf/a0/d7/rsp-47-06-1205.PMC4206102.pdf
Available from: http://bvsms.saude.gov.br/bvs/publicacoes/pnds_crianca_mulher.pdf  d World Health Organization.,Non-OADS,/arxiv_data1/oa_pdf/a0/d7/rsp-47-06-1205.PMC4206102.pdf
Available from: http://www.who.int/nutrition/publications/infantfeeding/9789241596664/en/,Non-OADS,/arxiv_data1/oa_pdf/a0/d7/rsp-47-06-1205.PMC4206102.pdf
Available from: <http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2003000700005&lng=pt&nrm=iso>.,OADS,/arxiv_data1/oa_pdf/a0/d7/rsp-47-06-1205.PMC4206102.pdf
Available from: http://www.whocc.no/atc_ddd_index/,OADS,/arxiv_data1/oa_pdf/b8/5d/rsp-47-06-1102.PMC4206103.pdf
Available from: http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/61/c9/rsp-47-06-1172.PMC4206105.pdf
Available from: http://www.scielo.,Non-OADS,/arxiv_data1/oa_pdf/61/c9/rsp-47-06-1172.PMC4206105.pdf
"Available from: http://www.childrenwithcancer.org.uk/infection-and-leukaemiaTable 3. Review of studies on daycare attendance and risk of childhood leukemia, 1973-2011.",Non-OADS,/arxiv_data1/oa_pdf/61/c9/rsp-47-06-1172.PMC4206105.pdf
Available from: http://www.epifloripa.ufsc.br c Instituto Brasileiro de Geografia e Estatística.,Non-OADS,/arxiv_data1/oa_pdf/69/ba/rsp-47-06-1028.PMC4206107.pdf
Available from: http://www.ibge.gov.br,Non-OADS,/arxiv_data1/oa_pdf/69/ba/rsp-47-06-1028.PMC4206107.pdf
Available from: http://tuberculosesp.cealag.com.br/ c Prefeitura Municipal de Ribeirão Preto.,Non-OADS,/arxiv_data1/oa_pdf/3b/cf/rsp-47-06-1149.PMC4206108.pdf
Available from: http://www.ribeiraopreto.sp.gov.br/ssaude/conselho/i16relatorio-gestao-09.pdf d Mamede S. Os modelos tradicionais para a educação continuada e seus resultados.,OADS,/arxiv_data1/oa_pdf/3b/cf/rsp-47-06-1149.PMC4206108.pdf
Available from: http://cnes.datasus.gov.br/,OADS,/arxiv_data1/oa_pdf/3b/cf/rsp-47-06-1149.PMC4206108.pdf
Disponível em: http://www.fen.ufg.br/fen_revista/v9/ n1/pdf/v9n1a08.pdf 15.,Non-OADS,/arxiv_data1/oa_pdf/3b/cf/rsp-47-06-1149.PMC4206108.pdf
"Available from: http://svs.aids.gov.br/dashboard/mortalidade/infantil.show.mtw b Szwarcwald CL, Morais Neto OL, Frias PG, Souza Jr PRB, Escalante JJC, Lima RB, et al.",Non-OADS,/arxiv_data1/oa_pdf/7c/af/rsp-47-06-1048.PMC4206109.pdf
Available from: http://www.un.org/esa/population/techcoop/DemMod/model_lifetabs/model_lifetabs.html,Non-OADS,/arxiv_data1/oa_pdf/7c/af/rsp-47-06-1048.PMC4206109.pdf
Available from: http://www.cve.saude.sp.gov.br/htm/cve_im.html,Non-OADS,/arxiv_data1/oa_pdf/a8/ab/rsp-47-06-1213.PMC4206110.pdf
Available from: http://www.infraero.,Non-OADS,/arxiv_data1/oa_pdf/a8/ab/rsp-47-06-1213.PMC4206110.pdf
Available from: http://www.epa.gov/iaq/schools d Portugal.,Non-OADS,/arxiv_data1/oa_pdf/b3/4c/rsp-47-06-1059.PMC4206112.pdf
Available  from: http://www.apambiente.pt/serviços/LaboratórioReferenvia/Documents/Manual%20QAI%20APA%20Maio%202010.,Non-OADS,/arxiv_data1/oa_pdf/b3/4c/rsp-47-06-1059.PMC4206112.pdf
Available from: http://americanhomeinspect.net/reference.html j American National Standards Institute.,OADS,/arxiv_data1/oa_pdf/b3/4c/rsp-47-06-1059.PMC4206112.pdf
Available from: http://www.capes.gov.br/sobre-a-capes/plano- nacional-de-pos-graduacao/pnpg-2011-2020.,Non-OADS,/arxiv_data1/oa_pdf/ab/3a/rsp-48-01-0001.PMC4206114.pdf
Available from: http://lattes.cnpq.br,Non-OADS,/arxiv_data1/oa_pdf/ab/3a/rsp-48-01-0001.PMC4206114.pdf
Available from: http://www.hesa.ac.uk Table 5.,Non-OADS,/arxiv_data1/oa_pdf/ab/3a/rsp-48-01-0001.PMC4206114.pdf
Available from: http://www.ebras.bio.br/autor/aulas/ estat_ambiental_2008.pdf c Machado OG.,OADS,/arxiv_data1/oa_pdf/c7/e5/rsp-48-01-0063.PMC4206115.pdf
DOI:http://dx.doi.org/10.1186/1472-6831-6-3 5.,Non-OADS,/arxiv_data1/oa_pdf/48/95/rsp-48-01-0142.PMC4206116.pdf
Available  from: http://www.planalto.gov.br/ccivil_03/leis/l8142.htm b Spinetti SR. A ouvidoria nos três níveis de gestão da saúde [tese de doutorado].,OADS,/arxiv_data1/oa_pdf/9a/09/rsp-48-01-0134.PMC4206117.pdf
Available from:  http://cidades.ibge.gov.br/xtras/home.php e Secretaria Municipal de Saúde de Brumadinho.,Non-OADS,/arxiv_data1/oa_pdf/9a/09/rsp-48-01-0134.PMC4206117.pdf
"Available from: http://www21.rio.rj.gov.br/siso/internet/ ouvidoria.htm o See, for example, the objectives of the National Civil Aviation Agency, Ombudsman.",Non-OADS,/arxiv_data1/oa_pdf/9a/09/rsp-48-01-0134.PMC4206117.pdf
Available from: http://www2.anac.,Non-OADS,/arxiv_data1/oa_pdf/9a/09/rsp-48-01-0134.PMC4206117.pdf
"Available from: http://www.sbp.com.br/pdfs/PRN-SBP-Reanima%C3%A7%C3%A3oNeonatalFinal-2011-25mar11.pdf  b Ministério da Saúde, DATASUS.",OADS,/arxiv_data1/oa_pdf/bf/92/rsp-48-01-0010.PMC4206121.pdf
Available  from: http://tabnet.datasus.gov.br/cgi/deftohtm.exe?sinasc/cnv/nvmg.defIron deficiency in the first few months of a child’s  life is a public health problem.,Non-OADS,/arxiv_data1/oa_pdf/bf/92/rsp-48-01-0010.PMC4206121.pdf
Available  from: http://www.ibge.gov.br/home/estatistica/populacao/censo2010/rendimentos_preliminares/default_rendimentos_preliminares.shtm f Dollar = 2.415 in 2014. g Instituto de Pesquisa Econômica Aplicada.,OADS,/arxiv_data1/oa_pdf/bf/92/rsp-48-01-0010.PMC4206121.pdf
Available from: http://exame.abril.com.br/negocios/empresas/ melhores-e-maiores/ranking/2013/,Non-OADS,/arxiv_data1/oa_pdf/02/92/rsp-48-01-0103.PMC4206122.pdf
Available  from: http://www.abep.org/novo/FileGenerate.ashx?id=252 b Equivalent value in dollar = US$ 834.5,OADS,/arxiv_data1/oa_pdf/73/64/rsp-48-01-0043.PMC4206123.pdf
Available from: http://bvsms.saude.gov.br/bvs/publicacoes/168comporamento.pdf e Ministério da Saúde.,Non-OADS,/arxiv_data1/oa_pdf/73/64/rsp-48-01-0043.PMC4206123.pdf
"Available from: http://www.strobe-statement.org/n = 495 n = 501 n = 461 n = 56 n = 40n = 40• Articles found in the bibliogr aphic databases • Articles identified from the bibliogr aphies    of reco vered articles = 6 • Repeated and redundant articles = 40 • Articles excluded for not meeting inclusion    criteria:    - Complete text not recovered: 18    - In other languages: 9 (Russian, 4;     German, 2; J apanese, 2; F innish, 1)    - Editorial, opinion, review and others: 170   - Not dealing with the topic: 208 • Articles eliminated after applying exclusion     criteria: dealing with GM and labeling and    not conducting an y interv ention = 16 • Total articles selected for the revie w Figure.",Non-OADS,/arxiv_data1/oa_pdf/62/63/rsp-48-01-0154.PMC4206125.pdf
Available from:  http://www.mds.gov.br,Non-OADS,/arxiv_data1/oa_pdf/ca/0a/rsp-48-01-0019.PMC4206126.pdf
Available from: http://www.observatoriorh.org/sites/default/files/webfiles/fulltext/OPS_desafios_toronto_2005.pdf b Organizacion Mundial de la Salud.,Non-OADS,/arxiv_data1/oa_pdf/65/fe/rsp-48-01-0170.PMC4206127.pdf
Available from: http://www.paho.org/spanish/gov/csp/csp27-10-s.pdfForming a team of health care professionals is a chal- lenge that pervades political settings and institutional practices in order to meet the expectations of the quality  of care provided to the community.,Non-OADS,/arxiv_data1/oa_pdf/65/fe/rsp-48-01-0170.PMC4206127.pdf
Available from: http://citrus.uspnet.usp.br/sibi/tutoriais/Manual_EndNoteWeb_publicacao.pdf d Ferraz F. Contextos e processos de desenvolvimento das comissões permanentes de integração de ensino-serviço: perspectiva dos sujeitos  sociais pautada na concepção dialógica de Paulo Freire [tese de doutorado].,OADS,/arxiv_data1/oa_pdf/65/fe/rsp-48-01-0170.PMC4206127.pdf
Available from: http://www.saude.gov.br/sgtes  h Ministério da Saúde.,Non-OADS,/arxiv_data1/oa_pdf/65/fe/rsp-48-01-0170.PMC4206127.pdf
Available  from: http://www.unfpa.org/hiv/women b Boletim Epidemiológico de DST/Aids.,Non-OADS,/arxiv_data1/oa_pdf/a7/2c/rsp-48-01-0036.PMC4206128.pdf
Available from: http://data.unaids.org/publications/irc-pub07/ jc1279-gcwa-5_es.pdf,Non-OADS,/arxiv_data1/oa_pdf/a7/2c/rsp-48-01-0036.PMC4206128.pdf
"Available from:  http://tabnet.datasus.gov.br/tabdata/cadernos/cadernosmap.htm f Sistema de Informação da Febre Amarela e Dengue, 2002 a 2006, versão 13.4. g Sistema de Informação da Febre Amarela e Dengue, 2007 e 2008, versão 14. h Sistema de Informação da Atenção Básica, 2002 a 2008 versão 5.0.",OADS,/arxiv_data1/oa_pdf/ab/da/rsp-48-01-0113.PMC4206130.pdf
Available from: http://brasilsus.com.br/legislacoes/gm/110154-2488.htmlFigure 3.,Non-OADS,/arxiv_data1/oa_pdf/ab/da/rsp-48-01-0113.PMC4206130.pdf
Disponível em: http://www.seer.perspectivasonline.com.br/index.php/CBS/article/viewFile/111/ 16.,Non-OADS,/arxiv_data1/oa_pdf/ab/da/rsp-48-01-0113.PMC4206130.pdf
Available from: http://www.euro.who.int/__data/assets/pdf_file/0003/163857/Social-determinants-of-health-and-well-being-among-young-people.pdf c Centro Brasileiro de Informações sobre Drogas Psicotrópicas (BR).,OADS,/arxiv_data1/oa_pdf/19/01/rsp-48-01-0052.PMC4206131.pdf
Available from: http://www.previdencia.gov.br/arquivos/office/3_090316-092117-572.pdf g Peritos do INSS encerram greve após decisão judicial.,Non-OADS,/arxiv_data1/oa_pdf/83/d4/rsp-48-01-0186.PMC4206132.pdf
Available from: http://bvsms.saude.gov.br/bvs/publicacoes/relatorio_2003a2006_politica_saude_mulher.pdf,Non-OADS,/arxiv_data1/oa_pdf/97/6b/rsp-48-02-0304.PMC4206134.pdf
Available from:  http://europeristat.com/images/doc/Peristat%202013%20V2.pdf,Non-OADS,/arxiv_data1/oa_pdf/97/6b/rsp-48-02-0304.PMC4206134.pdf
Available from: http://www.abep.org/novo/Content.aspx?ContentID,Non-OADS,/arxiv_data1/oa_pdf/24/c1/rsp-48-02-0266.PMC4206135.pdf
Available from: http://www.saopaulo.sp.gov.br/acoesdegoverno/saude/#dose-certa c Ministério da Saúde.,Non-OADS,/arxiv_data1/oa_pdf/48/8a/rsp-48-02-0275.PMC4206137.pdf
"Available from: https://titanita.cirp.usp.br/moodle/course/info.php?id=426Continuation H1N1 0 0 4 5.8 0 0 Tetanus + Diphtheria 17 50.0 29 42.0 2 33.3 Hepatitis 14 41.2 39 56.5 3 50.0 Agreements/Partnerships 9 27.7 23 33.8 4 66.6 Disabled  Wheelchairs/Crutches 26 76.4 53 76.8 3 50.0 Visual 13 38.2 35 50.7 4 66.6 Auditory 13 38.2 18 26.1 3 50.0 Speech 12 35.3 15 21.7 1 16.6 RC: remand center; PU: prison unit; MASC: male; FEM: female a Percentage relative to the total column for all categories, except for Category B, expressed in interquartile ranges.",Non-OADS,/arxiv_data1/oa_pdf/48/8a/rsp-48-02-0275.PMC4206137.pdf
Disponível em: http://www.npaonline.org/website/download.asp?id= 11.,Non-OADS,/arxiv_data1/oa_pdf/85/34/rsp-48-02-0357.PMC4206139.pdf
Available from: http://www.armazemdedados.rio.rj.gov.br/,Non-OADS,/arxiv_data1/oa_pdf/ba/9e/rsp-48-02-0249.PMC4206140.pdf
Available from: http://www.cochrane.org/ d U.S. Preventive Service Task Force [Internet].,OADS,/arxiv_data1/oa_pdf/94/b2/rsp-48-02-0347.PMC4206142.pdf
"Available from: http://www.uspreventiveservicestaskforce.org/ e Centers for Disease Control and Prevention, Office of Public Health Genomics.",OADS,/arxiv_data1/oa_pdf/94/b2/rsp-48-02-0347.PMC4206142.pdf
Available from: http://www.cdc.gov/genomics/hugenet/ f The complex object is a non-linear and multi-faceted systemic-model object.,OADS,/arxiv_data1/oa_pdf/94/b2/rsp-48-02-0347.PMC4206142.pdf
Available from: http://portal.anvisa.gov.br/wps/wcm/connect/d02994804745973f9fa1df3fbc4c6735/RDC+N%C2%BA.+DE+171-2006.pdf?MOD=AJPERESS,Non-OADS,/arxiv_data1/oa_pdf/94/b2/rsp-48-02-0347.PMC4206142.pdf
"Available from: http://www.unicef.org/publications/files/Children_and_the_MDGs.pdf m Maintaining the temperature of the transport so the product remains frozen between the point of origin and the destination, with no changes  in temperature which would cause microbiological or physicochemical non-compliance.",Non-OADS,/arxiv_data1/oa_pdf/94/b2/rsp-48-02-0347.PMC4206142.pdf
Available from: http://www.cryopraxis.com.br/home,Non-OADS,/arxiv_data1/oa_pdf/94/b2/rsp-48-02-0347.PMC4206142.pdf
Available from:  http://w3.datasus.gov.br/siscam/index.php?area=0401,OADS,/arxiv_data1/oa_pdf/b1/b7/rsp-48-02-0240.PMC4206144.pdf
Disponível em: http://www1.inca.gov.br/inca/Arquivos/Livro_DARAO_utero.pdf 18.,Non-OADS,/arxiv_data1/oa_pdf/b1/b7/rsp-48-02-0240.PMC4206144.pdf
Disponível em: http://www1.inca.gov.br/inca/Arquivos/Livro_DARAO_utero.pdf 19.,Non-OADS,/arxiv_data1/oa_pdf/b1/b7/rsp-48-02-0240.PMC4206144.pdf
Disponível em: http://www.inca.gov.br/estimativa/2010/ 20.,Non-OADS,/arxiv_data1/oa_pdf/b1/b7/rsp-48-02-0240.PMC4206144.pdf
Disponível em: http://www.who.int/cancer/modules/Early%20 Detection%20Module%203.pdf 28.,Non-OADS,/arxiv_data1/oa_pdf/b1/b7/rsp-48-02-0240.PMC4206144.pdf
Available from: http://www.ibge.gov.br/cidadesat/topwindow.htm?,Non-OADS,/arxiv_data1/oa_pdf/30/65/rsp-48-02-0326.PMC4206145.pdf
Available from: http://www.denatran.gov.br/frota2013.htmTable.,Non-OADS,/arxiv_data1/oa_pdf/30/65/rsp-48-02-0326.PMC4206145.pdf
Available from: http://www.iea.sp.gov.br/out/bioenergia/legislacao/2002_Lei_Est_11241.pdf d Secretaria do Meio Ambiente do Estado de São Paulo; Secretaria da Agricultura e Abastecimento do Estado de São Paulo; União da  Agroindústria de São Paulo.,OADS,/arxiv_data1/oa_pdf/30/65/rsp-48-02-0326.PMC4206145.pdf
"Available from: http://www.ambiente.sp.gov.br/etanolverde/files/2011/10/protocoloAgroindustriais.pdf e World Health Organization, Regional Office for Europe.",OADS,/arxiv_data1/oa_pdf/30/65/rsp-48-02-0326.PMC4206145.pdf
Available from: http://www.euro.who.int/_data/assets/pdf_file/0005/78638/E90038.pdf,OADS,/arxiv_data1/oa_pdf/30/65/rsp-48-02-0326.PMC4206145.pdf
Available from: http://www2.datasus.gov.br/ DATASUS/index.php?area=02,OADS,/arxiv_data1/oa_pdf/53/c4/rsp-48-02-0216.PMC4206148.pdf
Available from: http://www.ensp.fiocruz.br/portal-ensp/pos-graduacao/site/projetos-de-pesquisa/detalhes/?site=2&id=3259,Non-OADS,/arxiv_data1/oa_pdf/53/c4/rsp-48-02-0216.PMC4206148.pdf
Available from: http://digitalcommons.uconn.edu/nera_2008/31,Non-OADS,/arxiv_data1/oa_pdf/35/c1/rsp-48-02-0206.PMC4206150.pdf
"Available from: http://www.ispor.org/student/teleconferences/ISPORStudentForumPresentation022410.pdf b Ministério da Saúde, Secretaria de Atenção à Saúde.",Non-OADS,/arxiv_data1/oa_pdf/d8/a8/rsp-48-02-0284.PMC4206152.pdf
"Available from: http://bvsms.saude.gov.br/bvs/saudelegis/sas/2005/prt0741_19_12_2005.html c Ministério da Saúde, Secretaria de Atenção à Saúde, Departamento de Regulação, Avaliação e Controle, Coordenação Geral de Sistemas  de Informação.",OADS,/arxiv_data1/oa_pdf/d8/a8/rsp-48-02-0284.PMC4206152.pdf
"Available from: http://www1.inca.gov.br/inca/Arquivos/manual_oncologia_13edicao_agosto_2011.pdf d Ministério da Saúde, Instituto Nacional do Câncer José Alencar Gomes da Silva.",Non-OADS,/arxiv_data1/oa_pdf/d8/a8/rsp-48-02-0284.PMC4206152.pdf
Available from: http://www.inca.gov.br/estimativa/2012/estimativa20122111.pdf,Non-OADS,/arxiv_data1/oa_pdf/d8/a8/rsp-48-02-0284.PMC4206152.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/be/58/dddt-8-1923.PMC4206198.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 1923–1928Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1923Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/DDDT .S6979 1Influence of caffeine and hyaluronic acid   on collagen biosynthesis in human skin   fibroblasts Magdalena Donejko1 andrzej Przylipiak1 edyta rysiak2 Katarzyna Głuszuk2 Arkadiusz Surażyński2 1Department of Esthetic Medicine,   2Department of Medicinal Chemistry,   Faculty of Pharmacy, Medical  University of Białystok, Białystok,   PolandAim:  The aim of this study was to evaluate the effect of caffeine on collagen biosynthesis in  human skin fibroblasts and the influence of hyaluronic acid (HA) on this process.",Non-OADS,/arxiv_data1/oa_pdf/be/58/dddt-8-1923.PMC4206198.pdf
"This  protein affects the structure maintenance (elasticity and durability) of many organs, correspondence: Magdalena Donejko Department of Esthetic Medicine,  Faculty of Pharmacy, Medical University  of Białystok, 3 Akademicka Street,  15-267 Białystok, Poland email donejko@gmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Donejko et al Running head recto: Influence of caffeine and hyaluronic acid on collagen biosynthesis DOI: http://dx.doi.org/10.2147/DDDT.S69791",Non-OADS,/arxiv_data1/oa_pdf/be/58/dddt-8-1923.PMC4206198.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/be/58/dddt-8-1923.PMC4206198.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/be/58/dddt-8-1923.PMC4206198.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4d/7c/dddt-8-1911.PMC4206199.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 1911–1922Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1911Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/DDDT .S4958 4Animal models and therapeutic molecular   targets of cancer: utility and limitations Maria Cekanova Kusum Rathore Department of Small Animal   Clinical Sciences, College of  veterinary Medicine, The   University of T ennessee,    Knoxville, TN, USA Correspondence: Maria Cekanova   Department of Small Animal Clinical   Sciences, The University of Tennessee,   College of veterinary Medicine 2407   River Drive A122, Knoxville,   TN 37996-4550, USA   Tel +1 865 389 5222   Fax +1 865 974 5554   email mcekanov@utk.ed uAbstract:  Cancer is the term used to describe over 100 diseases that share several common  hallmarks.",Non-OADS,/arxiv_data1/oa_pdf/4d/7c/dddt-8-1911.PMC4206199.pdf
"Available from:  https://ccrod.cancer.gov/confluence/display/CCRCOPWeb/Hom e.  Accessed March 28, 2014.",OADS,/arxiv_data1/oa_pdf/4d/7c/dddt-8-1911.PMC4206199.pdf
"Available  from: http://www.lls.org/content/nationalcontent/resourcecenter/ freeeducationmaterials /generalcancer/pdf/facts.pd f. Accessed   April 29, 2014.",Non-OADS,/arxiv_data1/oa_pdf/4d/7c/dddt-8-1911.PMC4206199.pdf
Available from: http://www.akcchf.,Non-OADS,/arxiv_data1/oa_pdf/4d/7c/dddt-8-1911.PMC4206199.pdf
Available from: http://www.cancer.,Non-OADS,/arxiv_data1/oa_pdf/4d/7c/dddt-8-1911.PMC4206199.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/4d/7c/dddt-8-1911.PMC4206199.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4d/7c/dddt-8-1911.PMC4206199.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/78/0c/copd-9-1119.PMC4206200.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of COPD 2014:9 1119–1132International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1119RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S5447 7Lower airway colonization and inflammatory  response in COPD: a focus on Haemophilus  influenzae Lydia J Finney1 Andrew Ritchie1 elizabeth Pollard2 Sebastian L Johnston1 Patrick Mallia1 1Airway Disease Infection Section,   National Heart and Lung Institute,   Imperial College, London, United  Kingdom; 2King’s College London,   London, United Kingdom Correspondence: Patrick Mallia   Airway Disease Infection Section,   National Heart and Lung Institute,   Imperial College, Norfolk Place,   London w2 1PG, United Kingdom   Tel +020 7594 3751   email p.mallia@imperial.ac.u kAbstract:  Bacterial infection of the lower respiratory tract in chronic obstructive pulmonary  disease (COPD) patients is common both in stable patients and during acute exacerbations.",Non-OADS,/arxiv_data1/oa_pdf/78/0c/copd-9-1119.PMC4206200.pdf
Epub ahead of print http://dx.doi.org/10.1038/ismej.2014.12 4.,Non-OADS,/arxiv_data1/oa_pdf/78/0c/copd-9-1119.PMC4206200.pdf
Epub  ahead of print http://dx.doi.org/10.1016/j.jcv.2014.06.025.,Non-OADS,/arxiv_data1/oa_pdf/78/0c/copd-9-1119.PMC4206200.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/78/0c/copd-9-1119.PMC4206200.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/78/0c/copd-9-1119.PMC4206200.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ab/83/dddt-8-1929.PMC4206201.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 1929–1939Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1929Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S6737 6indole and synthetic derivative activate chaperone  expression to reduce polyQ aggregation in sca17  neuronal cell and slice culture models Pin-Jui Kung1,* Yu-chen Tao1,* ho-chiang hsu1 Wan-ling chen1 T e-hsien lin1 Donala Janreddy2 ching-Fa Yao2 Kuo-hsuan chang3 Jung-Yaw lin1 Ming-Tsan su1 chung-hsin Wu1 guey-Jen lee-chen1 hsiu-Mei hsieh-li1 1Department of life science,   2Department of chemistry, national  Taiwan normal University, Taipei,   Taiwan; 3Department of neurology,   chang gung Memorial hospital,   chang gung University college  of Medicine, Taipei, Taiwan  *These authors contributed equally  to this workAbstract:  In spinocerebellar ataxia type 17 (SCA17), the expansion of a translated CAG repeat  in the TATA box binding protein (TBP) gene results in a long polyglutamine (polyQ) tract  in the TBP protein, leading to intracellular accumulation of aggregated TBP and cell death.",Non-OADS,/arxiv_data1/oa_pdf/ab/83/dddt-8-1929.PMC4206201.pdf
"Keywords:  spinocerebellar ataxia type 17, TATA box binding protein, polyQ aggregation,  indole and derivative, therapeutics Introduction A large number of human disorders are caused by protein misfolding interfering  with diverse cellular processes.1 This is well illustrated by polyglutamine (polyQ)- mediated diseases such as Huntington’s disease and some forms of spinocerebellar  ataxias (SCA).2−9 As misfolded polyQ proteins result in aberrant protein aggregate  accumulation, the inhibition of aggregation is expected to also inhibit the associated  downstream pathogenic events.10  Among the polyQ-mediated SCA, SCA type 17 (SCA17) is caused by an expanded  polyQ in the TATA-box binding protein (TBP).9 In humans, the polyQ tract of TBP  normally contains 25–42 glutamine residues.11 TBP repeat expansions of greater than  43 repeats were found not only in the patients with cerebellar degeneration9,12−14 but  also in those with Parkinson’s disease, Alzheimer’s disease, multiple system atrophy- cerebellar type, and psychiatric disorders.15−18  Heat shock proteins (HSPs) are a group of evolutionarily conserved chaperones  that possess housekeeping function under physiological conditions to assist in protein  folding, transport, and refolding.19 Under conditions of stress, inducible HSPs are  highly up-regulated by heat shock factors (HSFs) to maintain cellular homeostasis and  develop cell survival functions.20,21 HSP70, the most conserved of the HSP families,  includes the cytosolic and nuclear constitutive HSC70 (HSPA8, heat shock 70 kDa  protein 8) and the stress-inducible H SP70 (HSPA1A, heat shock 70 kDa protein 1A) correspondence: guey-Jen lee-chen Department of life science, national  Taiwan normal University, 88 Ting-chou  rd, sec 4, Taipei 11677, Taiwan Tel +886 2 7734 6359 Fax +886 2 2931 2904 email t43019@ntnu.edu.t w  hsiu-Mei hsieh-li Department of life science, national  Taiwan normal University, 88 Ting-chou  rd, sec 4, Taipei 11677, Taiwan Tel +886 2 7734 6354 Fax +886 2 2931 2904 email hmhsieh@ntnu.edu.t w Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Kung et al Running head recto: Chaperone expression, polyQ aggregation in SCA17 neuronal cell and slice culture models DOI: http://dx.doi.org/10.2147/DDDT.S67376",Non-OADS,/arxiv_data1/oa_pdf/ab/83/dddt-8-1929.PMC4206201.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/ab/83/dddt-8-1929.PMC4206201.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ab/83/dddt-8-1929.PMC4206201.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a9/57/dddt-8-1839.PMC4206202.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 1839–1849Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1839Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S6730 5Potent tumor targeting drug release system  comprising MMP-2 specific peptide fragment  with self-assembling characteristics Dan hua1 Weiling Kong2 Xuemin Zheng2 Zhixing Zhou2 Bing Yu2 Yazhou li2 Yuli Wang2 Xue Yang2 changxiao liu2 lida Tang2 Ying li3 Min gong2 1School of Pharmacy, Tianjin Medical  University, 2Tianjin Institute of  Pharmaceutical research, state  Key Laboratory of Drug Delivery  and Pharmacokinetics, 3Tianjin  Neurological Institute, Tianjin Medical  University General Hospital, Tianjin,   People’s Republic of ChinaAbstract:  Self-assembling peptides are capable of forming a complex containing a cavity  where cytotoxic agents can be wrapped in a self-assembling manner.",Non-OADS,/arxiv_data1/oa_pdf/a9/57/dddt-8-1839.PMC4206202.pdf
"These enzymes help tumor cells to survive and grow  by breaking down the extracellular matrix, releasing growth factors to stimulate cell  proliferation and angiogenesis factors to promote blood vessel formation.8,9correspondence: Min gong  Tianjin Institute of Pharmaceutical  research, 308 anshan West rd,  Nankai Dist, Tianjin 300193,  People’s Republic of China  Tel +86 222 300 3529  Fax +86 222 300 6862 email gongm@tjipr.co m Ying li Tianjin Neurological Institute, Tianjin  Medical University general hospital,  154 Anshan Road, HePing District, Tianjin 300100, People’s Republic of China Tel +86 228 816 7056 email liying11_@hotmail.co mJournal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Hua et al Running head recto: MMP-2 specific peptide fragment with self-assembling properties DOI: http://dx.doi.org/10.2147/DDDT.S67305",Non-OADS,/arxiv_data1/oa_pdf/a9/57/dddt-8-1839.PMC4206202.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/a9/57/dddt-8-1839.PMC4206202.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/57/dddt-8-1839.PMC4206202.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/77/86/dmso-7-467.PMC4206203.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/77/86/dmso-7-467.PMC4206203.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/77/86/dmso-7-467.PMC4206203.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/52/43/copd-9-1133.PMC4206204.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of COPD 2014:9 1133–1144International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1133OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S7248 2Efficacy and safety of combining olodaterol  respimat® and tiotropium handihaler® in patients  with COPD: results of two randomized,   double-blind, active-controlled studies richard ZuWallack1 lisa allen2 gemzel hernandez2 Naitee Ting2 Roger Abrahams3 1saint Francis hospital and  Medical Center, hartford, CT,   Usa;  2Boehringer Ingelheim  Pharmaceuticals Inc., Ridgefield,   CT, Usa;  3Morgantown Pulmonary  Associates, Morgantown, WV, USA Correspondence: richard ZuWallack   saint Francis hospital and Medical  Center, Department of Pulmonary  Medicine,  114 Woodland street,  hartford, CT  06105, Usa   Tel +1 860 714 4055  Fax +1 860 714 8097  email rzuwalla@stfranciscare.or gBackground:  Combining bronchodilators with different mechanisms of action may improve  efficacy and reduce risk of side effects compared to increasing the dose of a single agent in chronic  obstructive pulmonary disease (COPD).",Non-OADS,/arxiv_data1/oa_pdf/52/43/copd-9-1133.PMC4206204.pdf
"Available  from: http://www.nhlbi.nih.gov/about/factbook-06/chapter4data.ht m.  Accessed March  21, 2014.",Non-OADS,/arxiv_data1/oa_pdf/52/43/copd-9-1133.PMC4206204.pdf
"Available from: http://www.goldcopd.org/uploads/ users/files/GOLD_Report_2013_Feb20.pd f. Accessed March  5,  2014.",OADS,/arxiv_data1/oa_pdf/52/43/copd-9-1133.PMC4206204.pdf
Available from http://clinicaltrials.gov/ show/NCT01694771.Identifier: NCT169477 1.,Non-OADS,/arxiv_data1/oa_pdf/52/43/copd-9-1133.PMC4206204.pdf
Available from http://clinicaltrials.gov/show/ NCT0169605 8.,Non-OADS,/arxiv_data1/oa_pdf/52/43/copd-9-1133.PMC4206204.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/52/43/copd-9-1133.PMC4206204.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/52/43/copd-9-1133.PMC4206204.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bf/d7/dddt-8-1941.PMC4206205.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 1941–1953Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1941Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/DDDT .S7195 7Anti-inflammatory effects of cordycepin  in lipopolysaccharide-stimulated ra W 264.7  macrophages through T oll-like receptor  4-mediated suppression of mitogen-activated  protein kinases and nF- κB signaling pathways Yung hyun choi1,2 gi-Y oung Kim3 hye hyeon lee4 1Department of Biochemistry,   Dongeui University College of  Korean Medicine, Busan, 2anti-aging  research center and Blue-Bio  industry ric, Dongeui University,   Busan, 3Laboratory of Immunobiology,   Department of Marine Life Sciences,   Jeju national University, Jeju, 4Daegu  Gyeongbuk Institute of Science and  T echnology, Daegu, Republic of KoreaAbstract:  Cordycepin is the main functional component of the Cordyceps species, which has  been widely used in traditional Oriental medicine.",Non-OADS,/arxiv_data1/oa_pdf/bf/d7/dddt-8-1941.PMC4206205.pdf
"Keywords:  cordycepin, anti-inflammation, mitogen-activated protein kinases, NF- κB, Toll- like receptor 4 Introduction Inflammation is part of a complex biological response of the body to harmful stimuli,  such as pathogens, damaged cells, or irritants; however, chronic inflammatory processes  are involved in the pathogenesis of common inflammation-associated diseases, such  as rheumatoid arthritis, atherosclerosis, chronic hepatitis, and pulmonary fibrosis.1,2  Macrophages, which are a type of differentiated tissue cells that originate as blood  monocytes, play a critical role in the initiation and propagation of inflammatory  responses by releasing proinflammatory mediators, ie, nitric oxide (NO) and pros - taglandin (PG)E2, and cytokines to promote inflammatory responses.3,4 Therefore,  the amount of proinflammatory mediators and cytokines may reflect the degree of  inflammation and provide information to investigate the effect of pharmacological correspondence: Yung hyun choi Department of Biochemistry,  Dongeui University College of Korean  Medicine, Busan 614-052,   Republic of Korea Tel +82 51 850 7413 Fax +82 51 853 4036 email choiyh@deu.ac.k r Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Choi et al Running head recto: Anti-inflammatory effects of cordycepin DOI: http://dx.doi.org/10.2147/DDDT.S71957",Non-OADS,/arxiv_data1/oa_pdf/bf/d7/dddt-8-1941.PMC4206205.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/bf/d7/dddt-8-1941.PMC4206205.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/bf/d7/dddt-8-1941.PMC4206205.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5a/24/copd-9-1145.PMC4206206.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of COPD 2014:9 1145–1154International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1145RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S5447 6Influence of sex on chronic obstructive  pulmonary disease risk and treatment outcomes Shambhu Aryal1 enrique Diaz-Guzman2 David M Mannino3 1Division of Pulmonary, Allergy  and Critical Care Medicine, Duke  University, Durham, NC, 2Division of  Pulmonary, Allergy and Critical Care,   University of Alabama, Birmingham,   AL, 3Department of Preventive  Medicine and Environmental Health,   University of Kentucky, Lexington,    KY, USA Correspondence: David M Mannino   Department of Preventive Medicine   and Environmental Health, University   of Kentucky, 111 Washington Avenue,   Lexington, KY 40536, USA   email dmannino@uky.ed uAbstract:  Chronic obstructive pulmonary disease (COPD), one of the most common chronic  diseases and a leading cause of death, has historically been considered a disease of men.",Non-OADS,/arxiv_data1/oa_pdf/5a/24/copd-9-1145.PMC4206206.pdf
"Available from:  http://www.cdc.gov/nchs/data/databriefs/db63.ht m.25Table  2 Summary of the influence of sex on the prevalence, diagnosis, and outcomes of chronic obstructive pulmonary  disease (COPD) Outcomes Male Female Prevalence –  Historically more prevalent in males by administrative   database analysis23 –  Prevalence decreasing in the US,24 but still rising   in developing countries –  Mostly emphysematous phenotype33,34–  Prevalence is higher by self-report,23,25 and is  increasing in females24 –  Mostly chronic bronchitis phenotype   In the US, the number of women diagnosed annually  with emphysema now surpasses that of men as of  201134 Quality of life –  Poor quality of life compared to general population –  Poorer quality of life than men and more intense  dyspnea40,44,46 Diagnosis –  More likely to be diagnosed with COPD50,51 –  Fewer reports of diagnostic delay or reaching physician–  More likely to be diagnosed with asthma50,51 –  More diagnostic delay, difficulty reaching physician,   or having adequate time52 Comorbidities –  IHD, arrhythmias, alcoholism, renal failure, cancers   more common45,53,54–  Depression, anxiety, osteoporosis, reflux, IBD more   common45,53–57 Acute exacerbations   and hospitalizations–  Mortality higher after exacerbation, higher average   number of hospitalizations per year42,75–77–  Mortality may be lower after exacerbation42,75–77 Responses   to treatment options–  More attempts at and more sustained quitting   of smoking; nicotine replacement more effective32,59,60 –  ICS reduces phlegm more63 –  Benefits of LTOT may not be as good as in women –  Effects of pulmonary rehabilitation may be more   sustained72–  Fewer quit attempts, less sustained quitting, but   better improvement in FEV1 with quitting32,59,60 –  ICS may not reduce phlegm as well.63 but  deterioration may be worse on stopping;65 chronic   macrolide therapy may be more effective66 –  More emotional and psychosocial benefits   from pulmonary rehabilitation73 Mortality –  Declining over last few decades23–  Increasing over last few decades; and predicted to   continue to rise;23 more women have died than   men from COPD in the US since 200023 Abbreviations:  IHD, ischemic heart disease; IBD, inflammatory bowel disease; FEV1, forced expiratory volume in 1 second; ICS, inhaled corticosteroids; LTOT, long-term  oxygen therapy.",Non-OADS,/arxiv_data1/oa_pdf/5a/24/copd-9-1145.PMC4206206.pdf
"Available from: http://www.who.int/whosis/whostat/ EN_WHS08_Full.pd f. Accessed June 1 , 2014.",OADS,/arxiv_data1/oa_pdf/5a/24/copd-9-1145.PMC4206206.pdf
Available from: http://www.cdc.gov/nchs/data/databriefs/db63.htm.,OADS,/arxiv_data1/oa_pdf/5a/24/copd-9-1145.PMC4206206.pdf
"Available  from: http://www.cdc.gov/nchs/nhis/nhis_2011_data_release.ht m.  Accessed September 9, 2014.",OADS,/arxiv_data1/oa_pdf/5a/24/copd-9-1145.PMC4206206.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/5a/24/copd-9-1145.PMC4206206.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5a/24/copd-9-1145.PMC4206206.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/da/e6/dhps-6-139.PMC4206207.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug, Healthcare and Patient Safety 2014:6 139–144Drug, Healthcare and Patient Safety Dove press submit your manuscript | www.dovepress.co m Dove press  139Original reSearcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DHPS.S6649 6evaluation of bactericidal activity of Hannon honey  on slowly growing bacteria in the chemostat najib Sufya1 noora Matar1 rawanda Kaddura1 abdulaziz Zorgani2 1Department of Microbiology and  immunology, Faculty of Pharmacy,   2Department of Microbiology and  immunology, Faculty of Medicine,   University of Tripoli, Tripoli, libya correspondence: abdulaziz Zorgani   Department of Microbiology and  immunology, Faculty of Medicine,  University of Tripoli, PO Box 12456  Tripoli, libya   Tel +218 91 371 8561   email zorgania@yahoo.co mAbstract:  There is renewed interest in the therapeutic use of honey, including use in the treatment  of infected wounds and burn patients.",Non-OADS,/arxiv_data1/oa_pdf/da/e6/dhps-6-139.PMC4206207.pdf
"Drug, Healthcare and Patient Safety Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-healthcare-and-patient-safety-journa lDrug, Healthcare and Patient Safety is an international, peer-reviewed  open-access journal exploring patient safety issues in the healthcare  continuum from diagnostic and screening interventions through to treat - ment, drug therapy and surgery.",Non-OADS,/arxiv_data1/oa_pdf/da/e6/dhps-6-139.PMC4206207.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/da/e6/dhps-6-139.PMC4206207.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/89/e5/copd-9-1155.PMC4206208.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of COPD 2014:9 1155–1161International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1155OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S4952 1Characteristics of undiagnosed COPD in a senior  community center simeão rodrigo santos1 elisângela silva lizzi2 elcio Oliveira Vianna3 1Postgraduate Community health  Program, school of Medicine of  ribeirão Preto, University of são  Paulo, 2Postgraduate Community  health Program, school of Medicine  of ribeirão Preto, University of  são Paulo, 3associate Professor,   respiratory Division, school of  Medicine of ribeirão Preto, University  of são Paulo, são Paulo, Brazil Correspondence: elcio Oliveira Vianna   seção de Pneumologia, hospital das  Clínicas de ribeirão Preto.",Non-OADS,/arxiv_data1/oa_pdf/89/e5/copd-9-1155.PMC4206208.pdf
"Available from: http://www.goldcopd.org/uploads/ users/files/GOLD_Report_2011_Feb21.pd f. Accessed August 29,  2014.",OADS,/arxiv_data1/oa_pdf/89/e5/copd-9-1155.PMC4206208.pdf
Available from: http://www.abep.,Non-OADS,/arxiv_data1/oa_pdf/89/e5/copd-9-1155.PMC4206208.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/89/e5/copd-9-1155.PMC4206208.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/89/e5/copd-9-1155.PMC4206208.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b1/fd/cpaa-6-149.PMC4206209.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Pharmacology: Advances and Applications 2014:6 149–159Clinical Pharmacology: Advances and Applications Dove press submit your manuscript | www.dovepress.co m Dove press  149OriginAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/CPAA.S6413 1lack of effect of ezogabine/retigabine on the  pharmacokinetics of digoxin in healthy individuals:  results from a drug–drug interaction study Debra J T ompson1 Christopher s Crean2 Mauro Buraglio1 Thangam Arumugham3 1Clinical Pharmacology Modelling  and simulation, glaxo smithKline,   stevenage, hertfordshire, UK;  2Clinical  Pharmacology and Pharmacokinetics,   Valeant Pharmaceuticals north  America, Durham, nC, UsA;  3Clinical  statistics, glaxo smithKline, raleigh- Durham, nC, UsA Correspondence: Debra J Tompson   glaxosmithKline, gunnels Wood road,   stevenage, hertfordshire, sg1  2nY, UK   Tel +44 1438 766 698  Fax +44 1438 762 798  email debra.j.tompson@gsk.co mIntroduction:  The potential for ezogabine/retigabine (EZG/RTG) and its N-acetyl metabolite  (NAMR) to inhibit the transporter protein P-glycoprotein-(P-gp)-mediated digoxin transport  was tested in vitro.",Non-OADS,/arxiv_data1/oa_pdf/b1/fd/cpaa-6-149.PMC4206209.pdf
Available from: http://www.accessdata.fda.,OADS,/arxiv_data1/oa_pdf/b1/fd/cpaa-6-149.PMC4206209.pdf
"Available from: http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Product_Information/human/001245/ WC500104835.pd f. Accessed July  16, 2013.",Non-OADS,/arxiv_data1/oa_pdf/b1/fd/cpaa-6-149.PMC4206209.pdf
"Clinical Pharmacology: Advances and Applications Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-pharmacology-advances-and-applications-journa lClinical Pharmacology: Advances and Applications is an international,  peer-reviewed, open access journal publishing original research, reports,  reviews and commentaries on all areas of drug experience in humans.",Non-OADS,/arxiv_data1/oa_pdf/b1/fd/cpaa-6-149.PMC4206209.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/fd/cpaa-6-149.PMC4206209.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseMay 2014 |  87  | e51432 | Page 1 of 8Video Article Manufacturing Of Robust Natural Fiber Preforms Utilizing Bacterial Cellulose as Binder Koon-Yang Lee1,2, Siti Rosminah Shamsuddin3, Marta Fortea-Verdejo1, Alexander Bismarck1,3 1Polymer and Composite Engineering (PaCE) Group, Institute of Materials Chemistry and Research, University of Vienna 2Department of Chemical Engineering, University College London 3Polymer and Composite Engineering (PaCE) Group, Department of Chemical Engineering, Imperial College London Correspondence to: Koon-Yang Lee at koonyang.lee@ucl.ac.uk , Alexander Bismarck at a.bismarck@imperial.ac.uk URL: http://www.jove.com/video/51432 DOI: doi:10.3791/51432 Keywords: Bioengineering, Issue 87, bacterial cellulose, natural fibers, preform, vacuum assisted resin infusion, hierarchical composites, binder Date Published: 5/22/2014 Citation: Lee, K.Y., Shamsuddin, S.R., Fortea-Verdejo, M., Bismarck, A.",Non-OADS,/arxiv_data1/oa_pdf/67/b1/jove-87-51432.PMC4206245.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/51432/ Introduction Steadily increasing oil prices and the public's growing demand for a sustainable future have sparked and revived the research and development of green materials, especially polymers and composites.",Non-OADS,/arxiv_data1/oa_pdf/67/b1/jove-87-51432.PMC4206245.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/63/07/tcrm-10-875.PMC4206247.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2014:10 875–883Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  875Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S7155 9Abstract:  Nearly all patients with end-stage renal disease develop hyperphosphatemia.,Non-OADS,/arxiv_data1/oa_pdf/63/07/tcrm-10-875.PMC4206247.pdf
"Therefore, patients with ESRD require tight control of serum phosphorus  in the form of dietary restrictions in conjunction with pharmacotherapy and mainte - nance dialysis.5,6 Current phosphorus-lowering treatments in ESRD patients include  calcium-containing phosphate binders and non-calcium containing phosphate binders, Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2014 Volume: 10 Running head verso: Shin and Lee Running head recto: Niacin and hyperphosphatemia management in dialysis patients DOI: http://dx.doi.org/10.2147/TCRM.S71559 Niacin as a drug repositioning candidate  for hyperphosphatemia management in  dialysis patients Sooyoung Shin Sukhyang Lee Ajou University College of Pharmacy,   Yeongtong-gu, Suwon-si, Gyeonggi-do,   Korea Correspondence: Sooyoung Shin Ajou University College of Pharmacy,  206, world cup-ro, Yeongtong-gu,  Suwon-si, Gyeonggi-do 443-749, Korea Tel +82 31 219 3456 Fax +82 31 219 3435 email syshin@ajou.ac.k r",Non-OADS,/arxiv_data1/oa_pdf/63/07/tcrm-10-875.PMC4206247.pdf
We also conducted another search through  http://clinicaltrials.gov  to identify ongoing clinical trials.,Non-OADS,/arxiv_data1/oa_pdf/63/07/tcrm-10-875.PMC4206247.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/63/07/tcrm-10-875.PMC4206247.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/63/07/tcrm-10-875.PMC4206247.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/90/33/dmso-7-469.PMC4206248.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014:7 469–479Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  469ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S6842 8Using the health action process approach   to predict and improve health outcomes   in individuals with type  2 diabetes mellitus Mariana MacPhail1 Barbara Mullan2 Louise Sharpe1 Carolyn MacCann1 Jemma T odd1 1School of Psychology, University  of Sydney, Sydney, NSW, Australia;   2School of Psychology and Speech  Pathology, Curtin University,    Bentley, WA, Australia Correspondence: Barbara Mullan   School of Psychology and Speech   Pathology, Curtin University,   Bentley, WA  6102, Australia   Tel +61 8 9266 3473  Fax +61 8 9266 2464  Email barbara.mullan@curtin.edu.a uBackground:  The purpose of this study was to explore the predictive utility of the Health  Action Process Approach (HAPA) and test a HAPA-based healthy eating intervention, in adults  with type  2 diabetes mellitus.",Non-OADS,/arxiv_data1/oa_pdf/90/33/dmso-7-469.PMC4206248.pdf
A vailable  from: http://www.aihw.gov.au/publication-detail/?id =644246807 5.,Non-OADS,/arxiv_data1/oa_pdf/90/33/dmso-7-469.PMC4206248.pdf
Available from: http://www.diabetesaustralia.com.au/Documents/ DA/What's New/12.10.02 Diabetes Management in General Practice.,Non-OADS,/arxiv_data1/oa_pdf/90/33/dmso-7-469.PMC4206248.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/90/33/dmso-7-469.PMC4206248.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/90/33/dmso-7-469.PMC4206248.pdf
"Available from: http://userpage.fu-berlin.de/ ∼health/ hapa.ht m. Accessed August  20, 2014.",Non-OADS,/arxiv_data1/oa_pdf/90/33/dmso-7-469.PMC4206248.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8c/72/cia-9-1741.PMC4206249.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 1741–1745Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1741CAse Repo Rtopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/ 10.2147/CIA.S6942 0Bradyarrhythmias secondary to topical  levobunolol hydrochloride solution Lianjun Lin* Yuchuan Wang* Yan Chen Meilin Liu Geriatric Department, peking  University First Hospital, Beijing,   people’s Republic of China *these authors contributed equally  to this workAbstract:  An 88-year-old man was admitted with fatigue, dizziness, and heart palpitations.",Non-OADS,/arxiv_data1/oa_pdf/8c/72/cia-9-1741.PMC4206249.pdf
"The lowest heart  rate was reached (25 bpm), approximately two hours after instillation of the eyedrops Correspondence: Meilin Liu Xishiku Avenue 8, Xicheng District,  Geriatric Department, peking University  First Hospital, Beijing  100034, people’s  Republic of China tel +86 10 8357 2986 email meilinliu@hotmail.co m Journal name: Clinical Interventions in Aging Article Designation: Case Report Y ear: 2014 Volume: 9 Running head verso: Lin et al Running head recto: Bradyarrhythmias secondary to levobunolol hydrochloride DOI: http://dx.doi.org/10.2147/CIA.S69420",Non-OADS,/arxiv_data1/oa_pdf/8c/72/cia-9-1741.PMC4206249.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/8c/72/cia-9-1741.PMC4206249.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/8c/72/cia-9-1741.PMC4206249.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/58/4d/ppa-8-1419.PMC4206250.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 1419–1425Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1419OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/PPA.S7253 2Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Chen et al Running head recto: Sonographic assessment of mandibular condylar mobility DOI: http://dx.doi.org/10.2147/PPA.S72532 Assessing the mobility of the mandibular condyle  by sonography Purpose:  Traditionally, the measurement of the maximal mouth opening was regarded as  the mobility of the temporomandibular joint.",Non-OADS,/arxiv_data1/oa_pdf/58/4d/ppa-8-1419.PMC4206250.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/58/4d/ppa-8-1419.PMC4206250.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b0/c1/cia-9-1721.PMC4206251.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 1721–1732Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1721OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S6471 8long-term outcome of ruptured abdominal aortic  aneurysm: impact of treatment and age Jelle W raats1 hans C Flu1 gwan h ho1 eelco J Veen1 louwerens D Vos2  ewout W steyerberg3 lijckle van der laan1 1Department of surgery, Amphia  hospital, Breda, 2Department  of radiology, Amphia hospital,   Breda, 3Department of  Public health, erasmus MC,   rotterdam, the netherlandsBackground:  Despite advances in operative repair, ruptured abdominal aortic aneurysm  (rAAA) remains associated with high mortality and morbidity rates, especially in elderly  patients.",Non-OADS,/arxiv_data1/oa_pdf/b0/c1/cia-9-1721.PMC4206251.pdf
"Although the established definition of “elderly patients” in the current  literature refers to people aged over 65 years, current demographic trends, improved Correspondence: Jelle W raats  Department of surgery, Amphia hospital,  PO Box 90518, 4800 rK Breda, the  netherlands email jraats@amphia.n l Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Raats et al Running head recto: Treatment, age, and long-term outcome of ruptured AAA DOI: http://dx.doi.org/10.2147/CIA.S64718",Non-OADS,/arxiv_data1/oa_pdf/b0/c1/cia-9-1721.PMC4206251.pdf
Available from: http://www.cookmedical.com/ai/datasheetFeature.,Non-OADS,/arxiv_data1/oa_pdf/b0/c1/cia-9-1721.PMC4206251.pdf
Available from: http://www.nationaalkompas.nl .,Non-OADS,/arxiv_data1/oa_pdf/b0/c1/cia-9-1721.PMC4206251.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/b0/c1/cia-9-1721.PMC4206251.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/b0/c1/cia-9-1721.PMC4206251.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e5/22/amep-5-383.PMC4206252.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pAdvances in Medical Education and Practice 2014:5 383–384Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  383LETTERopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S7176 3The CanMEDS scholar: the neglected competency  in tomorrow’s doctors Rele Ologunde1 Ivana Di Salvo2,3 Ankur Khajuria1 1Imperial College School of Medicine,   Imperial College London, London,   UK; 2Faculty of Medicine and Surgery,   University of Pavia, Pavia, Italy;   3International Federation of Medical  Students’ Associations, Ferney- Voltaire, France Correspondence: Rele Ologunde   Imperial College School of Medicine,  Imperial College London, Exhibition Road,  London SW7 2AZ, UK   Email r ele.ologunde09@imperial.ac.u kDear editor In 1996, the Royal College of Physicians and Surgeons of Canada proposed a   competency-based framework describing the core competencies of specialist physi - cians, one of which was a scholar.1 The UK General Medical Council has since pro - vided advice on developing teachers and trainers in undergraduate medical education.2  However, guidance about how to most effectively incorporate this advice into the  medical curriculum remains unclear.",Non-OADS,/arxiv_data1/oa_pdf/e5/22/amep-5-383.PMC4206252.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/e5/22/amep-5-383.PMC4206252.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e5/22/amep-5-383.PMC4206252.pdf
"Available from: http://grants.nih.gov/Grants/research_ integrity/ done.ht m. Accessed July 2, 2014.",Non-OADS,/arxiv_data1/oa_pdf/e5/22/amep-5-383.PMC4206252.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e4/26/ppa-8-1427.PMC4206253.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 1427–1435Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1427OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S6842 3southern saskatchewan Ticagrelor registry  experience Payam Dehghani1 Varun chopra1 Ali Bell2 sheila Kelly1 lori Zulyniak2 Jeff Booker1 rodney Zimmermann1 William semchuk2 Asim n cheema3 Andrea J lavoie1 1Prairie Vascular research network,   University of saskatchewan, regina,   sK, 2regina Qu’Appelle health region,   regina, sK, 3st Michael’s hospital,   University of T oronto, T oronto,    On, canadaBackground:  As ticagrelor enters into clinical use for acute coronary syndrome, it is  important to  understand patient/physician behavior in terms of appropriate use, adherence, and event rates.",Non-OADS,/arxiv_data1/oa_pdf/e4/26/ppa-8-1427.PMC4206253.pdf
"In patients  who have ACS, treatment with ticagrelor as compared with clopidogrel significantly  reduced the rate of death from vascular causes, myocardial infarction, or stroke without  an increase in the rate of overall major bleeding.1 This resulted in ticagrelor’s adoption  into the guidelines published by the Cardiovascular Society, the European Society  of Cardiology, the American College of Cardiology Foundation, and the American  Heart Association.2–6 However, gaps in the adoption of novel therapies for ACSs are  well documented.7 Primary nonadherence rates to the thienopyridine clopidogrel have  been reported to vary between 10% and 30% in situations in which that agent was correspondence: Payam Dehghani Prairie Vascular research network  (PVrn), Unit 3A, interventional  Cardiology Research Office, Regina  general hospital 1440 14th Avenue,  regina, sK s4P 0W5, canada Tel +306 781 7944 Fax +306 781 6997 email pdehghani@mac.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Dehghani et al Running head recto: Ticagrelor registry DOI: http://dx.doi.org/10.2147/PPA.S68423",Non-OADS,/arxiv_data1/oa_pdf/e4/26/ppa-8-1427.PMC4206253.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/e4/26/ppa-8-1427.PMC4206253.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c4/ce/cmar-6-405.PMC4206254.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pCancer Management and Research 2014:6 405–422Cancer Management and Research Dove press submit your manuscript | www.dovepress.co m Dove press  405Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CMAR.S3516 4MicroRNA dysregulation as a prognostic  biomarker in colorectal cancer Yujuan Dong1,2 Jun Yu2 Simon SM Ng1,2 1Division of Colorectal Surgery,   Department of Surgery, Prince  of wales Hospital, The Chinese  University of Hong Kong, Hong Kong;   2institute of Digestive Disease, State  Key Laboratory of Digestive Disease,   Li Ka Shing institute of Health  Sciences, The Chinese University  of Hong Kong, Hong Kong Correspondence: Simon SM Ng   Division of Colorectal Surgery,  Department of Surgery, Prince of   wales Hospital, Li Ka Shing Medical  Sciences Building, The Chinese   University of Hong Kong, 30-32 Ngan  Shing Street, Shatin, New Territories,  Hong Kong   Tel +852 2632 1495   Fax +852 2637 7974   email simonng@surgery.cuhk.edu.h kAbstract:  Colorectal cancer (CRC) is one of the most potentially curable cancers, yet it remains  the fourth most common overall cause of cancer death worldwide.",Non-OADS,/arxiv_data1/oa_pdf/c4/ce/cmar-6-405.PMC4206254.pdf
"Cancer Management and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/cancer-management-and-research-journa lCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of  preventative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/c4/ce/cmar-6-405.PMC4206254.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c4/ce/cmar-6-405.PMC4206254.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/04/af/cia-9-1747.PMC4206255.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 1747–1758Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1747OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/CIA.S6593 9Daily consumption of the collagen supplement  Pure gold Collagen® reduces visible   signs of aging Maryam Borumand sara sibilla Minerva research labs ltd.,   london, UKAbstract:  With age, changes in the metabolic processes of structural components of the skin  lead to visible signs of aging, such as increased dryness and wrinkle formation.",Non-OADS,/arxiv_data1/oa_pdf/04/af/cia-9-1747.PMC4206255.pdf
"All these Correspondence: sara sibilla Minerva research labs ltd., 1–6  Yarmouth Place, london, W1J 7BU, UK Tel +44 020 3137 7731 email ssibilla@minervalabs.co m Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Borumand and Sibilla Running head recto: Pure Gold Collagen® reduces visible signs of aging DOI: http://dx.doi.org/10.2147/CIA.S65939",Non-OADS,/arxiv_data1/oa_pdf/04/af/cia-9-1747.PMC4206255.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/04/af/cia-9-1747.PMC4206255.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/04/af/cia-9-1747.PMC4206255.pdf
"are shown in Supplementary Figure 1 (Supplemental digital content 1, http://links.lww.com/FPC/A773 ).",Non-OADS,/arxiv_data1/oa_pdf/e1/65/fpc-24-548.PMC4206345.pdf
"In a multiple linear regression model, we showed that the number of variant alleles for MYLIP rs9370867 (GG =0, GA =1, and AA =2) was significant in terms of the LDL-C response (SupplementaryTable 1, Supplemental digital content 2, http://links.lww.",OADS,/arxiv_data1/oa_pdf/e1/65/fpc-24-548.PMC4206345.pdf
"In the White group ( n=119), the presence of the G allelewas associated with a greater odds of not achieving the LDL-C target in a multivariate model (OR 1.98 per G allele, 95% CI 1.22 –3.21, P=0.006; Supplementary Table 2, Supplemental digital content 3, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/e1/65/fpc-24-548.PMC4206345.pdf
http://creativecommons.org/licenses/ by-nc-nd/3.0.,Non-OADS,/arxiv_data1/oa_pdf/78/8d/mpa-43-532.PMC4206346.pdf
The work cannot be changed in any way or used commercially.http://creativecommons.org/licenses/by-nc-nd/3.0.,Non-OADS,/arxiv_data1/oa_pdf/fd/26/tp-98-844.PMC4206351.pdf
"The closest matched bacterial species corresponding to the above 14 key band classes presented in the phyloge- netic tree, and the details were shown in Table S1 SDC, http://links.lww.com/TP/B35.",OADS,/arxiv_data1/oa_pdf/fd/26/tp-98-844.PMC4206351.pdf
"5B and E).Bacterial culture in the blood was shown in Figure 5(C) and ( Table S2, SDC, http://links.lww.com/TP/B35).",Non-OADS,/arxiv_data1/oa_pdf/fd/26/tp-98-844.PMC4206351.pdf
"The plot was obt ained from MEGA5 software (http://en.wi kipedia.org/wiki/MEGA,_Molecular_ Evolutionary_Genetics_Analysis).",Non-OADS,/arxiv_data1/oa_pdf/fd/26/tp-98-844.PMC4206351.pdf
"The primers for the genetic determinants and annealing temperatures were shown in Table S3 ( SDC, http://links.lww.com/TP/B35).850 www.transplantjournal.com Transplantation &Volume 98, Number 8, October 27, 2014",Non-OADS,/arxiv_data1/oa_pdf/fd/26/tp-98-844.PMC4206351.pdf
http://creativecommons.org/licenses/by-nc-nd/3.0.,Non-OADS,/arxiv_data1/oa_pdf/d7/20/mpa-43-198.PMC4206352.pdf
Pathway analyses were carried out usingthe Web-based integrated software suite MetaCore of GeneGO (http://thomsonreuters.com/products_s ervices/science/systems-biology/).,OADS,/arxiv_data1/oa_pdf/d7/20/mpa-43-198.PMC4206352.pdf
Table 2 presents the top 20 most significant differen- tially expressed genes (10 most significantly up-regulated and 10 most significantly down-regulated) between the normal and cancer samples as ranked by FC (a complete listing of signifi-cantly differentiated genes is presented in Supplemental Tables 1 http://links.lww.com/MPA/A282 an d 2 http://links.lww .com/MPA/A283).,Non-OADS,/arxiv_data1/oa_pdf/d7/20/mpa-43-198.PMC4206352.pdf
Pathways Functional analysis was carried out with the integrated software suite MetaCore of GeneGO (http://thomsonreuters.com/ products_services/science/systems-biology/) incorporating the287 differentially expressed genes.,OADS,/arxiv_data1/oa_pdf/d7/20/mpa-43-198.PMC4206352.pdf
presented in Table 5 (a complete list of all significantly differen- tially expressed probe sets is presented in Supplemental Tables 1 http://links.lww.com/MPA/A282 and 2 http://links.lww.com/MPA/ A283).,Non-OADS,/arxiv_data1/oa_pdf/d7/20/mpa-43-198.PMC4206352.pdf
"As shown in Figure 3 (see also Supplemental Tables 1[http://links.lww.com/MP A/A282] and 2 [http://links.lww.com/MPA/A283]), less than 6.5% (average, 3.3%) of the genes identifiedTABLE 6.",Non-OADS,/arxiv_data1/oa_pdf/d7/20/mpa-43-198.PMC4206352.pdf
4; Supplemental Table 3 http://links.lww.com/MPA/A284).,Non-OADS,/arxiv_data1/oa_pdf/d7/20/mpa-43-198.PMC4206352.pdf
"As shown in Figure 4 (see also Supplemental Table 3 http://links.lww.com/MPA/A284), less than 5% (average, 1.7%)of the pathways identified as significantly overrepresented inGlycolysis and gluconeogenesis p.3 0.03559 Estrone metabolism 0.02358 Cell cycle Vinitiation of mitosis 0.03837 Estradiol metabolism/human version 0.02486 Immune response VIL-23 signaling pathway 0.03837 Estrone metabolism/human version 0.02486 DNA damage VATM/ATR regulation of G2/M checkpoint0.04124 Estradiol metabolism/rodent version 0.02617 Glutathione metabolism/human version 0.04722 Cell cycle Vregulation of G 1/S transition (part 1) 0.0275 Glycolysis and gluconeogenesis (short map) 0.04904 Cell adhesion Vchemokines and adhesion 0.0306 Cell cycle Vrole of SCF complex in cell cycle regulation0.0503 Apoptosis and survival VBAD phosphorylation 0.03311 Apoptosis and survival Vp53-dependent apoptosis 0.0503 Signal transduction VAKT signaling 0.03457 Apoptosis and survival Vgranzyme A signaling 0.05346 Apoptosis and survival VFAS signaling cascades 0.03606 Cytoskeleton remodeling VRalA regulation pathway0.05346 Development Vadiponectin signaling 0.03758 Cytoskeleton remodeling Vtransforming growth factor, WNT, and cytoskeletal remodeling0.03985 NAC-AsPC-1 0.04682 NAC-AsPC-1 0.04682 Untitled 0.04682 Some pathways of EMT in cancer cells 0.04716 FIGURE 3 .Venn diagrams showing the unique, annotated genes identified as significantly differentially expressed in the group analysis and in the personalized analysis(es) of at least 1 patient.TABLE 7.",Non-OADS,/arxiv_data1/oa_pdf/d7/20/mpa-43-198.PMC4206352.pdf
6; Supplemental Table 4 http://links.lww.com/MPA/A285).,Non-OADS,/arxiv_data1/oa_pdf/d7/20/mpa-43-198.PMC4206352.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b0/ff/opth-8-2115.PMC4206355.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 2115–2119Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2115Case repO rtopen access to scientific and medical research Open access Full text article http: //dx.doi.org/ 10.2147/OPTH.S7075 9Findings of secondary corneal amyloidosis  with ultrahigh-resolution optical coherence  tomography Kaoru araki-sasaki1 Yasuhiro Osakabe2 Hideki Fukuoka3 ryuichi Ideta4 Koji Hirano5 1Department of Ophthalmology, Japan  Community Health Care Organization,   Hoshigaoka Medical Center, Hirakata,   2Department of Molecular pathology,   tokyo Medical University, tokyo,   3Department of Ophthalmology, Kyoto  prefectural University of Medicine,   Kyoto, 4Ideta eye Hospital, Kumamoto,   5Department of Ophthalmology, Ban  Buntane Hotokukai Hospital, school  of Medicine, Fujita Health University,   Nagoya, JapanPurpose:  To describe observations by ultrahigh-resolution optical coherence tomography  (OCT) in a secondary corneal amyloidosis (SCA) patient with histological analysis of excised  tissue.",Non-OADS,/arxiv_data1/oa_pdf/b0/ff/opth-8-2115.PMC4206355.pdf
"There have been many reports on using OCT  to examine the morphologic structure that is present during corneal diseases.11,12  Recently, Hurmeric et al and Roszkowska et al used OCT to obtain high-quality  images of the morphology of the cornea in Salzmann nodular degeneration.13,14 In our  current study, we used OCT to observe the corneal structure of both eyes in SCA  patient with histological analysis, especially lactoferrin expression, which is one of  the precursor proteins of SCA.15,16Correspondence: Kaoru araki-sasaki Department of Ophthalmology, Japan  Community Health Care Organization,  Hoshigaoka Medical Center,  4-8-1 Hoshigaoka, Hirakata, Osaka  573-8511, Japan tel +81 72 840 2641 Fax +81 72 840 2266 email sasakis@sa2.so-net.ne.j p Journal name: Clinical Ophthalmology Article Designation: Case report Y ear: 2014 Volume: 8 Running head verso: Araki-Sasaki et al Running head recto: OCT findings of secondary corneal amyloidosis DOI: http://dx.doi.org/10.2147/OPTH.S70759",Non-OADS,/arxiv_data1/oa_pdf/b0/ff/opth-8-2115.PMC4206355.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/b0/ff/opth-8-2115.PMC4206355.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b0/ff/opth-8-2115.PMC4206355.pdf
Available from:  http://www.who.int/nmh/publications/ncd_report_full_en.pdf.,OADS,/arxiv_data1/oa_pdf/d2/67/abc-103-04-0272.PMC4206357.pdf
Disponível em: http://www.ibge.gov.br/home/estatistica/ populacao/censo2010/default.shtm 35.,Non-OADS,/arxiv_data1/oa_pdf/26/40/abc-103-04-0299.PMC4206360.pdf
Available from: http://www.who.int/mediacentre/ factsheets/fs311/en/  2.,Non-OADS,/arxiv_data1/oa_pdf/b6/e3/abc-103-04-0330.PMC4206364.pdf
Available from: http://www.bhsoc.org/bp-monitors/bp-monitors/ 24.,OADS,/arxiv_data1/oa_pdf/24/0d/abc-103-04-0338.PMC4206365.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/70/14/opth-8-2095.PMC4206373.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 2095–2104Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2095Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/OPTH.S6953 4Journal name: Clinical Ophthalmology Article Designation: Review Y ear: 2014 Volume: 8 Running head verso: Tsilis et al Running head recto: Systematic review of dementia and glaucoma DOI: http://dx.doi.org/10.2147/OPTH.S69534 Systematic review of the association between  Alzheimer’s disease and chronic glaucoma Correspondence: Alexandros G Tsilis Department of Ophthalmology,  University Campus, University of ioannina  School of Medicine, ioannina 45110,  Greece Tel +30 69 4767 7146 Fax +30 26 5100 7853 email alex_tsilis@yahoo.g r Abstract:  A potential association between Alzheimer’s disease (AD) and chronic glaucoma  has been suggested but results of epidemiological studies have been inconsistent.",Non-OADS,/arxiv_data1/oa_pdf/70/14/opth-8-2095.PMC4206373.pdf
Available from:  http://www.ohri.ca/ programs/clinical_epidemiology/oxford.,Non-OADS,/arxiv_data1/oa_pdf/70/14/opth-8-2095.PMC4206373.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/70/14/opth-8-2095.PMC4206373.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/70/14/opth-8-2095.PMC4206373.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5d/3d/idr-7-253.PMC4206374.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInfection and Drug Resistance 2014:7 253–259Infection and Drug Resistance Dove press submit your manuscript | www.dovepress.co m Dove press  253ORIg Inal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IDR.S6626 8genotypes and phenotypes of shiga   toxin-producing Escherichia coli  (sTec)   in abeokuta, southwestern nigeria Olugbenga adekunle  Olowe1 Bukola W aboderin1,2 Olayinka O Idris3 Victor O Mabayoje4 Oluyinka O Opaleye1 O catherine adekunle1 Rita ayanbolade Olowe1 Paul akinniyi akinduti5 Olusola Ojurongbe1 1Department of Medical Microbiology  and Parasitology, college of health  sciences, Osogbo, Osun state, n igeria;   2Medical Microbiology Unit, Pathology  Department, Federal Medical centre,   abeokuta, nigeria; 3Department of  Microbiology, college of sciences, afe  Babalola University, ado ekiti, nigeria;   4Department of haematology, college  of health sciences, ladoke akintola  University, Osogbo, Osun state,   nigeria; 5Department of Medical  Microbiology and Parasitology, Olabisi  Onabanjo University, ago-Iwoye, Ogun  state, n igeria correspondence: Olugbenga adekunle  Olowe   Department of Medical Microbiology   and Parasitology, college of health  sciences, ladoke akintola University   of Technology, PMB  4400, Osogbo,   Osun state, nigeria   email oaolowe@lautech.edu.n gPurpose:  To characterize the prevalence of hemolytic Shiga toxin-producing Escherichia coli   (STEC) with a multidrug-resistant pattern in different age groups in Abeokuta, Nigeria.",Non-OADS,/arxiv_data1/oa_pdf/5d/3d/idr-7-253.PMC4206374.pdf
"Infection and Drug Resistance Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/infection-and-drug-resistance-journa lInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte - rial, fungal and viral) and the development and institution of preventive  strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/5d/3d/idr-7-253.PMC4206374.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5d/3d/idr-7-253.PMC4206374.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e9/85/ijn-9-4773.PMC4206375.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 4773–4783International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4773ExpErt OpINIONopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/IJN.S6813 4Development of taiwan’s strategies for  regulating nanotechnology-based pharmaceuticals  harmonized with international considerations Jiun-Wen Guo1 Yu-Hsuan Lee2 Hsiau-Wen Huang3 Mei-Chyun tzou3 Ying-Jan Wang2 Jui-Chen tsai1,4  1Institute of Clinical pharmacy  and pharmaceutical Sciences,   College of Medicine, National Chung  Kung University, tainan, taiwan;   2Department of Environmental  and Occupational Health, College  of Medicine, National Cheng Kung  University, tainan, taiwan; 3Food and  Drug Administration, Ministry of  Health and Welfare, taiwan; 4Center  for pharmaceutical regulatory  Science, National Cheng Kung  University, tainan, taiwan Abstract:  Nanotechnology offers potential in pharmaceuticals and biomedical developments  for improving drug delivery systems, medical imaging, diagnosis, cancer therapy, and regenera - tive medicine.",Non-OADS,/arxiv_data1/oa_pdf/e9/85/ijn-9-4773.PMC4206375.pdf
5687/5689 Fax +886 6 237 3149 Email jctsai@mail.ncku.edu.t w Journal name: International Journal of Nanomedicine Article Designation: Expert Opinion Y ear: 2014 Volume: 9 Running head verso: Guo et al Running head recto: Strategies for regulating nanotechnology-based pharmaceuticals DOI: http://dx.doi.org/10.2147/IJN.S68134,Non-OADS,/arxiv_data1/oa_pdf/e9/85/ijn-9-4773.PMC4206375.pdf
2004; http://www.nano.gov/nanotech-101/what/definition.,OADS,/arxiv_data1/oa_pdf/e9/85/ijn-9-4773.PMC4206375.pdf
Available from:  http://www.bost.ey.gov.tw/Default.aspx.,Non-OADS,/arxiv_data1/oa_pdf/e9/85/ijn-9-4773.PMC4206375.pdf
"Available  from: http://www.fda.gov.tw/MLMS/(S(xuro5q55k2sldgeu3smyi3qv))/ H0001.asp x. Accessed August 21, 2014.",Non-OADS,/arxiv_data1/oa_pdf/e9/85/ijn-9-4773.PMC4206375.pdf
Available from: http://www1.cde.,Non-OADS,/arxiv_data1/oa_pdf/e9/85/ijn-9-4773.PMC4206375.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/e9/85/ijn-9-4773.PMC4206375.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e9/85/ijn-9-4773.PMC4206375.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/be/42/ndt-10-1979.PMC4206377.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 1979–1986Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1979Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/NDT .S4953 1Long-term video eeG monitoring for diagnosis  of psychogenic nonepileptic seizures evan R Gedzelman Suzette M LaRoche Department of Neurology, emory  epilepsy Program, Atlanta, GA, USAAbstract:  Psychogenic nonepileptic seizures have long been known by many names.",Non-OADS,/arxiv_data1/oa_pdf/be/42/ndt-10-1979.PMC4206377.pdf
"PNES is commonly misdiagnosed as epilepsy, and patients are often treated for  years with an incorrect diagnosis.3 It is a common indication for referral to epilepsy  centers, where approximately 30% of epilepsy monitoring unit (EMU) admissions  for refractory epilepsy are appropriately diagnosed with PNES.3 In fact, it is the most  frequent nonepileptic condition seen at epilepsy centers, more common than physi - ological nonepileptic conditions.3 In addition, of the 1% of the US population with  epilepsy, 5%–20% also experience PNES.4Correspondence: evan R Gedzelman;  Suzette M LaRoche Department of Neurology, emory  epilepsy Program, 1365A Clifton Road  Ne, Atlanta, GA, 30322, USA Tel +1 404 778 3444 Fax +1 404 778 4216 email evan.r.gedzelman@emory.ed u;  slaroch@emory.ed uJournal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2014 Volume: 10 Running head verso: Gedzelman and LaRoche Running head recto: Video EEG monitoring for seizures DOI: http://dx.doi.org/10.2147/NDT.S49531",Non-OADS,/arxiv_data1/oa_pdf/be/42/ndt-10-1979.PMC4206377.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/be/42/ndt-10-1979.PMC4206377.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/be/42/ndt-10-1979.PMC4206377.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2e/89/ijwh-6-873.PMC4206378.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Women’s Health 2014:6 873–880International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  873OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S4918 8The use of the partograph in labor   monitoring: a cross-sectional study among  obstetric caregivers in general Hospital,   calabar, cross river state, nigeria Udeme asibong1 Ita B Okokon1 Thomas U agan2 affiong Oku3 Margaret Opiah4 e James essien5 emmanuel Monjok1,5 1Department of Family Medicine,   college of Medical sciences,   University of calabar and University  of calabar T eaching Hospital,   calabar, nigeria; 2Department of  Obstetrics and gynecology, college  of Medical sciences, University of  calabar and University of calabar  T eaching Hospital, calabar, nigeria;   3Department of community Medicine,   college of Medical sciences,   University of calabar and University  of calabar T eaching Hospital, calabar,   nigeria; 4Department of Maternal  and child Health, Faculty of nursing,   niger Delta University, Wilberforce  Island, Bayelsa state, nigeria; 5Institute  of community Health, University  of Houston, T exas Medical center,   Houston, TX, Usa correspondence: emmanuel Monjok   Department of Family Medicine,  University of calabar and University   of calabar Teaching Hospital,   calabar, nigeria   Tel +234 808 084 0737   email emonjok@yahoo.co mBackground:  Prolonged and obstructed labor is a significant cause of maternal morbidity and  mortality in Nigeria, one of the six countries contributing significantly to the global maternal  mortality crisis.",Non-OADS,/arxiv_data1/oa_pdf/2e/89/ijwh-6-873.PMC4206378.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/2e/89/ijwh-6-873.PMC4206378.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2e/89/ijwh-6-873.PMC4206378.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/16/e5/ijnrd-7-361.PMC4206379.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Nephrology and Renovascular Disease 2014:7 361–381International Journal of Nephrology and Renovascular Disease Dove press submit your manuscript | www.dovepress.co m Dove press  361RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/IJNRD.S4017 2Diabetic nephropathy – complications   and treatment Andy KH Lim1–3 1Department of Nephrology, Monash  Medical Center, Monash Health,   2Department of General Medicine,   Dandenong Hospital, Monash Health,   3Department of Medicine, Monash  University, Clayton, vIC, Australia Correspondence: Andy Lim   Department of Nephrology, Monash  Medical Center, 246 Clayton Road,  Clayton, vIC 3168, Australia   Tel +61 3 9594 6666   Fax +61 3 9594 6730   email a ndy.lim@monash.ed uAbstract:  Diabetic nephropathy is a significant cause of chronic kidney disease and end-stage  renal failure globally.",Non-OADS,/arxiv_data1/oa_pdf/16/e5/ijnrd-7-361.PMC4206379.pdf
"Available from: http://www.cdc.gov/diabetes/pubs/pdf/ ndfs_2011.pd f. Accessed September 2, 2014.",Non-OADS,/arxiv_data1/oa_pdf/16/e5/ijnrd-7-361.PMC4206379.pdf
"International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journa lThe International Journal of Nephrology and Renovascular Disease is  an international, peer-reviewed open-access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/16/e5/ijnrd-7-361.PMC4206379.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/16/e5/ijnrd-7-361.PMC4206379.pdf
"RT-qPCR GPCR, CME, and reference gene expression assays Assays were designed using the Roche real-time ready con- figurator ( https://www.roche-applied-science.com/sis/realtimeready/ index.jsp ) on the basis of those provided on the Roche GPCR panel to obtain the position of the amplicon on the gene of interest.",OADS,/arxiv_data1/oa_pdf/46/15/ypg-23-153.PMC4206381.pdf
probe library (UPL) assay design center ( https://www.roche- applied-science.com/sis/rtpcr/upl/index.jsp )w a su s e dt oi d e n t i f ya suitable predesigned UPL hydrolysis probe (Roche) for the amplicon sequence (Table 1).,Non-OADS,/arxiv_data1/oa_pdf/46/15/ypg-23-153.PMC4206381.pdf
"Where possible, intron-spanning gene-specific primers were designed (Table 1) and screened in silico for specificity using the UCSC genome browser BLAT ( http://genome.ucsc.edu/cgi-bin/ hgBlat?command = start ).",OADS,/arxiv_data1/oa_pdf/46/15/ypg-23-153.PMC4206381.pdf
Raw and normalized data are available at: http://www.ncbi.nlm.nih.gov/projects/geo/ query/acc.cgi?acc = GSE6512 .,OADS,/arxiv_data1/oa_pdf/46/15/ypg-23-153.PMC4206381.pdf
"The mean comparisons of treatment groups are notsignificantly different for AGTRAP ,P2YR1 ,GALR2 , HTR1A , and HTR7 genes at any time point ( P> 0.05).Clozapine expression profiles in the mouse brain The full Affymetrix array list of gene mRNA expression inthe mouse brain following a 12-week chronic treat- ment with clozapine or vehicle can be downloaded from http://www.ucl.ac.uk/ ˜rejuhxg/ClozHalStudy/ .",Non-OADS,/arxiv_data1/oa_pdf/46/15/ypg-23-153.PMC4206381.pdf
(http://www.pancreatic.org/).,Non-OADS,/arxiv_data1/oa_pdf/f4/e4/mpa-43-153.PMC4206385.pdf
"At the time, the Hirshberg family viewed pancreatic cancer as the ‘‘unknown enemy’’ (http://www.pancreatic.org/site/c.htJYJ8MPIwE/b.8276835/k.66CB/Agi_Hirshbergs_Story.htm).",Non-OADS,/arxiv_data1/oa_pdf/f4/e4/mpa-43-153.PMC4206385.pdf
http://creativecommons.org/licenses/by-nc-nd/3.0.,Non-OADS,/arxiv_data1/oa_pdf/f4/e4/mpa-43-153.PMC4206385.pdf
Video highlights of the seed grant re- cipients’ presentations are posted on the Foundation’ s Web site(http://www.pancreatic.org/site /c.htJYJ8MPIwE/b.8867159/ k.A425/APAScientific_Symposium_2013.htm).,Non-OADS,/arxiv_data1/oa_pdf/f4/e4/mpa-43-153.PMC4206385.pdf
Available at: http://www.cancer.gov/cancertopics/types/pancreatic.,Non-OADS,/arxiv_data1/oa_pdf/f4/e4/mpa-43-153.PMC4206385.pdf
Available at:http://www.pancreatic.org/site/c.htJYJ8MPIwE/b.6068067/k.D0E8/Foundation_Mission_Statement.htm.,Non-OADS,/arxiv_data1/oa_pdf/f4/e4/mpa-43-153.PMC4206385.pdf
"Available at: http://www.pancreatic.org/.Accessed August 28, 2013.",Non-OADS,/arxiv_data1/oa_pdf/f4/e4/mpa-43-153.PMC4206385.pdf
Funding by Cancer Type [National Cancer Institute Office of Budget and Finance Website] Available at: http://budgettool.cancer.gov/budget-spending/funding-by-cancer-type/fiscal-year-2003.aspx?e=&d=Ascending&v=Total.,Non-OADS,/arxiv_data1/oa_pdf/f4/e4/mpa-43-153.PMC4206385.pdf
http://creativecommons.org/licenses/by-nc-nd/3.0.,Non-OADS,/arxiv_data1/oa_pdf/af/6e/mpa-43-526.PMC4206386.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/91/bb/ndt-10-1973.PMC4206387.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 1973–1978Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1973OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/NDT .S6978 4clozapine-induced seizures, electroencephalography  abnormalities, and clinical responses in Japanese  patients with schizophrenia Yuka sugawara Kikuchi Wataru sato Keiichiro ataka Kiwamu Yagisawa Yuki Omori Takashi Kanbayashi T etsuo shimizu Department of Neuropsychiatry,   akita University graduate school  of Medicine, hondo, akita, JapanPurpose:  We describe electroencephalography (EEG) abnormalities and seizures associated with  clozapine treatment in Japanese patients with schizophrenia and retrospectively compare EEG results  and total Positive and Negative Syndrome Scale (PANSS [T]) scores before and after treatment.",Non-OADS,/arxiv_data1/oa_pdf/91/bb/ndt-10-1973.PMC4206387.pdf
"The poor  tolerance criterion is defined as a failure to adequately respond to monotherapy with at  least two atypical antipsychotics (eg, risperidone perospirone, olanzapine, quetiapine,  and aripiprazole) due to failure to increase the dose to a necessary level for any of the correspondence: Yuka sugawara Kikuchi Department of Neuropsychiatry, akita  University graduate school of Medicine,  1-1-1 hondo, akita 010-8543, Japan Tel +81 18 884 6122 Fax +81 18 884 6445 email yuka@med.akita-u.ac.j p Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2014 Volume: 10 Running head verso: Kikuchi et al Running head recto: Clozapine use in patients with schizophrenia DOI: http://dx.doi.org/10.2147/NDT.S69784",Non-OADS,/arxiv_data1/oa_pdf/91/bb/ndt-10-1973.PMC4206387.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/91/bb/ndt-10-1973.PMC4206387.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/91/bb/ndt-10-1973.PMC4206387.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/83/f9/ott-7-1891.PMC4206388.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOncoTargets and Therapy 2014:7 1891–1899OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1891Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S6781 2a survival analysis comparing women   with ovarian low-grade serous carcinoma   to those with high-grade histology Ming chen1 Ying Jin1 Yalan Bi2 Jie Yin1 Y ongxue Wang1 lingya Pan1 1Department of Obstetrics and  gynecology, Peking Union Medical  college hospital, chinese academy  of Medical sciences and Peking Union  Medical college, Beijing, People’s  republic of china; 2Department of  Pathology, Peking Union Medical  college hospital, chinese academy  of Medical sciences and Peking Union  Medical college, Beijing, People’s  republic of china correspondence: lingya Pan   Department of Obstetrics   and gynecology, Peking Union Medical   college hospital, chinese academy   of Medical sciences and Peking Union   Medical college, 1 shuai Fu Yuan,   Wang Fu Jing street, Beijing 100730,   People’s republic of china   Tel +86 10 6529 6218   Fax +86 10 6512 4875   email panly@pumch.c nAbstract:  Ovarian low-grade serous carcinoma (LGSC) and high-grade serous carcinoma have  distinct molecular profiles, clinical behaviors, and treatment responses.",Non-OADS,/arxiv_data1/oa_pdf/83/f9/ott-7-1891.PMC4206388.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/83/f9/ott-7-1891.PMC4206388.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/83/f9/ott-7-1891.PMC4206388.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4c/ba/jmdh-7-479.PMC4206389.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Multidisciplinary Healthcare 2014:7 479–488Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  479Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/JMDH.S6674 6extended roles for allied health professionals:   an updated systematic review of the evidence Robyn L Saxon1–3 Marion A Gray1,2 Florin i Oprescu1,2 1School of Health and Sports Sciences,   Faculty of Science, Health, education  and engineering,  2Cluster for Health  improvement, University of the  Sunshine Coast, Sippy Downs, QLD,   3Queensland Health, Brisbane, QLD,   Australia Correspondence: Robyn Saxon   Queensland Health, PO Box  547,  Nambour, QLD  4560, Australia   Tel +61 07 5470 6729  Fax +61 07 5470 6766  email r obyn.",Non-OADS,/arxiv_data1/oa_pdf/4c/ba/jmdh-7-479.PMC4206389.pdf
Available from; http://www.aihw.gov.au/publication- detail/?id=10737418329&tab =1.,OADS,/arxiv_data1/oa_pdf/4c/ba/jmdh-7-479.PMC4206389.pdf
Available from: http://www.nets.,Non-OADS,/arxiv_data1/oa_pdf/4c/ba/jmdh-7-479.PMC4206389.pdf
Available from: http://www.nets.nihr.,OADS,/arxiv_data1/oa_pdf/4c/ba/jmdh-7-479.PMC4206389.pdf
Available from: http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/4c/ba/jmdh-7-479.PMC4206389.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/4c/ba/jmdh-7-479.PMC4206389.pdf
Visit http://www.dove - press.com/testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4c/ba/jmdh-7-479.PMC4206389.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c6/9f/ndt-10-1965.PMC4206390.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 1965–1972Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1965OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/NDT .S7178 5cortisol levels and sleep patterns in infants  with orofacial clefts undergoing surgery andreas a Mueller1,2 Nadeem Kalak3 Katja schwenzer- Zimmerer1,2 edith holsboer-Trachsler3 serge Brand3,4 1craniomaxillofacial surgery,   University of Basel and University  hospital of Basel, Basel, switzerland;   2hightech research center of  craniomaxillofacial surgery,   University of Basel, Basel, switzerland;   3Psychiatric clinics of the University  of Basel, center for affective,   stress, and sleep Disorders, Basel,   switzerland; 4Department of sport  and health science, Division of sport  science, University of Basel, Basel,   switzerlandBackground:  Traumatic events during early infancy might damage infants’ psychobiological  functioning, such as sleep and cortisol secretion.",Non-OADS,/arxiv_data1/oa_pdf/c6/9f/ndt-10-1965.PMC4206390.pdf
"However, infants’ sleep schedules and cortisol secretion evolve over the first  12 months of life.correspondence: serge Brand Psychiatric clinics of the University of  Basel, center for affective, stress and  sleep Disorders, Wilhelm Klein-strasse  27, 4027 Basel, switzerland Tel +4161 325 51 14 Fax +4161 325 55 53  email serge.brand@upkbs.c h Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2014 Volume: 10 Running head verso: Mueller et al Running head recto: Orofacial clefts, sleep, and cortisol DOI: http://dx.doi.org/10.2147/NDT.S71785",Non-OADS,/arxiv_data1/oa_pdf/c6/9f/ndt-10-1965.PMC4206390.pdf
Available from: http://www.eurocat- network.eu.,Non-OADS,/arxiv_data1/oa_pdf/c6/9f/ndt-10-1965.PMC4206390.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/c6/9f/ndt-10-1965.PMC4206390.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c6/9f/ndt-10-1965.PMC4206390.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b8/b2/ndt-10-1961.PMC4206392.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 1961–1964Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1961Case repor Topen access to scientific and medical research open access Full T ext article http: //dx.doi.org/ 10.2147/NDT .S6903 9Neuropsychiatric symptoms and celiac disease Małgorzata Urban- Kowalczyk1 Janusz Śmigielski2 Agnieszka Gmitrowicz3 1affective and psychotic Disorders  Department, Medical University  of Łódź, Łódź, Poland; 2Department  of Geriatric Medicine Medical  University of Łódź, Łódź, Poland;   3Department of adolescent psychiatry,   Medical University of Łódź, Łódź,   polandBackground:  Neuropsychiatric symptoms may represent an atypical manifestation of celiac  disease that occur before a gastroenterological diagnosis is made.",Non-OADS,/arxiv_data1/oa_pdf/b8/b2/ndt-10-1961.PMC4206392.pdf
"The patient Correspondence: Małgorzata Urban- Kowalczyk affective and psychotic Disorders  Department, Medical University of Łódź,  Czechosłowacka 8/10, 92-216 Łódź,  poland Tel +48 42 675 7371 email malgorzata.urban1@wp.p l Journal name: Neuropsychiatric Disease and Treatment Article Designation: Case report Y ear: 2014 Volume: 10 Running head verso: Urban-Kowalczyk et al Running head recto: Celiac disease and depression DOI: http://dx.doi.org/10.2147/NDT.S69039",Non-OADS,/arxiv_data1/oa_pdf/b8/b2/ndt-10-1961.PMC4206392.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/b8/b2/ndt-10-1961.PMC4206392.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b8/b2/ndt-10-1961.PMC4206392.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ba/ea/ott-7-1875.PMC4206393.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOncoTargets and Therapy 2014:7 1875–1881OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1875Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S6652 5second-line docetaxel-based chemotherapy after  failure of fluorouracil-based first-line treatment  for advanced esophageal squamous cell carcinoma Zhengbo song Yiping Zhang Department of chemotherapy,   Zhejiang cancer hospital, hangzhou,   People’s republic of china correspondence: Yiping Zhang   Department of Medical Oncology,  Zhejiang cancer hospital, 38 guangji  road 310022, hangzhou, People’s  republic of china   Tel +865 718 812 2188   Fax +865 718 812 2182   email zjzlyy16@163.co mPurpose:  This retrospective analysis evaluates the clinical efﬁcacy and toxicity of second-line  docetaxel-based chemotherapy after failure of fluorouracil-based ﬁrst-line treatment for advanced  esophageal squamous cell carcinoma (ESCC).",Non-OADS,/arxiv_data1/oa_pdf/ba/ea/ott-7-1875.PMC4206393.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ba/ea/ott-7-1875.PMC4206393.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ba/ea/ott-7-1875.PMC4206393.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fb/51/ijn-9-4785.PMC4206394.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 4785–4794International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4785OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S6191 0cross-linked polyethylenimine–tripolyphosphate  nanoparticles for gene delivery Xianzhang huang1 sujing shen2 Zhanfeng Zhang1 Junhua Zhuang1 1Department of laboratory science,   second affiliated hospital   of guangzhou University of chinese  Medicine, 2Department of laboratory  science, guangdong second Provincial  Traditional chinese Medicine hospital,   guangzhou, People’s republic   of china correspondence: Xianzhang huang   Department of laboratory science,  Second Affiliated Hospital of Guangzhou  University of chinese Medicine, 111 Dade  road, guangzhou, guangdong 510120,  People’s republic of china   T el/fax +86 20 8188 7233 ext 32 908   email huangxz020@163.co mAbstract:  The high transfection efficiency of polyethylenimine (PEI) makes it an attractive  potential nonviral genetic vector for gene delivery and therapy.",Non-OADS,/arxiv_data1/oa_pdf/fb/51/ijn-9-4785.PMC4206394.pdf
To minimize the  cationic charge on PEI and Journal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Huang et al Running head recto: PEI-TPP NPs for gene delivery DOI: http://dx.doi.org/10.2147/IJN.S61910,Non-OADS,/arxiv_data1/oa_pdf/fb/51/ijn-9-4785.PMC4206394.pdf
"International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/fb/51/ijn-9-4785.PMC4206394.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s 4794huang et al 12.,Non-OADS,/arxiv_data1/oa_pdf/fb/51/ijn-9-4785.PMC4206394.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/11/3b/jbm-5-191.PMC4206399.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Blood Medicine 2014:5 191–206Journal of Blood Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  191Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/JBM.S4529 5Optimal management of hereditary   hemorrhagic telangiectasia Neetika Garg1 Monica Khunger2 Arjun Gupta3 Nilay Kumar4 1Department of Medicine, Beth israel  Deaconess Medical Center, Boston,   MA, USA;  2Department of Medicine,   All india institute of Medical Sciences,   New Delhi, india;  3Department of  Medicine, UT Southwestern Medical  Center, Dallas, TX, USA;  4Department  of Medicine, Cambridge Health  Alliance/Harvard Medical School,   Cambridge, MA, USA Correspondence: Nilay Kumar   Department of Medicine, Cambridge  Health Alliance/Harvard Medical School,   1493 Cambridge St, Cambridge, MA, USA   Tel +1 205 540 1971  Fax +1 617 665 1976  email nilaykumar83@gmail.co mAbstract:  Hereditary hemorrhagic telangiectasia (HHT), also known by the eponym  Osler–Weber–Rendu syndrome, is a group of related disorders inherited in an autosomal domi - nant fashion and characterized by the development of arteriovenous malformations (A VM) in the  skin, mucous membranes, and/or internal organs such as brain, lungs, and liver.",Non-OADS,/arxiv_data1/oa_pdf/11/3b/jbm-5-191.PMC4206399.pdf
Available from:  http://arup.utah.edu/database/HHT /.,OADS,/arxiv_data1/oa_pdf/11/3b/jbm-5-191.PMC4206399.pdf
Available from: http://www.hht.org/living-with-hht/ genetic-testing /.,Non-OADS,/arxiv_data1/oa_pdf/11/3b/jbm-5-191.PMC4206399.pdf
"Journal of Blood Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/Journal-of-blood-medicine-journa lThe Journal of Blood Medicine is an international, peer-reviewed, open  access, online journal publishing laboratory, experimental and clinical aspects  of all topics pertaining to blood based medicine including but not limited to:  Transfusion Medicine; Blood collection, Donor issues, Transmittable diseases,  and Blood banking logistics; Immunohematology; Artificial and alternative blood based therapeutics; Hematology; Biotechnology/nanotechnology of  blood related medicine; Legal aspects of blood medicine; Historical perspec - tives.",Non-OADS,/arxiv_data1/oa_pdf/11/3b/jbm-5-191.PMC4206399.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/11/3b/jbm-5-191.PMC4206399.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4c/b0/nss-6-113.PMC4206400.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pNature and Science of Sleep 2014:6 113–122Nature and Science of Sleep Dove press submit your manuscript | www.dovepress.co m Dove press  113ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NSS.S7115 9Performance evaluation of an automated single- channel sleep–wake detection algorithm Richard F Kaplan1 Ying Wang1 Kenneth A Loparo1,2 Monica R Kelly3 Richard R Bootzin3 1General Sleep Corporation, Euclid,   OH, USA;  2Department of Electrical  Engineering and Computer Science,   Case Western Reserve University,   Cleveland, OH, USA;  3Department  of Psychology, University of Arizona,   T ucson, AZ, USA Correspondence: Richard F Kaplan   General Sleep Corporation,   26250 Euclid Avenue, Suite  709,   Euclid, OH  44132, USA   Tel +1 216 289 2331  Fax +1 216 393 0079  Email k aplan@ general sleep.co mBackground:  A need exists, from both a clinical and a research standpoint, for objective  sleep measurement systems that are both easy to use and can accurately assess sleep and wake.",Non-OADS,/arxiv_data1/oa_pdf/4c/b0/nss-6-113.PMC4206400.pdf
"Nature and Science of Sleep Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/nature-and-science-of-sleep-journa lNature and Science of Sleep is an international, peer-reviewed, open  access journal covering all aspects of sleep science and sleep medicine,  including the neurophysiology and functions of sleep, the genetics of  sleep, sleep and society, biological rhythms, dreaming, sleep disorders and  therapy, and strategies to optimize healthy sleep.",Non-OADS,/arxiv_data1/oa_pdf/4c/b0/nss-6-113.PMC4206400.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4c/b0/nss-6-113.PMC4206400.pdf
"Available from: http://www.asahq.org/Home/ For-Members/Clinical-Information/ASA-Physical-Status-Classifica - tion-Syste m. Accessed September 9, 2014.",Non-OADS,/arxiv_data1/oa_pdf/4c/b0/nss-6-113.PMC4206400.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e4/02/ndt-10-1953.PMC4206401.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 1953–1959Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1953OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S6829 7Tardive dyskinesia in a south asian population  with first episode psychosis treated  with antipsychotics Usman U adam  Nusrat husain Peter M haddad Tariq Munshi Fauzia Tariq Farooq Naeem imran B chaudhryBackground:  Tardive dyskinesia (TD) is a side effect of antipsychotic treatment that  often only appears after months or years of treatment.,Non-OADS,/arxiv_data1/oa_pdf/e4/02/ndt-10-1953.PMC4206401.pdf
"Second- generation antipsychotics (SGAs)  were specifically developed and marketed as hav - ing a lower risk of EPS.2 However, the Clinical Antipsychotic Trials of Intervention  Effectiveness (CATIE) study3 showed no significant difference in the incidence of  Parkinsonism, dystonia, akathisia, or tardive dyskinesia (TD) between patients treated correspondence: Tariq Munshi Department of Psychiatry, Queen’s  University, 385 Princess street, Kingston,  Ontario K7l1B9, canada Tel +1 613 5441356 Fax +1 613 5442162 email munshit@providencecare.c a Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2014 Volume: 10 Running head verso: Adam et al Running head recto: Tardive dyskinesia in a South Asian population DOI: http://dx.doi.org/10.2147/NDT.S68297",Non-OADS,/arxiv_data1/oa_pdf/e4/02/ndt-10-1953.PMC4206401.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/e4/02/ndt-10-1953.PMC4206401.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e4/02/ndt-10-1953.PMC4206401.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6e/3e/opth-8-2105.PMC4206402.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 2105–2113Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2105Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/OPTH.S6676 0Optical bench performance of acrysof®   iQ resTOr®, aT lisa® tri, and FineVision®  intraocular lenses Daniel Carson1 Warren e hill2 Xin hong1 Mutlu Karakelle1 1alcon research, ltd., Fort Worth,   TX, Usa; 2east Valley Ophthalmology,   Mesa, aZ, Usa  Correspondence: Warren e hill   east Valley Ophthalmology, 5620 e  Broadway road, Mesa, aZ 85206, Usa   T el +1 480 981 6111   Fax +1 480 985 2426   email hill@doctor-hill.co m Journal name: Clinical Ophthalmology Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Carson et al Running head recto: Optical bench performance of four multifocal IOLs DOI: http://dx.doi.org/10.2147/OPTH.S66760 Purpose:  To compare the resolution and optical quality of the ReSTOR® +3.0 D and  ReSTOR +2.5 D multifocal intraocular lenses (IOLs) with the AT LISA® tri and FineVision®  trifocal IOLs.",Non-OADS,/arxiv_data1/oa_pdf/6e/3e/opth-8-2105.PMC4206402.pdf
Available from: http://bmctoday.net/ crstodayeurope/pdfs/0312_supp.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6e/3e/opth-8-2105.PMC4206402.pdf
Available from: http://www.aao.org/publications/ eyenet/201205/feature.cfm.,Non-OADS,/arxiv_data1/oa_pdf/6e/3e/opth-8-2105.PMC4206402.pdf
Available from: http://www.alconsurgical.co.za/acrysof-iq-restor-2-5- d-iol.aspx.,Non-OADS,/arxiv_data1/oa_pdf/6e/3e/opth-8-2105.PMC4206402.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/6e/3e/opth-8-2105.PMC4206402.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 2113Optical bench performance of four multifocal iOls  18.,Non-OADS,/arxiv_data1/oa_pdf/6e/3e/opth-8-2105.PMC4206402.pdf
Available from: http://meditec.zeiss.com/content/ dam/  Meditec/downloads/pdf/ESCRS/czm_AT LISA.pdf.,OADS,/arxiv_data1/oa_pdf/6e/3e/opth-8-2105.PMC4206402.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0b/c9/ppa-8-1383.PMC4206524.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 1383–1392Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1383ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S6821 3CoCo trial: Color-coded blood pressure Control,  a randomized controlled study Corinne Chmiel Oliver Senn Thomas Rosemann Valerio Del Prete Claudia Steurer-Stey  Institute of General Practice and  Health Services Research, University  of Zurich, Zürich, SwitzerlandBackground:  Inadequate blood pressure (BP) control is a frequent challenge in general practice.",Non-OADS,/arxiv_data1/oa_pdf/0b/c9/ppa-8-1383.PMC4206524.pdf
"Home BP measurement (HBPM) is an important skill for patients to monitor  their disease and has been consistently recommended in  hypertension guidelines.6,7 Y et Correspondence: Corinne Chmiel Institute of General Practice and Health  Services Research, University of Zurich,  Pestalozzistrasse 24, 8091 Zürich,  Switzerland Tel +41 04 4255 9855   Fax +41 04 4255 90 97  Email corinne.chmiel@usz.c h Journal name: Patient Preference and Adherence Article Designation: ORIGINAL RESEARCH Y ear: 2014 Volume: 8 Running head verso: Chmiel et al Running head recto: CoCo trial DOI: http://dx.doi.org/10.2147/PPA.S68213",Non-OADS,/arxiv_data1/oa_pdf/0b/c9/ppa-8-1383.PMC4206524.pdf
Available from http://www.bfs.admin.ch/bfs/portal/de/index/ themen/14/02/01/key/02.html.,Non-OADS,/arxiv_data1/oa_pdf/0b/c9/ppa-8-1383.PMC4206524.pdf
Available from http://www.nice.org.uk/ guidance/cg127.,Non-OADS,/arxiv_data1/oa_pdf/0b/c9/ppa-8-1383.PMC4206524.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/0b/c9/ppa-8-1383.PMC4206524.pdf
"Merozoites realeased from hepatocytes infect red blood cells, producing the clinical manifestation of the malaria (please see http://www.cdc.gov/malaria/about/biology/ for more details).",Non-OADS,/arxiv_data1/oa_pdf/1a/75/auto-10-1487.PMC4206529.pdf
Besides the ATG8 *Correspondence to: Noboru Mizushima; Email: nmizu@m.u-tokyo.ac.jp Submitted: 02/28/2014; Revised: 07/26/2014; Accepted: 07/28/2014; Published Online: 08/04/2014http://dx.doi.org/10.4161/auto.32183ATG8 localization in apicomplexan parasites Apicoplast and more?,Non-OADS,/arxiv_data1/oa_pdf/1a/75/auto-10-1487.PMC4206529.pdf
Nat Cell Biol 2010; 12:831- 5; PMID:20811355 ; http://dx.doi.org/10.1038/ ncb0910-831 2.,OADS,/arxiv_data1/oa_pdf/1a/75/auto-10-1487.PMC4206529.pdf
Dev Cell 2008; 15:344-57; PMID:18804433 ;  http://dx.doi.org/10.1016/j.devcel.2008.08.012 5.,OADS,/arxiv_data1/oa_pdf/1a/75/auto-10-1487.PMC4206529.pdf
Cell 2011; 147:728-41;  PMID:22078875 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1a/75/auto-10-1487.PMC4206529.pdf
Nature 2011; 469:323- 35; PMID:21248839 ; http://dx.doi.org/10.1038/ nature09782 7.,Non-OADS,/arxiv_data1/oa_pdf/1a/75/auto-10-1487.PMC4206529.pdf
Nat Rev Mol Cell Biol  2009; 10:458-67;  PMID:19491929 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1a/75/auto-10-1487.PMC4206529.pdf
Genes Cells 2007; 12:209-18;  PMID:17295840 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1a/75/auto-10-1487.PMC4206529.pdf
Autophagy 2007; 3:106-16; PMID:17204848 ;  http://dx.doi.org/10.4161/auto.359510.,Non-OADS,/arxiv_data1/oa_pdf/1a/75/auto-10-1487.PMC4206529.pdf
Autophagy 2011; 7:127- 58; PMID:20962583 ; http://dx.doi.org/10.4161/ auto.7.2.13310 11.,Non-OADS,/arxiv_data1/oa_pdf/1a/75/auto-10-1487.PMC4206529.pdf
Biochem Soc Trans  2010; 38:775-82;  PMID:20491664 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1a/75/auto-10-1487.PMC4206529.pdf
Cell Mol Life Sci 2011; 68:1285-96; PMID:21380560 ; http://dx.doi.org/10.1007/ s00018-011-0646-1 13.,OADS,/arxiv_data1/oa_pdf/1a/75/auto-10-1487.PMC4206529.pdf
PLoS One  2012; 7:e42977;  PMID:22900071 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1a/75/auto-10-1487.PMC4206529.pdf
Autophagy 2014; 10:80-92; PMID:24275162 ; http://dx.doi.org/10.4161/ auto.26743 15.,Non-OADS,/arxiv_data1/oa_pdf/1a/75/auto-10-1487.PMC4206529.pdf
J Cell Biol 2000; 151:263- 76; PMID:11038174 ; http://dx.doi.org/10.1083/ jcb.151.2.26317.,OADS,/arxiv_data1/oa_pdf/1a/75/auto-10-1487.PMC4206529.pdf
EMBO J 2000; 19:5720-8; PMID:11060023 ; http://dx.doi.org/10.1093/ emboj/19.21.5720 19.,Non-OADS,/arxiv_data1/oa_pdf/1a/75/auto-10-1487.PMC4206529.pdf
Nature 2000;  408:488-92;  PMID:11100732 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1a/75/auto-10-1487.PMC4206529.pdf
Autophagy 2014; 10:269- 84; PMID:24342964 ; http://dx.doi.org/10.4161/ auto.27166 21.,Non-OADS,/arxiv_data1/oa_pdf/1a/75/auto-10-1487.PMC4206529.pdf
PLoS One 2013; 8:e79059; PMID:24278114 ;  http://dx.doi.org/10.1371/journal.pone.0079059 22.,Non-OADS,/arxiv_data1/oa_pdf/1a/75/auto-10-1487.PMC4206529.pdf
J Struct Biol 2012; 180:551-62; PMID:22982544 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1a/75/auto-10-1487.PMC4206529.pdf
Autophagy  2013; 9:568-80;  PMID:23388496 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1a/75/auto-10-1487.PMC4206529.pdf
PLoS One 2013; 8:e67047;  PMID:23825614 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1a/75/auto-10-1487.PMC4206529.pdf
Autophagy 2013; 9:1540-52; PMID:24025672 ; http://dx.doi.org/10.4161/ auto.25832 26.,Non-OADS,/arxiv_data1/oa_pdf/1a/75/auto-10-1487.PMC4206529.pdf
Trends Parasitol 2012; 28:358-64;  PMID:22819059 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1a/75/auto-10-1487.PMC4206529.pdf
PLoS One 2012; 7:e42107;  PMID:22848721 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1a/75/auto-10-1487.PMC4206529.pdf
Autophagy  2013; 9:1334-48;  PMID:23748741 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1a/75/auto-10-1487.PMC4206529.pdf
Autophagy 2010; 6:764- 76; PMID:20639694 ; http://dx.doi.org/10.4161/ auto.6.6.12709 30.,Non-OADS,/arxiv_data1/oa_pdf/1a/75/auto-10-1487.PMC4206529.pdf
Eukaryot Cell 2010; 9:1519-30; PMID:20709789 ; http://dx.doi.org/10.1128/ EC.00124-1031.,Non-OADS,/arxiv_data1/oa_pdf/1a/75/auto-10-1487.PMC4206529.pdf
J Biol Chem 2010;  285:10850-61;  PMID:20123989 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1a/75/auto-10-1487.PMC4206529.pdf
Cell  Microbiol 2012; 14:589-607; PMID:22212386 ;  http://dx.doi.org/10.1111/j.1462-5822.2011.01745.x 33.,Non-OADS,/arxiv_data1/oa_pdf/1a/75/auto-10-1487.PMC4206529.pdf
Mol Microbiol  2010; 76:1358-75;  PMID:20398214 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1a/75/auto-10-1487.PMC4206529.pdf
Mol Microbiol  2010; 76:1340-57;  PMID:20444089 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1a/75/auto-10-1487.PMC4206529.pdf
Mol Biol Cell 2008; 19:668-81; PMID:18077553 ;  http://dx.doi.org/10.1091/mbc.E07-08-0826 36.,Non-OADS,/arxiv_data1/oa_pdf/1a/75/auto-10-1487.PMC4206529.pdf
Autophagy 2011; 7:1423-33; PMID:22024743 ;  http://dx.doi.org/10.4161/auto.7.12.18027 38.,Non-OADS,/arxiv_data1/oa_pdf/1a/75/auto-10-1487.PMC4206529.pdf
Curr Opin Cell Biol 2010; 22:132-9;  PMID:20056399 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1a/75/auto-10-1487.PMC4206529.pdf
Cell 2010; 140:313- 26; PMID:20144757 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1a/75/auto-10-1487.PMC4206529.pdf
Autophagy 2012; 8:445- 544; PMID:22966490 ; http://dx.doi.org/10.4161/ auto.19496 42.,Non-OADS,/arxiv_data1/oa_pdf/1a/75/auto-10-1487.PMC4206529.pdf
Eukaryot Cell 2009; 8:1146-54;  PMID:19502580 ; http://dx.doi.org/10.1128/ EC.00061-09 43.,Non-OADS,/arxiv_data1/oa_pdf/1a/75/auto-10-1487.PMC4206529.pdf
Eukaryot Cell  2009; 8:1134-45;  PMID:19502583 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1a/75/auto-10-1487.PMC4206529.pdf
Trends Cell Biol  2012; 22:374-80;  PMID:22608991 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1a/75/auto-10-1487.PMC4206529.pdf
Traffic 2013; 14:1029-41; PMID:23837619 ; http://dx.doi.org/10.1111/ tra.12091 46.,OADS,/arxiv_data1/oa_pdf/1a/75/auto-10-1487.PMC4206529.pdf
EMBO Rep 2013;  14:143-51;  PMID:23337627 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1a/75/auto-10-1487.PMC4206529.pdf
"9-11 *Correspondence to: Christopher HK Cheng; Email: chkcheng@cuhk.edu.hk Submitted: 06/02/2013; Revised: 04/12/2014; Accepted: 05/08/2014; Published Online: 06/19/2014http://dx.doi.org/10.4161/auto.29164Silencing of EEF2K (eukaryotic elongation factor-2  kinase) reveals AMPK-ULK1-dependent autophagy  in colon cancer cells chuan-Ming Xie,1, † Xiao-Yu Liu,1, † Kathy WY Sham,1 Josie MY Lai,1 and c hristopher h K cheng1, 2,* 1School of Biomedical Sciences; The c hinese University of h ong Kong; h ong Kong, c hina; 2center of Novel Functional Molecules; The c hinese University of h ong Kong;   hong Kong, c hina †These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/fe/38/auto-10-1495.PMC4206530.pdf
Proc Natl Acad Sci U S A 1985; 82:7939- 43; PMID:3906654 ; http://dx.doi.org/10.1073/ pnas.82.23.7939 2.,OADS,/arxiv_data1/oa_pdf/fe/38/auto-10-1495.PMC4206530.pdf
Eur J Biochem  2002 ; 269:5360 -8; PMID:12423334 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fe/38/auto-10-1495.PMC4206530.pdf
FEBS Lett  1999 ; 457:189- 92; PMID:10471776 ; http://dx.doi.org/10.1016/ S0014-5793(99)01034-0 4.,OADS,/arxiv_data1/oa_pdf/fe/38/auto-10-1495.PMC4206530.pdf
J Biol  Chem  2004 ; 279:12220 -31; PMID:14709557 ;  http://dx.doi.org/10.1074/jbc.M3097732005.,OADS,/arxiv_data1/oa_pdf/fe/38/auto-10-1495.PMC4206530.pdf
FEBS Lett  1999 ; 444:97-101;  PMID:10037155 ; http://dx.doi.org/10.1016/ S0014-5793(99)00039-3 6.,OADS,/arxiv_data1/oa_pdf/fe/38/auto-10-1495.PMC4206530.pdf
Biochem J   2001 ; 353:621-6; PMID:11171059 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fe/38/auto-10-1495.PMC4206530.pdf
Eur J Biochem 1990 ; 191:639-45; PMID:2390990 ;  http://dx.doi.org/10.1111/j.1432-1033.1990.,Non-OADS,/arxiv_data1/oa_pdf/fe/38/auto-10-1495.PMC4206530.pdf
Nature  1988 ;  334:170-3; PMID:3386756 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fe/38/auto-10-1495.PMC4206530.pdf
